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General Abstract 
INTRODUCTION: There is currently limited longitudinal data investigating the performance and 
health-related influence of ultra-endurance training and participation. Cross-sectional investigations 
have highlighted a potential for those performing most exercise to be at an increased risk of 
cardiovascular events. If such risks occur, they are likely to be due to a combination of the stress 
provided through training and events together.  
PURPOSE: To assess the development of several physiological factors associated with exercise training 
and to gain a greater insight regarding the changes in cardiac electrical conductance from endurance 
training. A sub-study sought to investigate the short and longer-term influence of an iron-distance 
triathlon on indirect measures of arterial stiffness.  
METHOD: Part 1: Seventy-six previously recreationally active participants underwent a 6 month 
endurance training programme in preparation for an iron-distance triathlon, consisting of a 3.86km 
swim, 180.25km cycle, and a 42.2km run. Multiple assessments were performed at months 0, 2, 4 and 
6; including submaximal and exhaustive cycling tests, anthropometric measurements and 12-lead 
ECG’s. Part 2: Eleven athletes from part 1 (TRI) and 10 recreational control participants (NOTRI) were 
assessed on 4 occasions with identical time intervals. Arterial stiffness and cardiovascular functional 
parameters were obtained 7 days prior (T1) to an iron-distance triathlon, 12–18 hours post-event, 7 
days post-event, and 28 days post-event.  
RESULTS: Part 1: Cardiorespiratory fitness and performance parameters increased over the training 
period, irrespective of age, with greatest improvements from month 0–2 and the least improvements 
from month 4–6. Additionally, a progressive increase was observed in the frequency of both training-
related and training-unrelated ECG findings. Part 2: A significant difference in central arterial stiffness 
was found between TRI and NOTRI 12–18 hours post-event and 7 days post-event but not prior to or 
28 days post-event. No differences were observed between groups for peripheral stiffness at any time-
point. Additionally, no time effect was observed when the TRI group were treated separately.  
CONCLUSION: Training caused significant improvements to fitness related physiological factors. In a 
minority of individuals, endurance training induced bioelectrical patterns of what is currently referred 
to as abnormal criteria, which may reflect a normal change to what was previously thought of as 
abnormal findings or, alternatively, be pathological manifestations in previously healthy individuals. 
Part 2 of this study showed a delayed central arterial stiffening may occur one day and one week 
following a single day ultra-endurance event. Importantly, all measurements were found to be similar 
one month post-event; implying only a transient exercise-induced elevation to arterial stiffness. 
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Ventricle = two main chambers of the heart 
responsible for pumping blood to the lungs (right 
ventricle) and the rest of the circulation (left 
ventricle). 
Viscoelastic = the property of a substance to exhibit 
both viscous and elastic characteristics under the 
application of temporary deformation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1 
 
 
 
 
 
 
Chapter One: Introduction     
 
 
 
 
 
 
 
 
 
Chapter One: Introduction 
2 
 
1.1 Rationale 
The ironman distance triathlon is a relatively new event which has dramatically increased in 
participation rates over recent years. The event requires participants to swim 3.86 km, cycle 180.25 
km, and run 42.2 km. The purpose of this study was to assess the wide range of physiological 
adaptations and adaptive responses occurring in humans exposed to prolonged physical endurance 
load. The implications of this study are in relation to the importance of ethical safety in regards to 
ultra-endurance exercise. 
Abundant research has highlighted the beneficial aspects of exercise in healthy and diseased 
individuals (Warburton, Nichol and Bredin, 2006), including cardiovascular (CV) health and longevity 
(Dai, Rabinovitch and Ungvari, 2012; Seals et al., 2009). However, the mechanisms underlying these 
effects are not fully known. Although moderate activity levels have received extensive praise, there is 
a necessary importance to ascertain whether excessive exercise induces harm to the human body. 
Studies have identified an increased relative risk of CV disease (CVD) in those performing most aerobic 
exercise, highlighting the possible adverse effects of exercise (Burr, et al., 2014; O’Keefe et al., 2012; 
Paffenbarger et al., 1986; Quinn et al., 1990; Schnohr, Marott, Lange & Jensen, 2013; Schnohr, 
O’Keefe, Marott, Lange & Jensen, in press). For this reason, ultra-endurance athletes may represent a 
group of individuals at an elevated risk of CV events. The majority of recent intervention studies 
suggest a purely transient reduction in cardiac health in response to a single bout of excessive 
endurance exercise (La Gerche et al., 2008; Shave et al., 2010). However, epidemiological studies 
suggest an accumulative detrimental response to long-term involvement in excessive endurance 
exercise (Lee, Pate, Lavie & Blair, 2012; O’Keefe et al., 2012). Participation rates in ultra-endurance 
events have increased greatly within recent decades (Hoffman, Ong, & Wang, 2010; Knechtle, 
Knechtle & Lepers, 2011) therefore, the need to assess the health risks associated with such events 
has become more important. Studies investigating the cardiac and vasculature responses to excessive 
endurance exercise are predominantly limited to individuals who have been competing in such events 
for a period of time previous to the study. For this reason, events may have been masked by previous 
exposure to the exercise stimuli. The purpose of this study was to investigate the CV adaptations of 
the ‘athlete’s heart’ induced by a long-term incremental endurance training programme in previously 
recreationally active individuals. 
The athletic heart is a non-pathological condition associated with normal cardiac adaptations to 
routine exercise, predominantly endurance. This concept was introduced to differentiate serious heart 
diseases from normal athletic hearts, creating a new set of parameters for those meeting the athletic 
criteria. The heart of an endurance athlete is more than likely to undergo physiological changes in 
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structure, function and electrical activity as training progresses. These changes may place the 
individual in the diagnostic ‘grey zone’, representing uncommon cardiac changes which may be caused 
by an underlying pathological disease (Baggish & Wood, 2011). In a small minority of individuals, 
endurance training may trigger a pathological cascade placing them at an increased risk of sudden 
cardiac death (SCD) during exercise (George et al., 2012). The characterisation of the athlete's heart 
has helped in the differentiation from normal adaptation of the heart and several inherited cardiac 
diseases, most prominently hypertrophic cardiomyopathy, which may predispose to SCD (Baggish & 
Wood, 2011; Drezner, 2012; Drezner et al., 2012). Providing an insight of the changes to the electrical 
activity of the heart over a long-term, high load, training programme will provide an understanding of 
normal adaptations of the ‘athletes heart’. 
Carotid to femoral (cf) PWV represents the speed at which the pressure pulse travels from the 
carotid artery site to the femoral artery site and is considered the gold standard measure of arterial 
stiffness. Stiffer arteries allow the pressure wave to travel faster through the artery. Aix is an index of 
wave reflections, representing a manifestation of systemic arterial stiffness. Larger elastic arteries 
buffer pulsations from the heart; muscular arteries can alter the speed of travel of waves, whilst 
arterioles serve as major reflecting sites. Aix changes therefore may represent an altered wave 
reflection from peripheral arteries, without changing central arterial stiffness, through adaptations in 
the muscular arteries or arterioles (Edwards and Lang, 2005). Equally, changes in PWV may represent 
an alteration in central arteries, without affecting peripheral arterial stiffness. The two measurements 
are not mutually exclusive and may differ depending on the internal adaptations occurring. 
Repetitive episodes of cyclical arterial shear stress provide a stimulus promoting vascular adaptations 
through endothelium-dependent remodelling. Longer exposure to such stimuli however may 
compromise the system mimicking disease states, inducing pro-atherosclerotic processes and 
coronary calcification in otherwise healthy individuals (Möhlenkamp et al., 2008).  Studies 
investigating the cardiac and vasculature adaptations/responses to excessive endurance training and 
ultra-endurance bouts are predominantly limited to individuals who have been training and 
competing in such events for a period of time previous to the study. For this reason, subsequent 
effects of aforementioned events may have been masked by previous exposure to the exercise stimuli. 
Evaluating these responses in individuals who are unexposed to ultra-endurance events may give a 
greater insight as to whether these transient changes are associated with tissue damage or are 
potentially adaptive processes, and further, what the long-term consequences might be. On the other 
hand, It has been hypothesised that the detrimental responses may in fact be mitigated in ultra-
endurance athletes as a result of exercise-induced adaptations i.e. antioxidant defence and 
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attenuated reactive oxygen species (ROS) production and overall greater care for protecting their 
bodies (Knez, Coombes & Jenkins, 2006). The results of this study will provide evidence as to whether 
a single bout of ultra-endurance exercise influences the vascular system. This evidence will contribute 
to the ethical standpoint as to the safety of participating in such events for the general population. 
 
1.2 Aims 
The general aim of this study was to assess several cardiovascular-related physiological changes 
occurring over a 6 month progressively incremental training period with reference to normal 
adaptations. Additionally it was sought to investigate the incidence of training-related and unrelated 
electrocardiographic (ECG) findings in response to endurance training. A secondary general aim was 
to investigate athletic status, as well as the acute and longer term effects of a long-distance triathlon 
on markers of arterial stiffness in a subgroup of participants. 
 
1.3 Objectives 
 Measure physiological variables every 2 months for a 6 month period. 
o Perform multi-stage submaximal cycling tests and measure lactate threshold. 
o Perform exhaustive cycling test and measure maximal volume of oxygen consumption 
(V̊O2max), maximal power output, maximal heart rate (HRmax). 
o Measure body fat (BF) with use of bioelectrical impedance assessment equipment. 
o Measure resting 12-lead ECG activity. 
 Obtain training diary information and produce training load assessments for individuals. 
 Identify training-related and training-unrelated 12-lead ECG findings. 
 Measure arterial stiffness markers in a control population of recreationally active individuals. 
 Measure arterial stiffness markers before and after long-distance triathlon in trained 
population. 
 
1.4 Hypotheses 
1.4.1 Study 1: Part 1 
H0: Endurance training will not result in a statistically significant (p < 0.05) change to base variables: i) 
V̊O2max, ii) lactate threshold and iii) maximal cycling power production. 
H1: Endurance training will result in a statistically significant (p < 0.05) increase to base variables: i) 
V̊O2max, ii) lactate threshold and iii) maximal cycling power production. 
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H0: Endurance training will not result in a statistically significant (p < 0.05) difference to variables: i) 
HRmax and ii) BF percentage. 
H2: Endurance training will statistically significantly (p < 0.05) decrease to variables: i) HRmax and ii) BF 
percentage. 
1.4.2 Study 1: Part 2 
H0: Endurance training will not result in a statistically significant (p < 0.05) difference in ECG variables: 
i) rHR, ii) QRS axis, iii) P wave axis, iv) T wave axis, v) QTc interval.  
H3: There will be a statistically significant (p < 0.05) change in ECG variables: i) rHR, ii) QRS axis, iii) P 
wave axis, iv) T wave axis, v) QTc interval. 
H0: Endurance training will not result in a change in the frequency of individuals showing: i) group 1 
abnormal, training-unrelated ECG findings and ii) group 2, training-related ECG findings.  
H4: Endurance training will result in a change in the frequency of individuals showing: i) group 1 
abnormal, training-unrelated ECG findings and ii) group 2, training-related ECG findings. 
H0: Endurance training will not result in a change in the frequency of findings from i) group 1 abnormal, 
training-unrelated ECG criteria and ii) group 2, training-related ECG criteria. 
H5: Endurance training will result in a change in the frequency findings from i) group 1 abnormal, 
training-unrelated ECG criteria and ii) group 2, training-related ECG criteria. 
1.4.3 Study 2 
H0: There will be no statistically significant (p < 0.05) differences in arterial stiffness variables: i) PWV 
ii) Aix and iii) Aix@HR75, at any time-points between TRI and NOTRI groups. 
H6: There will be a statistically significant (p < 0.05) difference in arterial stiffness variables: i) PWV ii) 
Aix and iii) Aix@HR75, at one or more time-points between TRI and NOTRI groups.  
H0: There will be no statistically significant (p < 0.05) difference in cardiovascular variables: i) rHR, ii) 
aSBP, iii) aDBP and iv) LVED, at one or more time-points between TRI and NOTRI conditions. 
H7: There will be a statistically significant (p < 0.05) difference in cardiovascular variables: i) rHR, ii) 
aSBP, iii) aDBP and iv) LVED, at one or more time-points between TRI and NOTRI conditions. 
H0: There will be no statistically significant (p < 0.05) differences in arterial stiffness variables: i) PWV 
ii) Aix and iii) Aix@HR75 between any time-points in TRI participants only. 
H8: There will be a statistically significant (p < 0.05) difference in arterial stiffness variables: i) PWV ii) 
Aix and iii) Aix@HR75 between any time-points in TRI participants only. 
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H0: There will be no statistically significant (p < 0.05) difference in cardiovascular variables: i) rHR, ii) 
aSBP, iii) aDBP and iv) LVED, between time-points in TRI participants only. 
H9: There will be a statistically significant (p < 0.05) difference in cardiovascular variables: i) rHR, ii) 
aSBP, iii) aDBP and iv) LVED, between time-points in TRI participants only. 
H0: There will be no statistically significant (p < 0.05) differences between S and NS groups for urinary 
variables: i) lipid peroxide concentration, ii) 8-hydroxydeoxyguanosine concentration, iii) glutathione 
requirement scores. 
H10: There will be statistically significant (p < 0.05) differences between S and NS groups for urinary 
variables: i) lipid peroxide concentration, ii) 8-hydroxydeoxyguanosine concentration, iii) glutathione 
requirement scores. 
H0: There will be no statistically significant (p < 0.05) differences in arterial stiffness variables: i) PWV 
ii) Aix and iii) Aix@HR75 at any time-point between S and NS groups. 
H11: There will be a statistically significant (p < 0.05) difference in arterial stiffness variables: i) PWV ii) 
Aix and iii) Aix@HR75 at one or more time-points between S and NS groups. 
H0: There will be no statistically significant (p < 0.05) difference in cardiovascular variables: i) rHR, ii) 
aSBP, iii) aDBP and iv) LVED, at one or more time-points between S and NS groups. 
H12: There will be a statistically significant (p < 0.05) difference in cardiovascular variables: i) rHR, ii) 
aSBP, iii) aDBP and iv) LVED, at one or more time-points between TRI and NOTRI conditions. 
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2.1 Study 1 
2.1.1 Background: Ultra-Endurance Exercise and the Associated Changes 
Ultra-endurance events have become increasingly popular in recent years throughout the world 
(Knechtle, Knechtle & Lepers, 2011; Hoffman, Ong, & Wang, 2010). Long-distance triathlons represent 
one type of ultra-endurance sport, which consist of three components: swimming, cycling and 
running; the iron-distance triathlon is the most popular of which, involving a 3.8km swim, 180km cycle 
and a 42.2km run (Knechtle, Knechtle & Lepers, 2011). Few longitudinal studies have investigated the 
pattern of CV and performance-related physiological adaptations, which occur in recreationally active 
individuals deciding to train for ultra-endurance events. Furthermore, the volume of exercise training, 
and the extent of training-induced adaptations, which is necessary to develop individuals to a level 
whereby they are able to complete such events is not well recognised. Improvements in this area will 
help future individuals wishing to train for ultra-endurance events monitor their progress. 
An important aspect of investigation pertains to the safety of undertaking large training volumes, and 
the risk of repeatedly competing in prolonged endurance exercise. Several cross-sectional studies 
have noticed a potential for excessive exercise to induce damaging effects on the CV system (Lee, 
Pate, Lavie & Blair, 2012; O’Keefe et al., 2012; Paffenberger et al., 1986; Schwartz et al., 2014). In a 
small minority of individuals, endurance training may trigger a pathological cascade placing them in 
an increased risk of sudden death (George et al., 2011; George et al., 2012). Advancements in the area 
of CV responses and adaptations to prolonged endurance exercise and endurance training will 
contribute to the management of athletes and the identification of at risk individuals. 
2.1.2 Endurance Exercise-Induced Physiological Adaptations 
Completing repeated exercise bouts over a period of time provides stimulus for multiple physiological 
adaptations resulting in better performance in that activity. The extent of physiological change is 
multifactorial, dependent on age, gender and genetics of individuals, as well as the specificity, dose 
and recovery period of the training schedule (Jones & Carter, 2000). Endurance exercise relies heavily 
on the aerobic energy production pathway; adequate delivery of oxygen and fuels such as 
carbohydrate and lipids are essential to success in endurance performance. As such, endurance 
training is followed by adaptations to cardiorespiratory fitness, improving oxygen delivery to 
mitochondria of cells in the body (Jones & Carter, 2000).  Habitual endurance training provides a 
stimulus for numerous physiological adaptations that facilitate improved endurance exercise capacity; 
for example, being able to sustain a submaximal workload for a longer period, or being able to attain 
a higher power output over a specified distance (Hawley, 2002). A training programme can be broken 
Chapter Two: Literature Review 
 
9 
 
down to three components, volume, intensity, and frequency of exercise sessions. Chronic exercise 
adaptations occur as a result of repeated acute signalling responses due to exercise stimulus.  
2.1.3 Performance-Related Adaptations of Endurance Training 
Multiple physiological adaptations occur with endurance training, resulting in an enhanced capacity 
to perform well. Joyner and Coyle, (2008) have provided a schematic of these interacting physiological 
factors, which combine as determinants of performance (figure 1). One such adaptation refers to the 
high proportion of type I (slow twitch) muscle fibres found in endurance athletes, which possess a 
higher capillary density and oxidative potential than type II muscle fibres (Coyle, Sidossis, Horowitz & 
Beltz, 1992). Furthermore, type I fibres are associated with a greater gross efficiency during exercise 
than type II (fast twitch) fibres (Joyner & Coyle, 2008). The capillary supply to skeletal muscle is 
increased with endurance training, resulting in a reduction in the diffusion distance for substrates and 
gaseous exchange (Hawley, 2002). Enzymatic activity of the mitochondrial electron transport chain is 
increased with endurance exercise, resulting in a greater oxidative potential (Hawley, 2002). This 
increased oxidative potential is at least in part responsible for the endurance training associated shift 
in substrate utilisation during submaximal exercise. This is demonstrated by a decreased reliance on 
plasma glucose production and oxidation, with proportional increases in fat oxidation (Jeukendrup, 
Saris & Wagenmakers, 1998; Martin et al., 1993; Venables & Jeukendrup, 2008). A reduced reliance 
on glucose as a primary fuel during exercise contributes in part to a reduction in cellular acidosis and 
increased aerobic energy production combined with increased lactate clearance (Robergs, Ghiasvand 
& Parker, 2004. A resultant outcome is a delayed lactate accumulation, which for reasons discussed 
in chapter 2.1.5, is concurrent with increased endurance performance (Faud, Kindermann & Meyer, 
2009). 
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The response to exercise is not constant throughout the population. In fact, genetic polymorphisms 
have been identified to predict the extent of adaptation to exercise of fitness variables such as V̊O2max 
(Bouchard et al., 2011; Ghosh et al., 2013). The complexity regarding responders and non-responders 
is exacerbated by the finding that individuals who show an attenuated training response in one 
parameter do not necessarily show the same low training response in other parameters (Scharhag-
Rosenberger et al., 2012; Vollaard et al., 2009). Furthermore, the contribution of different factors is 
not uniform and improved performance may occur in the absence of some factors (Gibala et al., 2006). 
2.1.4 The Importance of Cardiorespiratory Fitness and Methodologies of Tests 
V̊O2max, a measurement of the highest rate of oxygen consumption attained during maximal exercise, 
has long been associated with performance in endurance sports (Jones & Carter, 2000; Wilmore & 
Costill, 1999). Indeed, V̊O2max is the most common parameter used to demonstrate a training effect, 
and is frequently used to indicate the cardiorespiratory fitness of an individual (Bassett & Howley, 
2000). The major limitation to V̊O2max is the ability of the cardiorespiratory system to deliver oxygen 
to exercising muscles (Bassett & Howley, 2000). The rate of ATP production that can be maintained 
during exercise is dependent on V̊O2max (Bassett & Howley, 2000). As such, V̊O2max sets the upper limit 
Figure 1.  Schematic of several physiological factors interacting as determinants of performance. 
Taken from Joyner & Coyle (2008). 
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for energy production during endurance events, but does not necessarily determine performance, 
since endurance events are not competed at 100% of V̊O2max (Jones & Carter, 2000). The product of 
stroke volume and HR comprise cardiac output, the volume of blood pumped out by the heart per 
minute; it is now considered that variations in V̊O2max are primarily due to differences in stroke volume, 
since HRmax is far less varied between individuals and delivery of oxygen is primarily facilitated by this 
mechanism (Bassett & Howley, 2000). A multitude of studies have recognised that the greatest change 
in V̊O2max occurs at the beginning of a training programme, followed by smaller adaptations with  
further enhanced endurance ability, and may eventually stabilise (Hickson, Hagberg, Ehsani & 
Holloszy, 1980; Isawaki et al., 2003; Scharhag-Rosenberger, Meyer, Walitzek & Kindermann, 2009). As 
such, further improvements in performance may be attributed to further improvements in factors 
such as exercise economy and lactate threshold (Jones & Carter, 2000). 
In order to accurately measure V̊O2max an individual is usually expected to perform a graded physical 
exertion test for a sufficient duration which takes the individual to maximal effort whilst respiratory 
measurements are obtained. V̊O2max is attained when a plateau in oxygen consumption occurs. V̊O2max 
and V̊O2peak are often used interchangeably despite differences in definitions. V̊O2peak represents the 
highest value of V̊O2 attained during a test. However, this value is determined independent of the 
athlete’s effort, and so does not always reflect the highest value which is attainable by the individual 
(Day, Rossitier, Coat, Skasick & Whipp, 2003). Corroborative indices are used to ascertain whether a 
value reflects a sufficient effort given by the individual to produce an accurate V̊O2max. These include 
a maximum heart rate (HR) greater than 90% predicted; a respiratory exchange ratio above 1.10 and 
a blood lactate level greater than 8mmol·L-1 (Midgley, McNaughton, Polman & Marchant, 2007). A 
study by Astorino (2009) found sampling interval to largely affect the corresponding V̊O2max values. 
Sampling intervals of 60 seconds appeared to reduce the incidence of V̊O2 plateau independent of 
fitness status as demonstrated by previous research (Astorino et al., 2000; Doherty, Nobbs & Noakes, 
2003; Lucia et al., 2006). 
Despite heavy criticisms to the current V̊O2max determination criteria (Midgley et al., 2007), an 
improved uniform set of criteria have not been validated. In contrast, Day et al. (2003) suggest that a 
plateau in oxygen consumption is not an essential prerequisite for ascertaining V̊O2max in maximal 
effort incremental ramp tests. In this study of 71 individuals, V̊O2peak attained from a ramp test did not 
differ from the plateau in the plot of V̊O2 vs work rate (in constant-load tests). It is of particular 
importance that various studies have identified that V̊O2 plateaus are rarely attained during ramp style 
maximal effort protocols (Day et al., 2003; Duncan, Howley & Johnson, 1997; Howley et al., 1995; 
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Rossiter, Kowalchuk & Whipp, 2005). Lactate threshold may be a firmer index of functional status than 
V̊O2max, since it is not confounded by the participant’s subjective effort (Faud et al., 2009). 
2.1.5 The Use of Lactate Threshold as a Functional Assessment of Endurance Performance 
As mentioned previously, exercise training can induce a change to the numbers and proportions of 
type I and II skeletal muscle fibres and also the detailed properties of individual muscle fibres (Coyle 
et al., 1992; Hawley, 2002). Changes in lactate accumulation occur secondary to this (Brooks, 2007; 
Joyner & Coyle, 2008). Endurance training can increase lactate clearance and reduce lactate 
production (Bergman et al., 1999). Since lactate production coincides with cellular acidosis, reducing 
its accumulation is associated with a delayed active muscular fatigue (Robergs et al., 2004). Hydrogen 
(H+) is produced during ATP break down, and used during mitochondrial respiration for energy 
production (Robergs et al., 2004). In the mitochondria, H+ molecules accumulate at high exercise 
intensities, where there is a shift towards a greater reliance on anaerobic respiration. In order to 
prevent acidosis and pyruvate accumulation, H+ binds with pyruvate to form lactate, providing an 
energy source during recovery from exercise and regenerating NAD+. The coenzyme NAD+ is needed 
for glycolysis during anaerobic metabolism (Robergs et al., 2004).  
Along with V̊O2max, the submaximal exercise intensity at the point by which blood lactate increases 
above resting levels is a strong predictor of endurance performance (Jones & Carter, 2000). An 
increased power output at lactate threshold allows a greater exercise intensity to be sustained in the 
absence of blood lactate accumulation. Blood lactate accumulation is concurrent with more rapid 
fatigue, due to the effects of metabolic acidosis on contractile function or depletion of muscle 
glycogen (Jones & Carter 2000; Robergs et al., 2004).  
2.1.6 Health-Related Cardiovascular Adaptations of Endurance Training 
Abundant research has highlighted the beneficial aspects of exercise in healthy and diseased 
individuals (Warburton, Nichol and Bedin, 2006), including CV health and longevity (Dai, Rabinovitch 
and Ungvari, 2012; Seals et al., 2009). However, the mechanisms underlying these effects are not fully 
known. Increasing training volume and hence haemodynamic demand, influences the loading 
conditions of the heart and may provide sufficient stimulus for morphological changes to the heart.   
2.1.6.1 Endurance Athlete’s Heart 
The athletic heart is a non-pathological condition associated with normal cardiac adaptations to 
routine exercise, which in current perspective predominantly relates to endurance type training 
(Scharhag, Löllgen & Kindermann, 2013). Training-induced adaptations to the heart include enlarged 
LV and RV volumes, increased LV wall thickness and cardiac mass. At least five hours of endurance 
training per week is suggested to be necessary to elicit dimensional changes to the heart (Scharhag, 
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2013). This concept was introduced to differentiate serious heart diseases from normal athletic hearts.  
New parameters have been set for those meeting the athletic criteria (Drezner et al., 2012). Normal 
training-related ECG findings and abnormal, training-unrelated findings are displayed in table 1. The 
heart of an endurance athlete is more than likely to undergo physiological changes in structure, 
function and electrical activity as training progresses. These changes may place the individual in the 
diagnostic ‘grey zone’, providing difficulty in the diagnosis of underlying pathological disease (Baggish 
& Wood, 2011). For the most part, these adaptations represent normal physiological adaptation, 
however accumulating evidence suggests that some of the remodelling may not be entirely benign 
(Ector et al., 2007, O’Keefe et al., 2012). The characterisation of the athlete's heart has helped in the 
differentiation from normal adaptation of the heart and several inherited cardiac diseases, most 
prominently hypertrophic cardiomyopathy, which may predispose to SCD (Baggish & Wood, 2011; 
Drezner, 2012; Drezner et al., 2012). Nevertheless, in a minority of individuals endurance training may 
trigger a pathological cascade, placing them in an increased risk of SCD (George et al., 2012). Providing 
an insight of the changes to the electrical activity of the heart over a long-term, high load, training 
programme will provide an understanding of normal adaptations of the ‘athletes heart’. 
 
Table 1. Group 1, abnormal training-unrelated and group 2, training-related ECG findings in athletes, adapted 
from Drezner et al. (2012).  
ECG finding Description 
Group 1 Abnormal, Training-
Unrelated 
 
T Wave inversion > 1 mm in depth from baseline in 2 or more adjacent leads not including 
aVR or V1 
ST segment depression ≥ 1 mm in depth in 2 or more adjacent leads 
Pathological Q waves > 3 mm  in depth or > 0.04s in duration in 2 or more leads 
Complete left bundle branch block QRS > 120 ms, predominantly negative QRS complex in lead V1, and 
upright monophasic R wave in leads I and V6 
Complete right bundle branch 
block 
QRS > 120 ms, terminal R wave in lead V1, and wide terminal S wave in 
leads I and V6 
Intraventricular conduction delay Non-specific QRS > 120 ms 
Left atrial enlargement Prolonged P wave duration > 120ms in leads I or II with negative portion 
of the wave ≥ 1 mm in depth and ≥ 0.04s in duration in lead V1 
Left axis deviation QRS axis -30° to -90° 
Right atrial enlargement P wave ≥ 2.5 mm in leads II and III or V1 
Right ventricular hypertrophy Right QRS axis deviation ≥ 120° or voltage criteria > 10.5 mm (R in V1 + 
S in V5) 
Mobitz type II 2° AV block Intermittently non-conducted P waves not preceded by PR prolongation 
and not followed by PR shortening 
3° AV block Complete heart block 
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Ventricular pre-excitation PR interval < 0.12 s with a delta wave 
Long QT interval QTc ≥ 470 ms (male) 
QTc ≥ 480 ms (female) 
QTc ≥ 500 ms (unequivocal LQTS) 
Short QT interval QTc ≤ 340 ms 
Epsilon wave Small negative deflection just beyond the QRS in V1 or V2 
Profound sinus bradycardia Resting heart rate < 30 beats·min-1 
Atrial tachyarrhythmias Supraventricular tachycardia, atrial-fibrillation, atrial flutter 
Premature ventricular 
contractions 
≥ 2 per tracing 
Ventricular arrhythmias Couplets, triplets or non-sustained ventricular tachycardia 
Group 2 Common, Training-
Related 
 
Sinus bradycardia Resting heart rate < 60 beats·min-1 
First degree AV block PR interval > 200 ms 
Early repolarisation J point 0.1 mV above isoelectric line in limb leads and 0.2 mV in 
precordial leads 
Incomplete right bundle branch 
block 
QRS duration > 100 ms and < 120 ms, terminal R wave in V1 & slurred S 
wave in leads I and V6 
Isolated QRS voltage criteria for 
left ventricular hypertrophy  
Sokolow-Lyon criteria > 3.5 mV (S in V1 + greatest R wave in V5 or V6) 
Note: Isolated QRS voltage criteria for LVH does not involve non-voltage criteria for LVH such as left axis 
deviation, a ‘strain’ pattern of repolarisation, ST-segment depression, T-wave inversion, or pathological Q 
waves). Criteria for early repolarisation is one of many among literature and so results for which should be 
taken with caution. 
 
2.1.6.2 Cardiovascular Risk and Possible Exercise-Induced Myocardial Injury 
Although moderate activity levels have received extensive praise, there is a necessary importance to 
ascertain whether excessive exercise induces harm to the human body. Some studies have found an 
increased relative risk of CV disease in those performing most aerobic exercise, highlighting the 
possible adverse effects of exercise (Burr, et al., 2014; O’Keefe et al., 2012; Paffenbarger et al., 1986; 
Quinn et al., 1990; Schnohr, Marott, Lange & Jensen, 2013; Schnohr, O’Keefe, Marott, Lange & Jensen, 
in press). In the recent Copenhagen City Heart Study, a large scale longitudinal study, researchers 
observed a U-shaped curve for mortality risk relating to jogging quantity, frequency and speed 
(Schnohr et al., 2013). For this reason, ultra-endurance athletes may represent a group of individuals 
at an elevated risk of CV events. The majority of recent intervention studies suggest a purely transient 
reduction in cardiac health in response to a single bout of excessive endurance exercise (La Gerche et 
al., 2008; Shave et al. 2002; Shave et al., 2010). For example, Shave et al. (2002) found evidence of 
elevated cardiospecific biomarker cardiac troponin (cTn) T above the 99th percentile of 0.01 µg/L, but 
not above the clinical threshold for myocardial infarction of 0.1 µg/L, as a result of prolonged 
endurance exercise in 13 participants (50%). Additionally, systolic and diastolic cardiac dysfunction 
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following prolonged exercise is a common finding, which usually resolves shortly (~1 week) after 
participation (La Gerche et al., 2008; La Gerche et al., 2012). However, several epidemiological studies 
suggest an accumulative detrimental response to long-term involvement in excessive endurance 
exercise (Lee, Pate, Lavie & Blair, 2012; O’Keefe et al., 2012).  
Several studies have reported elevations to myocardial injury biomarkers after endurance exercise, 
and it is now considered a common outcome with higher intensities and lesser athletic status (Neilan 
et al., 2006; Scherr et al., 2013; Shave et al., 2007; Shave et al., 2010). Two theories exist regarding 
the importance of post-endurance exercise elevations in cardiac injury biomarkers. Biomarkers such 
as creatine kinase and cTn used to determine cardiomyocite damage remain controversial due to the 
kinetics of release. cTn appears rapidly in the bloodstream and likewise are cleared rapidly, opposing 
from the sustained release occurring with acute myocardial infarction. Some suggest this release may 
in fact represent normal adaptive physiological processes (Neumayr 2005; Shave et al., 2007). Normal 
physiologic skeletal muscle adaptation is preceded by protein breakdown, perhaps exercise-induced 
cardiac hypertrophy follows a similar adaptive process. The first hypothesis therefore is that 
myocardial injury provides a physiological stimulus for adaptation, leading to both an enhanced 
structure and function (Whyte, 2003). Contrasting this is the hypothesis that the observed myocardial 
damage is followed by scarring and fibrosis and increased risk of arrhythmogenic presentations 
(Whyte, 2003). Furthermore, the injury is suspected to become permanent as a result of inadequate 
recovery time between exercise bouts (Rowe, 1992). The postulation that exercise-induced 
myocardial injury leads to a deleterious and pathological process in the heart is supported by a limited 
number of studies.  
There appears to be contrasting views regarding chronic training and CV health. On the one hand, 
those with the greatest endurance experience elicit the least cardiac damage biomarker response to 
prolonged exercise (Neilan et al., 2006; Shave et al., 2007). However, those training most (≥4 
times/week, >2/2.5h/week) show greatest signs of reduced CV health compared with those training 
less (≤3 times/week, <1h) (O’Keefe et al., 2012; Schnohr et al., 2013; Schwartz et al., 2014). The 
reduction in biomarker release in experienced endurance athletes could be explained by greater 
myocardial scarring replacing normal cardiac tissue. Additionally, the potential for exercise-induced 
damage appears to increase with middle age and above (O’Keefe et al., 2012). Wen et al. (2011) found 
health benefits to accrue dose-dependently until around an hour per day of high intensity exercise, 
whereby further endurance training resulted in a much reduced benefit to all-cause mortality (figure 
2). O’Keefe et al. (2012) have interpreted this data to show there exists a dose of exercise beyond 
which further CV benefits are not yielded. It has been suggested that exercise shares the same 
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principle as other factors, such as sleep and calorie intake, in that “just because some is good, more is 
not always better” (O’Keefe, Schnohr & Lavie, 2013, p.588). 
 
 
In further support of the potentially accumulative damaging impact of endurance exercise, recent 
studies have observed increases in myocardial scarring in older-aged endurance athletes. Breuckmann 
et al. (2009) found a 3-fold increase in patchy myocardial scarring in older age long-distance runners 
compared with age-matched controls. Similarly, Wilson et al., (2011) observed a high prevalence of 
patchy myocardial fibrosis of 50% of 12 lifelong veteran endurance athletes. No cases of cardiac 
fibrosis were found for age-matched controls and younger endurance athletes, indicating a link 
between habitual endurance exercise and myocardial fibrosis. 
2.1.7 Endurance Training-Related Changes to the Cardiac Electrical Conductance  
High endurance sports such as cycling, rowing, and cross country skiing have been shown to be 
significantly associated with a higher frequency and greater extent of ECG changes such as sinus 
bradycardia and increased QRS voltages compared to strength and speed type sports (Pellicia et al., 
2000). ECG changes in athletes usually reflect electrical and structural remodelling as an adaptation 
to habitual exercise. This is likely to be related to the large cardiac output acquired during endurance 
training resulting in cardiac remodelling involving in part the LV and RV dimensions and wall thickness 
Figure 2. Relationship between volume and intensity of physical activity and all-cause mortality. 
Taken from Wen et al. (2011). 
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(Maron & Pelliccia, 2006; Scharhag et al., 2002). For this reason, different ECG criteria are now used 
to identify underlying CVD in athletes compared to non-athletes. The changes associated with athletes 
are split into training-unrelated (group 1) and training-related (group 2) ECG changes (Drezner, 2012). 
Table 1 identifies these different criteria. 
Recent investigation has found that training-unrelated ECG findings were more common in elite 
endurance trained athletes than non-endurance athletes (Brosnan et al., 2014). Right ventricular 
hypertrophy (RVH) (4.4% vs. 1.5%) and T wave inversion, particularly right precordial (14.3% vs. 4.7%), 
were most prevalent in endurance athletes. Importantly, cardiac imaging did not identify features of 
arrhythmogenic RV cardiomyopathy. This finding is supportive of non-pathological cardiac 
bioelectrical abnormalities in a small cohort of individuals, induced by endurance training. 
2.1.7.1 Group 1 Training-Unrelated ECG Findings 
2.1.7.1.1 Profound Sinus Bradycardia 
Profound sinus bradycardia, defined as a rHR below 30 beats·min-1, occurs in some highly trained 
athletes without the presence of pathological condition. However, this condition should be 
distinguished from sinoatrial dysfunction. Corrado (2010) notes the clarification can be made if: (i) 
there is an absence of dizziness or syncope, (ii) HR normalises during exercise with preservation of 
HRmax, (iii) bradycardia reverses with detraining. 
2.1.7.1.2 Left Atrial Enlargement 
Left atrial enlargement (LAE) is currently considered an uncommon finding in athletes, which is 
prevalent in around 10-21% of HCM patients (Drezner et al., 2013). LAE is defined as a P wave duration 
> 120 ms in leads I and II with a negative portion ≥ 0.1 mV in depth and longer than 40 ms in V1. The 
clinical significance of left atrial remodelling in athletes has been questioned. Pelliccia et al. (2005) 
observed a relatively common (20%) prevalence of LAE in competitive athletes, largely without clinical 
consequence. Recently, Gati et al. (2013) found that of the 13% of group 2 changes present in 14 to 
35 year olds, 42.6% were comprised of isolated left axis deviation (LAD) together with isolated LAE. 
Furthermore, echocardiographic evaluation failed to identify any structural or functional 
abnormalities of the 579 athletes displaying these patterns. Exclusion of isolated LAD and LAE 
improved specificity from 90-94% and only reduced sensitivity by 1.5%. LAE is unlikely to uncover 
underlying heart disease in competitive athletes and although current consensus recommends follow-
up investigation, doing so may be unnecessary. 
2.1.7.1.3 Right Atrial Enlargement and Right Ventricular Hypertrophy 
Right atrial enlargement (RAE) and RV hypertrophy (RVH) are uncommon findings in athletes. A 
prevalence of 0.08% in athletes has been reported for RAE (P wave axis >70°) and 0.6% for right axis 
deviation (QRS axis >110°) (Pelliccia et al., 2000). Other investigators use a high P wave ≥ 0.25mV in 
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leads I and II or V1 to identify RAE (Drezner, 2012; Drezner et al., 2013). Sokolow-Lyon voltage criteria 
for RVH (R in VI + S in V5 ≥ 1.5 mV) identified just one of 172 professional soccer players, representing 
a prevalence of 0.6% (Sumauroo, Pyatt, Jackson, Perry and Ramsdale, 2001). According to Corrado et 
al. (2010) RAE and RVH do not represent a manifestation of exercise-induced cardiac remodelling. 
Instead, Corrado et al. (2010) suggested that underlying heart diseases associated with increased right 
atrial size and pathological RV dilation or hypertrophy should be excluded. Indeed, recent 
investigations have recognised the effects of prolonged endurance exercise on RV function after acute 
exercise and the enlarged RV dimensions resulting from endurance training (La Gerche, Connelly, 
Mooney, Maclsaac & Prior, 2007; Predel, 2014; Scharhag et al., 2002; Scharhag, Löllgen & Kindermann, 
2013).  
2.1.7.1.4 ST-Segment Depression 
ST-segment depression (≥ 0.1mV depression of ST segment below isoelectric line in two or more 
adjacent leads) is usually associated with T wave inversion, therefore true incidence rates are 
obscured (Corrado et al., 2010). In any case, this ECG pattern is a rare occurrence indicative of 
underlying heart disease. In a resting ECG, ST-segment depression should prompt follow-up 
investigation to eliminate the existence of heart disease (Drezner, 2012). 
2.1.7.1.5 T-wave Inversion 
One of the most pertinent and easily recognisable ECG patterns for a potential CVD is T-wave 
inversion. T wave inversion > 0.1 mV in two or more adjacent leads (excluding aVR and V1) is a 
common finding with HCM, and uncommon in healthy athletes (Drezner 2012, Drezner et al., 2013). 
The prevalence of T-wave inversion is similar among sedentary individuals and elite athletes and has 
been identified in around 2.7% and 4.4% of individuals (Pelliccia et al., 2000; Sharma et al., 1999). 
Discrepancy exists regarding the criteria for this ECG pattern, with some clinicians recommending 
0.1mV inversions and some using 0.2mV criteria. Additionally, the location of the pattern, for example 
the leads associated with the pattern, is frequently different among different investigators (Corrado 
et al., 2010; Drezner, 2012; Pelliccia et al., 2000; Sharma et al., 1999). As with ST segment elevation, 
it is common for healthy Afrocaribbean athletes to develop a T-wave inversion in V2 to V4, 
representing normal early repolarisation changes (Corrado et al., 2010). 
2.1.7.1.6 Intraventricular Conduction Delays 
Intraventricular conduction delay, identified as a non-specific QRS duration ≥ 120 ms, is an uncommon 
finding affecting less than 2% of athletes and may represent a serious underlying CVD (Corrado et al., 
2010). Likewise, LBBB and RBBB patterns have low incidence rates, identified in 1% and 0.8% of highly 
trained athletes (Pelliccia et al., 2006). Intraventricular delay is likely to occur in the myocardium 
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whereas bundle branch block may develop due to a degenerative lesion of the conducting tissue, or 
from various cardiac pathologies (Corrado et al., 2010). 
2.1.7.1.7 Ventricular Pre-Excitation  
Ventricular pre-excitation (PR interval < 120 ms with a delta wave, slurred upstroke in the QRS 
complex) is another condition unrelated to training status. The prevalence of this ECG pattern in 
athletes and the general population is around 0.1% to 0.3% and most individuals are without 
symptoms (Corrado et al 2010). The condition occurs due to early activation of the ventricles resulting 
from impulses bypassing the AV node via an accessory pathway (Kulig & Koplan, 2010). 
2.1.7.1.8 QT Interval 
The duration of the QT interval (the beginning of the QRS complex and the end of the T-wave) is 
influenced by HR, therefore calculations can be made to create a QT duration which is corrected for 
HR (QTc). Bazett’s formula is considered the standard method of correcting for HR (QTc = QT/√RR). 
However, corrections are not advised for HR below 40 and above 120 beats·min-1 due to accuracy 
issues, which can be problematic for athletic individuals with sinus bradycardia (Corrado et al., 2010).  
A QTc interval is considered long when it exceeds 470 ms in males and 480 ms in females. An individual 
presenting a QTc interval exceeding 500 ms is considered to have unequivocal long-QT syndrome 
(Drezner, 2012). Usually, athletes will have longer QTc intervals than less active controls due to the 
extent of sinus bradycardia and sinus arrhythmia. Transient causes associated with prolonged QTc 
include metabolic changes and electrolyte disorders; therefore stringent assessment of nutritional 
intake should be undertaken prior to conclusions being made (Corrado et al., 2010). 
Short-QT syndrome (QTc < 380 ms) is an inheritable ion-channel disease characterised by short cardiac 
repolarisation (Drezner, 2012). Rapid cardiac repolarisation predisposes individuals to life threatening 
atrial and ventricular fibrillation in the absence of structural disease (Corrado et al., 2010). Transient 
QT shortening may be caused by hypercalcaemia, hyperkalaemia, hyperthermia, acidosis, and some 
drugs. As with long QT interval, alternative assessments should be conducted to account for these 
confounding factors prior to making assumptions.  
2.1.7.1.9 Axis Deviation 
The QRS axis represents the average direction in which the excitatory process spreads throughout the 
myocardium. Likewise vectors are obtained for the P and T waves. QRS axis deviation alone is not a 
specific finding of pathological condition, but should warrant further investigation as an abnormal 
finding in athletes (Drezner, 2012). Normal QRS axis is age dependent until 8 years old. At birth there 
is a right axis deviation which progressively shifts leftward to reach normal adult ranges. Thereafter 
QRS axis remains stable dependent of conductive tissue abnormalities apparent with older age 
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(Humes, 2014). As mentioned previously, LAD without structural or functional abnormalities is not as 
infrequent as formerly thought (Gati et al., 2013). Therefore the inclusion of such patterns as 
uncommon training-unrelated warranting further investigation is disputed and potentially unjustified. 
2.1.7.2 Group 2 Training-Related ECG Findings 
2.1.7.2.1 Sinus Bradycardia 
Resting sinus bradycardia, defined as a resting heart rate (rHR) less than 60 beats·min-1, is a common 
finding in athletes reported in up to 91% of endurance athletes (Drezner, 2012; Thompson, 2007). 
Sinus bradycardia is suggested to reflect the level of athletic condition (Corrado et al., 2010). The 
mechanisms underlying this adaptation are multifactorial including the autonomic nervous system, 
sinoatrial remodelling, cardiac hypertrophy, baroreflex resetting and genetic predispositions (Corrado 
et al., 2010; Matelot, Schnell, Kervio, Du Boullay & Carré, 2013). Alterations to HRmax with endurance 
training likely involve similar mechanisms (Zavorsky, 2000). 
2.1.7.2.3 First-Degree and Mobitz Type I Second-Degree Atrioventricular Block 
First degree and Mobitz type I second-degree AV block are common findings in athletes, displayed in 
around 35% and 10% of athletes respectively (Corrado et al., 2010; Drezner, 2012). As with sinus 
bradycardia, up regulated parasympathetic tone and down regulated resting sympathetic tone largely 
mediates the slowing and block of AV electrical conduction (Corrado et al., 2010). 
2.1.7.2.4 Isolated Voltage Criteria for Left Ventricular Hypertrophy 
Morphologic cardiac changes including increased wall thickness and ventricular mass, associated with 
athletic conditioning, are reflected in the 12-lead ECG. Isolated increases of QRS amplitude (normal 
QRS axis, normal ST-segment and T wave repolarisation) are the usual product of LV Hypertrophy 
(LVH) of trained individuals. Isolated QRS amplitude assessed by the Sokolow-Lyon voltage criteria (S 
wave in V1 + maximal R wave in V5 or V6 > 3.5mV), accounted for around 60% of the abnormal ECG’s 
in elite Italian athletes (Pellicia et al., 2000). In this study 40% of 1005 athletes ECG’s were considered 
abnormal. Non-voltage ECG criteria for LVH such as atrial enlargement or left axis deviation, are 
normally absent in healthy athletes. On the other hand, an isolated increase of QRS voltage is an 
uncommon finding in hypertrophic cardiomyopathy (HCM) patients. 
2.1.7.2.5 Incomplete Right Bundle Branch Block 
Incomplete right bundle branch block (RBBB) is another adaptation which is highly associated with 
athletes, in particular those with an endurance type background (Drezner, 2012). This finding is 
identified by ECG criteria of a QRS duration <120 ms, with an RSR pattern in V1, V2 or V3 (figure 3). 
Studies estimate the prevalence of incomplete RBBB to range from 35-50% in athletes compared with 
less than 10% prevalence in healthy controls (Corrado et al., 2010). Arrhythmogenic RV 
cardiomyopathy (ARVC), a life threatening condition, is suspected when incomplete RBBB is 
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accompanied with (i) T-wave inversion included in leads V3 and V4, or (ii) premature ventricular beats 
with left bundle branch block (LBBB) morphology. 
 
 
 
 
 
 
 
2.1.7.2.6 Early Repolarisation 
Early repolarisation, defined as an elevation of the QRS-ST junction (J-point) of at least 0.1 mV from 
baseline accompanied by slurring of the terminal QRS complex. The early repolarisation pattern is 
generally considered a benign ECG finding in athletes, being prevalent in around 50-80% of athletic 
individuals (Corrado et al., 2010). This ECG finding is more frequent during resting conditions and 
disappears with deconditioning, reflecting the hypervagotonia induced by exercise training (Corrado 
et al., 2010). With individuals of Afrocaribbean descent, the presence of an elevated ST-segment with 
T-wave inversion in V2-V4 is often a benign finding. 
2.1.8 Sudden Cardiac Death and Exercise 
Over the last few decades, participation in endurance and ultra-endurance events has risen 
considerably. SCD in endurance sports is very rare, with around 1 event for every 100,000 marathon 
participants (Lee, Pate, Lavie & Blair, 2012; O’Keefe et al., 2012). The 12-lead ECG has a greater clinical 
success for identifying asymptomatic athletes with potentially lethal heart disorders over and above 
history and physical examination (Corrado, Basso, Schiavon, Pelliccia & Thiene, 2008; Corrado & 
McKenna, 2007; Drezner, 2008; Myerburg & Vetter, 2007; Papadakis, Whyte & Sharma, 2008). Those 
athletes presenting training-unrelated abnormalities, representative of underlying heart disease, are 
at an increased risk of SCD and of developing life threatening conditions such as arrhythmias and 
fibrillations (Corrado et al., 2010). A national, state sponsored, pre-participation screening programme 
was introduced in Italy over 30 years ago as part of a legislation known as the “Medical Protection of 
Athletic Activities” law. The law states that all individuals engaged in sport must be routinely examined 
in regards to eligibility to participate in competitive sport which includes 12-lead ECG, as well as a 
history and physical examination (Pelliccia & Maron, 1995). Those with abnormalities are referred for 
further investigation including cardiac magnetic resonance imaging (cMRI) and echocardiography, and 
Figure 3. Characteristic electrocardiography tracing of an individual with incomplete right bundle 
branch block; RSR pattern in V1 and slurred S wave in V6 and QRS duration < 120 ms.  
ECG tracing is from a participant of study 1, of which details are provided in chapter four. 
V6 V1 
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those with potentially serious abnormalities are disqualified from competitive sport. The 
implementation of pre-participation screening resulted in a reduction in the incidence of SCD from 3.6 
per 100,000 person years before screening to 0.4 per 100,000 person years 25 years after 
implementation in 2003-2004 (Corrado, Basso, Pavei, Michieli, Schiavon & Thiene, 2006). The Italian 
model was assessed in a study involving 4450 elite athletes who were judged eligible for participation 
after 12-lead ECG assessment. Subsequent echocardiography was conducted to assess previously 
undetected HCM (Pelliccia et al., 2006). Over an 8 year follow-up period only one individual was 
diagnosed with definitive HCM (0.02%) indicating a high negative predictive value of a normal ECG for 
HCM. Nonetheless, false positive detection of cardiomyopathies is a concern with 12-lead ECG 
interpretation. Even experienced cardiologists, with knowledge of the exercise-induced adaptations 
similar to the phenotypic manifestations of cardiomyopathies, have found an unacceptably high rate 
of false positive results (Pelliccia et al., 2000).  
The causes of SCD resulting from physical exertion in individuals over the age of 30 commonly include 
coronary artery disease, coronary heart disease and myocardial infarction (Albano, Thompson & 
Kapur, 2012; Maron et al., 1996). Hypertophic cardiomyopathy (HCM) is responsible for a large 
proportion of SCD in young athletes under the age of 30 (Albano, Thompson & Kapur, 2012; Maron & 
Pelliccia, 2006; Pelliccia et al., 2005). An ECG is unable to identify premature coronary artery disease 
and congenital coronary anomalies, therefore alternative measurement techniques are required to 
identify those at risk, such as arterial stiffness indices.  
Emerging evidence suggests that exercise-induced cardiac remodelling may have a pathological 
component (La Gerche et al., 2010; O’Keefe et al., 2012; Wilson et al., 2011). Further study is 
warranted to determine if potentially pathological findings have any clinical impact and if any ECG 
findings may help identify the sub-population at risk of triggering this pathological remodelling 
(Weiner et al., 2011). Pre-participation screening with the use of ECG is an effective procedure in 
reducing SCD from cardiomyopathies, with a potential ethical concern regarding false positive results. 
This is a particularly effective tool for young athletes at a greater risk of SCD from cardiomyopathies. 
Coronary anomalies and premature coronary atherosclerosis are not detected by ECG and are 
responsible for a large proportion of SCD in athletes above 30 years of age. An appropriate pre-
participation tool in the older population of athletes may involve greater use of measurements 
pertaining arterial stiffness. 
Chapter Two: Literature Review 
 
23 
 
2.2 Study 2 
2.2.1 Background: Ultra-Endurance Exercise and Arterial Health 
Substantial evidence supports the concept that moderate levels of exercise are effective for the 
prevention and treatment of many common illness’ and disease states (Warburton, Nichol and Bredin, 
2006). Nevertheless, acute exercise transiently elevates the risk of SCD and CV events (Corrado, Basso, 
Rizzoli, Schiavon & Thiene, 2003); yet the associated CV changes implicated in this transient period 
are not well understood. Furthermore, repeated exposure to prolonged exercise is linked with 
accumulative detrimental indices regarding CV health (O’Keefe et al., 2012; Schwartz et al., 2014). In 
light of recent increases in participation rates in ultra-endurance events (Hoffman, Ong, & Wang, 
2010; Knechtle, Knechtle & Lepers, 2011), it is striking that we have a less than full understanding of 
the acute and long-term CV changes. 
The arterial system is comprised of a complex organisation of elastic tubes, within which the cardiac 
pump generates pressure waves, which travel through the system. The pressure difference induced 
by the wave allows blood to flow through the system, albeit at a considerably reduced transfer rate 
to the wave itself (Caro et al., 1978). Early physicists recognised that no single arterial segment shares 
identical viscoelastic properties, therefore the properties of one segment cannot be generalised for 
the whole arterial tree (Edwards & Lang, 2005; Laurent et al., 2006). Extensive progress has been made 
in recent years to develop parameters of measuring arterial properties which includes the clinical 
application of such techniques. Current practice is now at a point that clinicians can predict outcome 
and assess arterial health in different populations (Laurent et al., 2006; Mattace-Raso et al., 2006). 
Furthermore, the degree of arterial stiffening is a direct risk factor for CV events and mortality, and 
has greater significance than central blood pressures (CBP) (Laurent et al., 2006).  
Large elastic central arteries, such as the aorta, and medium sized muscular arteries, such as the 
femoral artery, have important roles as a conduit vessel and a buffer (or cushion) for blood flow 
pulsations (Nichols, O’Rourke & Vlachopoulos, 2011). There are two different concepts of these great 
vessels, that of compliance function, and that of conduit function. An artery with lower stiffness, and 
inversely greater compliance, allows for a higher pressure buffering capacity which creates a more 
efficient system during systole. Efficiency is increased due to compliant arteries attenuating energy 
loss and allowing the blood to flow more smoothly along the vessel (Davies, 2011). The most simplistic 
way to illustrate the cushioning function of arteries is to use the Windkessel model (figure 4). In this 
model, the large arteries are represented by a chamber (Windkessel) and peripheral arteries by the 
spout. The volume in the Windkessel is directly proportional to the excess pressure within it, and the 
flow rate is proportional to the pressure difference, with resistance in peripheral arteries at a constant 
(Caro et al., 1978). When the pressure in the large arteries rises during systole they expand, 
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subsequently when the pressure falls they contract to maintain a near constant flow-rate through 
peripheral vessels. This model is very simplistic since elastic properties are different throughout the 
arterial system and the model assumes that all arteries are distended simultaneously, which is not 
true. The Windkessel model has since been adapted to account for further characteristics of the 
arterial system (Westerhof, Lankhaar & Westerhof, 2009). Arterial compliance capacity may be 
augmented during moderate exercise to tolerate the increased blood flow (Kingswell et al., 1997; 
Maeda et al., 2008) or reduced after longer lasting endurance exercise (Burr et al., 2012; Vlachopoulos 
et al., 2010) and shorter eccentric exercise (Burr Boulter & Beck, in press). Reduced arterial compliance 
as a result of excessive exercise training is also not an uncommon finding (Burr et al., 2013).  
 
 
 
 
 
 
 
 
 
 
2.2.1.1 Endurance Athlete’s Artery 
The Athlete’s heart, as discussed previously (chapter 2.1.6.1), is now an accepted term to describe the 
characteristic morphology of the heart of some athletes. It is acknowledged that the heart of athletic 
individuals may develop different structural or functional characteristics as a result of exercise 
exposure (George et al., 2012). Likewise, the ‘athlete’s artery’ has been suggested as a morphologic 
development, which like the athletes heart largely refers to endurance type exercise. Green et al. 
(2012) summarise findings of several studies with interest in the development of resistance and 
conduit vessels in response to training. Longer term studies assessed in this review support the 
hypothesis that athletes possess larger arteries with reduced wall thickness than non-athletic 
counterparts, as presented in figure 5 (Rowley et al., 2011; Schmidt-Truckäss et al., 2000; Thijssen, 
Cable & Green, 2012).  Short-term studies such as Hambrecht et al. (2000) suggest adaptation of 
Figure 4. The Windkessel model of the arteries. Taken from Westerhof et al., 2008. 
The large arteries act as the Windkessel. The combination of compliance, with aortic valve function and 
peripheral resistance results in a near constant peripheral flow.  
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resistance arteries precede that of conduit vessels. Interestingly, and rather paradoxically, evidence 
suggests athletes do not possess functionally enhanced arteries (DeSouza et al 2000; Green et al 1994; 
Green et al., 2013; Rowley, Dawson, Hopman et al., 2011). It may be that whilst moderate exercise 
exposure initially improves arterial function, the response is transient before returning to baseline 
(Tinken, et al., 2010; Tinken, Thijssen, Black, Cable & Green, 2008) and furthermore is superseded by 
structural remodelling. This remodelling including increased lumen size and reduced wall thickness is 
suggested to normalise shear stress; negating the need for functional enhancement. Excessive 
exercise may induce a different arterial stress response which is not fully understood.  
 
 
 
 
 
 
 
 
 
 
2.2.1.2 The Possibility for Excessive Exercise Dose: Debate 
Recently, the health consequences of prolonged exercise on the CV system have been questioned. 
The potential of excessive exercise to elicit unfavourable CV consequences has been proposed in both 
epidemiological and intervention studies (Burr, et al., 2013; Lee, Pate, Lavie & Blair, 2012; O’Keefe et 
al., 2012; Paffenbarger et al., 1986; Quinn et al., 1990; Vlachopoulos et al., 2010). The U shaped dose-
response regarding exercise-related benefits to health/mortality in these studies represents a 
disconcerting finding. For this reason, ultra-endurance athletes may represent a group of individuals 
at an elevated risk of CV events and death. The majority of recent intervention studies suggest a purely 
transient reduction in cardiac health in response to a single bout of excessive endurance exercise (La 
Gerche et al., 2008; Shave et al., 2010). However, epidemiological studies suggest an accumulative 
detrimental response to long-term involvement in excessive endurance exercise (Lee et al., 2012; 
O’Keefe et al., 2012).  
Figure 5. Typical representation of the structural characteristics of the endurance ‘athlete’s artery’ 
adapted from Green et al. (2012). 
Athlete’s artery comprises of a larger lumen dimension and reduced wall thickness in comparison to a 
healthy non-athletic artery. It is proposed that the increase in lumen size and reduction in wall thickness 
helps to normalise shear stress and supersedes the functional responses to exercise. 
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Arterial stiffness is associated with increased CAD and CV events and can be assessed by validated and 
reproducible techniques and equipment such as the SphygmoCor apparatus (Laurent et al., 2006; 
Mancia et al., 2009). CAD accounts for a large portion of exercise-induced SCD fatalities, especially in 
individuals over the age of 35 (Albano, Thompson & Kapur, 2012; Maron & Pelliccia, 2006; Pelliccia et 
al., 2005). Despite these associations, arterial compliance changes in response to excessive training 
and exercise bouts has received very limited attention, especially when compared with literature 
pertaining to the cardiac consequences. Indirect arterial stiffness indices such as pulse wave velocity 
(PWV) and wave reflections including augmentation index (Aix) are powerful independent predictors 
of CV events and mortality (Laurent et al., 2006). In the chronic setting it has been indicated that ultra-
endurance athletes may present with elevated arterial stiffness, and therefore CV risk, than 
recreationally active individuals (Burr et al., 2014; Vlachopoulos et al., 2010). Acute responses to 
prolonged endurance exercise indicate a possibility for differential peripheral and large arterial 
stiffening immediately after exercise. Stiffness in large arteries may be increased whereas peripheral 
arteries may have a decreased stiffening response, however the time frame is not clarified and is 
suspected to be transient, as with cardiac alterations. Short-term changes in arterial stiffness involve 
sympathetic tone, oxidative stress, cellular alterations and subsequent endothelial function. Longer 
term changes in arterial stiffness involve structural remodelling regarding arteriogenesis, 
angiogenesis, and collagen and elastin contributions to vessel walls. Oxidative stress likely has a major 
role in mediating the exercise-induced adaptations. Antioxidant supplementation therefore may 
alleviate oxidative stress and subsequent responses by maintaining a normal redox balance. Due to 
the growing number of participants in ultra-endurance exercise, there is an increased need to assess 
the health risks associated with such events. This is especially true for individuals preparing for their 
first ultra-endurance event; who may be unknowingly at risk of pathological CV remodelling. 
The following review will discuss the findings of previous literature regarding the effects of differing 
volumes and intensities of exercise on markers of arterial stiffness. Additionally, mechanisms of action 
of the transient and long-term influences of exercise on arterial stiffness will be described. 
Furthermore, gold standard measuring techniques for arterial stiffness and central blood pressures 
are assessed with reference to reliability, validity and clinical applicability. 
2.2.2 Habitual Moderate Exercise and Arterial Compliance 
Habitual moderate activity has widespread benefit to the physiological systems, preventing disease, 
improving health, and improving mortality (Corrado, Migliore, Basso & Thiene 2006; Warburton, 
Nichol and Bredin, 2006). Repetitive moderate cyclic stress to the physiological system with adequate 
recovery stimulates adaptation to various systems of the body, including arterial function and 
structure. 
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Moderate aerobic exercise has been shown to increase central arterial compliance, the inverse of 
arterial stiffness, after a brief period of 3 months in healthy middle-aged men irrespective of changes 
to body weight, blood pressure (BP), cholesterol, or rHR (Tanaka et al., 2000). Conversely, in this study 
peripheral muscular arterial compliance did not change with exercise training. Therefore it may be 
that some mechanical factors interact with structural or functional mechanisms to improve arterial 
compliance. Maeda et al. (2008) provided evidence of the beneficial influence of aerobic exercise 
training on arterial compliance. It was found that systemic arterial compliance was enhanced both at 
rest and following acute exercise after 6 months of aerobic training (30 min at 80% of ventilatory 
threshold, 5 days per week). Arterial compliance was not enhanced after acute exercise alone in this 
study indicating a training-induced functional sensitivity to exercise. The authors suggest the training-
induced adaptation to arterial compliance was in response to the increased cardiac output 
experienced during exercise. The mechanism underlying the acute exercise-induced increase in 
arterial compliance in this instance was likely due to enhanced endothelial function. Acute stress 
responses are followed with accommodating, usually beneficial, adaptations to physiological systems 
chronic stress responses precede potentially detrimental remodelling and dysfunction.  
2.2.3 Participation in Ultra-Endurance Events 
Ultra-endurance athletes represent a unique cohort of the athletic population taking part in long-
term, highly demanding endurance training sessions. Ultra-endurance can be defined as exercise 
events lasting longer than 6 hours (Wortley & Islas, 2011; Zaryski & Smith, 2005); those participating 
in such events usually train between 20-40 hours each week, capable of expending over 70,000 kJ per 
week (O’Toole, Douglas & Hiller, 1989). Participation rates in ultra-endurance events has increased 
greatly within recent decades (Hoffman et al., 2010; Knechtle et al., 2011, Knez, Coombes & Jenkins, 
2006). For example, since 1978 a greater than 10-fold rise in the number of finishers of 161 km ultra-
marathon races has been observed in North American (Hoffman et al., 2010). Additionally, in 2007 
over 1700 athletes competed in the annual Hawaii ironman, which is considerably greater than the 
very first ironman triathlon in 1978 which involved 12 finishers (Lepers, 2008). 
2.2.4 Acute Effects of Endurance and Ultra-Endurance Exercise on Vasculature 
Ultra-endurance athletes may be at greater risk of CV abnormalities due to chronically increased 
physiological stress placed on the CV system (O’Keefe et al., 2012). Emerging data suggests that 
excessive endurance training may compromise vascular structure and function and may induce 
endothelial stiffening via accelerated atherosclerosis (Knez et al., 2008; Mastaloudis et al., 2001). Low 
to moderate exercise typically enhances flow mediated dilation (FMD) and endothelial function; 
however intense prolonged exercise is associated with increased oxidative stress and inflammation, 
capable of impairing NO-mediated dilation in blood vessels (Fisher-Wellman & Bloomer, 2009; Goto 
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et al., 2003; Green, Maiorana, O’Driscoll & Taylor, 2004).  Nonetheless, the acute impact of prolonged 
endurance exercise on the vascular system has not been well studied. Oxidative stress and its effects 
on the vasculature is discussed further in chapter 2.2.7.2.7. 
A single bout of prolonged endurance exercise is capable of eliciting at least transient differential 
changes in measurements of arterial stiffness depending on the regions influencing the measurement. 
Vlachopoulos et al. (2010b) present findings that a marathon race caused a significant fall in both Aix 
(12.2% vs. -5.8%, P < 0.001) and Aix@HR75 (7% vs 0.0%, p < 0.01), whereas PWV did not change 
significantly (6.66m·s-1 vs. 6.74m·s-1, p = 0.690). Burr et al. (2012) on the other hand found no 
significant difference in small artery compliance, however found a significant reduction in large artery 
compliance measured via applanation tonometry. The differential response in Aix and Aix@HR75 with 
PWV post-exercise may be indicative of enhanced peripheral artery function, but not aortic or 
large/medium artery function. This is because of the large reliance of wave reflections on peripheral 
arteries, discussed further in chapter 2.2.9.2. Whereas, reduced large artery compliance and 
indifferent small artery compliance observed by Burr et al. (2010) indicates the contrary. Both studies 
failed to elucidate the time course of the vascular response to ‘excessive’ endurance exercise 
therefore the long-term consequences of such events remain to be clarified. 
 This area remains a pertinent field of investigation since recently, only 40 minutes of downhill running 
was found to induce delayed and prolonged elevations to arterial stiffness and muscular soreness 
(Burr Boulter & Beck, in press). Measures of cfPWV and subjective muscle pain peaked 2 days post-
exercise, and remained elevated 3 days post-exercise which marked the end of the study. The 
summation of these results imply that endurance exercise may reduce peripheral arterial stiffness, 
and increase large to medium arterial stiffness. In addition, previous investigations could have 
underestimated the maximal change in stiffness by performing measurements immediately post-
exercise. Possible mechanisms regarding both transient and long-term changes in arterial stiffness in 
response to excessive exercise are discussed further in chapter 2.2.7 
Table 2. Acute effects of exercise on measures of arterial stiffness post-exercise. 
Author (Year) Participants 
(Exercise)  
Measurement 
timing 
Arterial stiffness 
measure 1 
Arterial stiffness 
measure 2 
Arterial 
stiffness 
measure 3 
Vlachopoulos, 
et al. (2010b) 
n = 20  (foot 
race, 42.2km) 
1 day pre-race 
vs. 10-15mins 
post-
marathon 
No change – PWV; 
6.66m·s-1 vs. 6.74m·s-1, 
p = 0.69 
 
Reduction – Aix; 12.2% 
vs. -5.8%, p < 0.001 
Reduction – 
Aix@HR75; 
7.0% vs. 0.0%, 
p < 0.01 
Burr et al. 
(2012) 
n = 26 (foot 
race, 120-
195km) 
1 day pre-race 
vs. 20-60mins 
post-race 
Reduction – large 
artery compliance (16.1 
± 4.4 ml/mmHgx10 vs. 
13.5 ± 3.8 ml/mmHgx10, 
p = 0.003) 
No change – small 
artery compliance (8.5 
± 3.4 mL/mmHgx100 vs. 
7.7 ± 8.2 mL/mmHgx100, 
p = 0.65). 
Increased rHR, 
reduced SV, 
reduced SBP 
and DBP 
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Burr et al. (in 
press) 
n = 12  
(40min run at -
12° gradient at 
60% V̊O2max) 
Pre vs.  
1)  Post-run 
2) 6hrs post 
3) 24hrs post 
4) 48hrs post 
5) 72hrs  post 
No change – 
PWV;  
Pre: 5.1m·s-1 vs. 
1) 5.3m·s-1 
2) 5.3m·s-1 
3) 5.4m·s-1 
Increase –  
PWV; Pre: 5.1m·s-1 vs. 
4) 5.6m·s-1 
5) 5.5 m·s-1 
No change 
Aix@HR75 
Pre: -2% vs. 
1) -0.7 
2) -1.1 
3) -1.5 
4) -0.8 
5) -1.8 
 
Aix = augmentation index, PWV = pulse wave velocity, rHR = resting heart rate, SV = stroke volume, SBP = systolic blood 
pressure, DBP = diastolic blood pressure. 
 
Short duration exercise induces an initial, acute increase in arterial stiffness determined 
measurements. Sharman et al. (2005) showed that measures of arterial stiffness were increased at 
short durations of various cycling exercise intensities. Aix and PWV were significantly and 
progressively increased due to the initiation of exercise, as was HR and systolic blood pressure (SBP). 
Although markers of arterial stiffness were increased during exercise, so too were confounding factors 
HR and SBP (Lantelme et al., 2002). Therefore one should take caution when inferring changes to 
arterial stiffness irrespective of concomitant measurement error towards other biophysical 
properties. Furthermore the training status and endurance event experience may also influence the 
CV response to prolonged exercise. Those with limited previous experience to endurance exercise 
have been shown to elicit the greatest extent of cardiac damage biomarkers and ventricular 
dysfunction post-event (Neilan, Jannuzi et al., 2006; Sahlén et al., 2009). It would therefore be 
important to investigate the arterial health of experienced and less-experienced endurance athletes 
in response to prolonged exercise. 
2.2.4.1 Summary: Acute effects of Ultra-Endurance on Arterial Stiffness 
The area of prolonged endurance exercise bouts and arterial stiffness is limited by a lack of research. 
Recent evidence indicates that endurance exercise at least transiently influences arterial stiffness 
however studies have found conflicting results regarding the direction and location of this change. 
Nonetheless it is possible that prolonged exercise reduces peripheral arterial stiffness and increases 
large to middle arterial stiffness. The larger arteries are highly compliant, therefore would be expected 
to have different properties as a feature of their role in the circulatory Windkessel model (Westerhof, 
Lankhaar & Westerhof, 2009). Further investigations are required to determine the time frame of the 
arterial response to a single bout of excessive endurance exercise.  
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2.2.5 Long-term Effects of Habitual Prolonged Exercise on Vasculature 
As mentioned previously, habitual ultra-endurance athletes may be at a greater risk of CV 
abnormalities due to the chronically increased physiological stress placed on the CV system (O’Keefe 
et al., 2012). Recent evidence suggests the large arteries may be at risk of adverse adaptation, which 
is possibly a result of elevated pro-atherogenic processes evidenced by plaque accumulation in ultra-
endurance athletes (Burr et al., 2014; Schwartz et al., 2014). In consequence, long-term prolonged 
endurance training may place individuals at an increased risk of CV events (O’Keefe et al., 2012; Quinn 
et al., 1990). 
Recent comparisons of habitual endurance athletes and recreationally active controls is presented in 
table 3. In a study by Vlachopoulos et al. (2010a) investigating marathoners and recreationally active 
controls, exercise volume (min·day-1) was an independent determinant of increased arterial stiffness 
measured via carotid-femoral PWV (6.33m·s-1 vs. 6.89m·s-1, P < 0.01). No significant difference was 
observed in Aix between the groups. However, BP (both aortic and brachial) was also higher in the 
marathon group, which has a direct influence on PWV. Burr et al. (2014) observed a reduction in large 
artery compliance in ultra-marathoners compared to physically active age-matched controls, however 
no difference was observed between small artery compliance between the groups. This finding would 
indicate that the large conduit arteries, but not smaller arteries, are at greater risk of exercise-induced 
structural remodelling which would compromise vascular health.  
In a study involving explicitly normotensive individuals, Radtke et al. (2013) observed no significant 
differences in Aix or brachial-ankle PWV between recreational, marathon, and ultra-endurance 
athletes. Hypertensive (>140/90 mmHg, n = 5) participants were excluded to avoid bias on arterial 
stiffness measures, however evidence suggests this be an expected adaptation in ultra-endurance 
athletes. Nonetheless, ultra-endurance athletes had significantly higher SBP values over 24 hours (8-
9 mmHg) confirming that ultra-endurance exercise may predispose individuals to higher BP. Isawaki 
et al. (2003) demonstrated this adaptation in a study of 11 previously sedentary participants over a 
progressive 12 month training programme. In this study, diastolic BP, systolic BP, and total peripheral 
resistance (TPR) are reduced from month 3 to month 9. However no significant difference from 
baseline was observed at month 12, where training was most intense. Since BP is reported to be a 
powerful and independent predictor of aortic PWV (Cecelja & Chowienczyk, 2009; Radtke et al., 2013) 
excluding this common adaptation may result in potentially misguided conclusions. In the studies 
analysed in table 3, half found increases to large artery stiffness with endurance training, and the 
other half presenting no difference. Additionally 1 in 4 studies presented attenuated artery stiffness 
from wave reflections, with the other studies revealing no significant differences compared with 
recreationally active controls.  
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Table 3. Chronic effects of endurance exercise on measures of arterial stiffness. 
Author (Year) Participants  Duration of 
Involvement 
Arterial 
stiffness 
measure 1 
Arterial 
stiffness 
measure 2 
Other related 
measurements 
Endurance Exercise    
Edwards et al. 
(2005) 
 
n = 16 
competitive 
endurance vs.  
16 
recreationally 
active 
Not-stated Not measured Difference – Aix 
-2.1 ± 2.1% vs. 
4.5 ± 2.9%, p < 
0.05 
V̊O2max 65 ±1.9 vs. 
49 ±1.8 
Vlachopoulos, et 
al. (2010a) 
n = 49 
marathoners 
vs. 
n = 46 
recreationally 
active 
11.6 years ± 9.1 
years 
Difference – 
PWV 
6.89m·s-1 vs. 
6.33m·s-1, p < 
0.01 
No difference – 
Aix 
13.8% vs. 13.9%, 
p = 0.34 
Marathoners had 
higher SBP, DBP, 
pulse pressure and 
mean pressures. 
  
Ultra-Endurance Exercise    
Knez et al. (2008) n = 44 ultra-
endurance vs.  
n = 44 
recreationally 
active 
6.2 ± 5.5 years 
of ultra-
endurance 
training 
Not 
measured 
No difference – 
Aix 
6 ± 12% vs. 
6 ± 13%, p > 0.05 
Exercise training 
volume related to 
central pulse 
pressure (r = -0.46, 
p = 0.002) 
 
Radtke et al. 
(2013) 
n = 16 
recreationally 
active vs. 
n = 19 
marathoners 
vs. 
n = 16 ultra-
endurance 
Lifetime 
training 
assessment 
No difference 
– between 
groups 
baPWV, p = 
0.95 
No difference – 
between groups 
CAVI, p = 0.60 
 
 
 
 
 
Burr et al. (2014)  n = 18 ultra-
marathon vs. 
18 
recreationally 
active 
10 years ± 5 
years 
Difference - 
lower large 
artery 
compliance in 
ultra-
marathon, p = 
0.03  
No difference - 
In small artery 
compliance 
Decreased 
compliance 
related to longer 
running distance 
per training 
session 
r = -0.72, p = 0.03 
Aix = aortic augmentation index, PWV = pulse wave velocity, baPWV = brachial to ankle pulse wave velocity, CAVI 
= cardio-ankle vascular index SBP = systolic blood pressure, DBP = diastolic blood pressure, V̊O2max = maximal 
volume of oxygen consumption per minute. 
 
It is well acknowledged that the risk of CV events and mortality is associated with exercise 
volume (Burr, et al., 2014; O’Keefe et al., 2012; Paffenbarger et al., 1986; Quinn et al., 1990; Schnohr, 
O’Keefe, Marott, Lange & Jensen, in press; Schwartz et al., 2014). Increasing evidence suggests more 
may not always be better in terms of exercise load. For example, accelerated coronary plaque 
development was greater in marathon runners compared with sedentary control participants in a 
study conducted by Schwartz et al. (2014). Despite a lower BMI and lesser frequency of hypertensive 
participants, the marathon group had a paradoxically larger total coronary plaque volume, including 
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calcified plaque and non-calcified plaque (figure 6). Additionally, Möhlenkamp et al. (2008) found an 
association in healthy runners between the number of completed marathons and coronary artery 
calcification (CAC). Calcium deposition reduces vessel elasticity resulting in arterial stiffening and 
increased CV risk. The mechanisms underlying this paradoxical phenomenon, whereby the beneficial 
effects of exercise are reversed, are not fully understood. Nevertheless, several hypotheses have been 
identified including; an excessive release of circulating pro-inflammatory cytokines (Neubauer and 
Konig et al., 2008), elevated oxidative stress, (Knez, Jenkins & Coombes, 2007), and an increased 
production of vasoactive substances (Otsuki et al., 2007).  
As discussed in chapter 2.1.8, exercise-induced SCD affects relatively few individuals, however 
its occurrence receives extensive publicity due to the seemingly healthy individuals at risk. Coronary 
artery disease (CAD) accounts for a large portion of SCD fatalities, especially in individuals over the 
age of 35 (Albano, Thompson & Kapur, 2012; Virmani, Burkem, Farb & Kark, 1997). Increased coronary 
plaque development and calcification increases the risk of CV events (Lafonte, 2003) and may 
represent an important underlying cause for correlations between CV events and exercise volume. 
Therefore potential elevations in arterial stiffness in habitual ultra-endurance athletes represents an 
increased risk of a CV event occurrence.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Marathon runners had significantly greater total coronary plaque volume, calcified plaque 
volume, and non-calcified plaque volume compared with sedentary control participants. Redrawn 
from Schwartz et al. (2014). 
Coronary plaque volumes were assessed using high resolution coronary computed tomographic angiography 
(CCTA) in male marathon runners (n = 50) and sedentary male control participants (n = 23). Greater levels of 
non-calcified plaque accumulation leads to a greater risk of rupture leading to thrombotic occlusion. 
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2.2.5.1 Summary: Chronic Effects of Prolonged Exercise on Arterial Stiffness 
The aforementioned studies suggest habitual prolonged endurance exercise may promote arterial 
stiffening in large and medium size conduit arteries, whilst sparing or potentially enhancing peripheral 
arterial stiffness. Furthermore, accelerated coronary plaque development and calcification supports 
the hypothesis of large arterial stiffening in endurance athletes. Lastly, long-term prolonged 
endurance training may place individuals at an increased risk of CV events. 
 
2.2.7 Proposed Mechanisms of Exercise-Induced Changes in Arterial Stiffness 
The underlying mechanisms responsible for the level of arterial stiffness in response to exercise 
involve different structural and functional processes. Usually, functional alterations such as changes 
in endothelial vasodilation occur first as a short-term adaptation, followed by subsequent structural 
remodelling. That being said the two adaptations are not mutually exclusive, for example structural 
changes such as vessel wall composition and relative contributions of smooth muscle cells would have 
an immediate effect on endothelial function as discussed in the following sections.  
2.2.7.1 Structural Adaptations to Blood Vessels 
Structural adaptations influencing arterial stiffness involves the physical remodelling of arteries and 
vessel walls including the enlargement of existing vessels and creation of new vessels. Stiffening of the 
arterial tree is not uniform throughout, but rather sporadic occurring predominantly in central, 
conduit vessels and sparing peripheral arteries (Burr et al., 2012; Burr et al., 2014; Vlachopoulos et al., 
2010; Zieman, Melenovsky & Kass, 2005). The compliance of the vascular wall is primarily dependent 
on the relative content of the two proteins collagen and elastin. An imbalance to the regulation of 
both proteins induced by an inflammatory environment leads to an increased production of collagen 
and reduced elastin, contributing to stiffness in the vessel walls (Intengan & Schiffrin, 2001). Within 
the extracellular matrix (ECM) of the vessel wall collagen and elastin are regulated by catabolic matrix 
metalloproteases (MMPs) (Zieman, Melenovsky & Kass, 2005). Advanced glycation end products 
(AGEs), the result of nonenzymatic protein glycation, form irreversible cross-links between long-lived 
proteins such as collagen. AGE-linked collagen is stiffer and less disposed to hydrolytic turnover 
leading to an accumulation of structurally unsatisfactory collagen molecules. Elastin molecules are 
similarly susceptible to AGE modification affecting the elastic component of vessel walls (Kuzuya et 
al., 2001). AGEs are up regulated by conditions of increased blood glucose levels and oxidative stress 
caused by exercise (Goldin, Beckman, Schmidt & Creager, 2006; Henry et al., 2003). Frequent ingestion 
of high carbohydrate, high sugar foods, combined with excessive exercise characterised by ultra-
endurance exercise may promote AGEs and subsequent damage to blood vessel structure. 
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Enlargement of vessels, termed arteriogenesis, and angiogenesis, the development of new 
blood vessels, occur in part as a response to increased cyclical blood flow leading to increased wall 
stress. Initially, wall mass increases to accommodate the higher pressure in the arteries caused by 
exercise which eventually leads to a larger mechanical stretch on the arterial wall (Prior, Yang & 
Terjung, 2004). Long-term training is therefore associated with lower arterial wall thickness likely due 
to normalisation of BP via increased lumen size (Rowley et al., 2011; Thijssen, Cable & Green, 2012). 
This process reflects a beneficial adaptation to arterial compliance, and concomitant arterial stiffness. 
However, endofibrosis and iliac artery kinking have been attributed to a small number of athletes, 
most prominent in cyclists (Feugier & Chevalier, 2004; Peach et al., 2012). Endofibrosis is characterised 
as the thickening of the iliac tunica intima, the innermost layer (Feugier & Chevalier, 2004). The 
physical position, muscular hypertrophy, arterial fixation, and endothelial dysfunction may contribute 
to the deformation of the iliac artery in high volume cyclists. These factors exacerbate endofibrosis 
and kinking due to: hyperflexion of the hip joint, mechanical vessel trauma, inability to move freely 
during exercise, and functional mechanisms discussed in chapter 2.2.7.2 (Peach et al., 2012).  
2.2.7.2 Exercise-Associated Functional Mechanisms Influencing Arterial Stiffness 
The functional properties of arteries can be influenced transiently or longer term in response to 
exercise and endurance training. Neural innervation, genotype expression, oxidative stress, 
inflammatory stress all influence the functional ability of arterial blood vessels which is largely 
mediated by shearing stress along the vessel walls.  
2.2.7.2.1 Neural Innervation 
Sympathetic tone refers to the degree of activation of the sympathetic nervous system (SNS), which 
together with the parasympathetic nervous system (PNS) and enteric nervous system form the 3 main 
divisions of the autonomic nervous system. Complex autonomic mediators have a major role during 
exercise for increasing HR, stroke volume (SV), and the relaxation of pre-capillary sphincters in active 
muscle capillary beds allowing a greater supply to working skeletal muscle (Sala-Mercado et al., 2006). 
Metabolic by-products are created by active skeletal and respiratory muscle when blood flow is 
providing inadequate oxygen and nutrients. The metaboreflex is characterised by the ability of the 
accumulation of these metabolites to stimulate group III and IV afferent nerve fibres which elicit 
selective elevations in sympathetic tone (Dempsey, Romer, Rodman, Miller & Smith, 2006; Sala-
Mercado et al., 2006). Normal exercise does not elicit the metaboreflex as high levels of metabolites 
must be produced, as in high intensity or prolonged exercise. The metaboreflex has been shown to 
increase arterial stiffening and CBP (Davies et al., 2007). Sustained catecholamine exposure and 
sympathetic tone likely influences arterial stiffness by increasing HR, resulting in overall shortening of 
the cardiac cycle. Vessel recoil may then be shortened during diastole therefore restricting the degree 
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of compliance (Heffernan, et al., 2013). Indeed, markers of arterial stiffness including aortic Aix and 
PWV are influenced by HR (Burr et al., in press; Lantelme et al., 2002).  
2.2.7.2.2 Post-Exercise Hypotension in Blood Vessels 
Prolonged endurance exercise is followed by exercise-induced hypotension and altered left ventricular 
function (Raine et al., 2001; Hart et al., 2010). Reductions in BP following exercise are suggested to 
normalise within minutes to hours of exercise (Rabowchuk, Stuckey, Millar, Gurr & MacDonald, 2009). 
One mechanism suspected to have a major role in this phenomenon is the arterial baroreflex which 
may be reset to operate at a lower point to maintain vasodilation after exercise (Raine et al., 2001). 
Subsequent BP reductions are concomitant with elevated HR to maintain adequate blood flow. Hart 
et al. (2010) found that after a 4 hour rowing protocol, carotid baroreflex control was reset to function 
at a lower arterial pressure and an elevated HR, and decreased LV ejection fraction. It was 
hypothesised that the observed LV dysfunction was at least in part caused by an attenuated LV filling 
during diastole, in agreement with previous research (George et al., 2005). These studies suggest the 
cardiac and arterial pressure baroreflex arcs do not respond in a mutually exclusive manner (Hart et 
al., 2010). The purpose and benefits of post-exercise vasodilation are not fully understood, although 
suggestions of greater angiogenesis, increased oxygen delivery, and enhanced glucose delivery may 
be explain the primary responses (Halliwill, Buck, Lacewell & Romero, 2013). 
2.2.7.2.3 Endothelial Cell Phenotype 
Low-to-moderate exercise loads may be associated with improvements in endothelial function, 
whereas greater exercise loads may attenuate such improvements via cellular and mechanical 
disruptions (Bergholm et al., 1999; Dawson et al., 2008; Goto et al., 2003). Chronic BP elevation results 
in epigenetic changes, specifically resulting in pro-atherogenic endothelial cell phenotypes (lower 
eNOS messenger ribonucleiuc acid (mRNA) expression, higher vascular cell adhesion protein-1 (VCAM-
1), interceullular adhesion molecule 1 (ICAM-1), endothelin-1 (ET-1) and ROS) (Laughlin, Newcomer & 
Bender, 2008). Overexpression of said phenotypes are associated with endothelial dysfunction and 
are suspected to differ when pressure stimulus involves transient cyclical elevation as opposed to 
chronic increases in BP (Laughlin, Newcomer & Bender, 2008; Widlansky Gokce, Keaney & Vita, 2003). 
It is conceivable that ultra-endurance exercise presents a more chronic elevation in BP than the body 
is accustomed to, potentially allowing these mechanisms to be at least transiently promoted.  
2.2.7.2.4 Inflammatory Processes 
As mentioned previously, ultra-endurance athletes may be at an elevated risk of increased AGEs 
formation and inflammatory cytokines. AGEs stimulate stress signalling and inflammatory processes, 
increasing NF-KB, ROS, proinflammatory cytokines, growth factors, and vascular adhesion molecules. 
Ultra-endurance exercise bouts can generate a significant inflammatory cytokine release into the 
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bloodstream, which can remain elevated for prolonged periods (Mastaloudis, Marrow, Hopkins, 
Devaraj & Traber, 2004; Marklund et al., 2013). Prolonged inflammatory stress leads to alternate, 
damaging structural remodelling of biological systems than would occur with acute inflammatory 
responses (Margonis et al., 2007). Abovementioned mediators can increase vascular stiffness via 
MMPs, contribute to endothelial dysfunction and oxidative stress, depress endothelial FMD and 
promote atherosclerotic plaque formation (Goldin et al., 2006; Kuzuya et al., 2001).  
2.2.7.2.5 Role of Shear Stress on Vascular Function 
Shear stress refers to the frictional drag experienced by endothelial cells as blood flows along is 
surface. Shear stress stimulates the release of vasodilators which serve to relax and expand arteries. 
Moens et al. (2005) defines this endothelium dependent process facilitating the relaxation of an artery 
as FMD. Shear stress relates directly to blood flow, blood viscosity, and arterial radius and is a major 
stimulant for arterial remodelling (Silver & Vita, 2006). Transient inflammatory responses in vascular 
smooth muscle cells resulting from shear stress stimulates normal arterial remodelling. However, in 
the presence of atherosclerosis the remodelling becomes uncontrolled leading to excessive 
remodelling, and contributing to plaque vulnerability (Silver & Vita, 2006). Rupture of vulnerable 
plaque results in the contents being released into the bloodstream, causing coagulants to form on the 
blood vessel. This process leads to thrombotic occlusion of the associated artery resulting in 
obstructed blood flow and potentially SCD (Lafonte, 2003). Dawson et al. (2008) observed non-
significant increases to shear stress of 20% in the femoral artery and decreases of 16% in brachial 
artery after marathon running. Furthermore a concomitant reduction in femoral, but not brachial, 
artery FMD was found post-marathon indicative of endothelial dysfunction only in the femoral artery. 
This localised endothelial dysfunction provides an explanation towards the differential response in 
arterial stiffening observed post-exercise as demonstrated in chapter 2.2.4. 
2.2.7.2.6 Nitric Oxide for Cellular Signalling 
Nitric oxide, a potent blood vessel vasodilator, is upregulated by shear stress forces upon the 
endothelial cells releasing calcium, and in turn activating eNOS; an enzyme responsible for NO 
production. NO is produced from the amino acid L-arginine by nitric oxide synthase (NOS) with the 
use of several cofactors such as, oxygen, tetrahydrobiopterin (BH4), NADPH and flavin adenine 
nucleotides (Forstermann & Sessa, 2012). The two types of endothelial NOS (eNOS) are inducible NOS 
(iNOS) and constitutive NOS (cNOS). Expression of iNOS not calcium dependent, but is stimulated 
during inflammatory conditions by endotoxins, cytokines and other agents and once expressed in 
constantly active (Forstermann & Sessa, 2012). Shearing forces acting within the blood vessels induce 
a calcium release which activates cNOS. The enzyme cNOS converts L-arginine to NO inside the 
endothelial cell. NO has a very short half-life due to its high affinity for the free radical superoxide 
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anion (O2-), forming peroxynitrate (ONOO-). Consequently, NO bioavailability is reduced by the O2-. NO 
predominantly takes one of two pathways; some NO diffuses into the blood, binding to haemoglobin 
in red blood cells (RBC’s) where it is suggested to assist gaseous exchange by inducing vasodilation 
(Jensen, 2009). Interestingly RBC’s have been shown to produce NO through the reduction of nitrite, 
which may escape during transport thereby encouraging vasodilation (Cosby et al., 2003). Another, 
more recognised pathway, is for NO to diffuse from the endothelium into the smooth muscle cells 
where it has a high affinity towards the enzyme guanylyl cyclase (figure 7). The consequential 
activation of the messenger cyclic guanosine monophosphate (cGMP) proactively influences 
vasodilation, inflammation and vascular wall thickness (Moncada & Higgs, 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Nitric oxide (NO)- guanylate cyclase (GC)- cyclic guanosine monophosphate (cGMP) pathway 
resulting from shearing forces on the endothelial cells. Adapted from Higashi & Yoshizumi (2004). 
Blood flow shearing forces stimulates a calcium (Ca) release within the endothelial cell leading to activation of 
constitutive NO synthase (cNOS) and subsequent NO production from L-arginine. Inflammatory processes also 
instigate NO production via activation of inducible NOS (iNOS). iNOS and cNOS are types of endothelial NOS 
(eNOS). NO diffuses into the smooth muscle cell where it has a high affinity with the enzyme GC. GC converts 
guanosine triphosphate (GTP) to cGMP which influences several physiological responses such as vasodilation. 
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Greater NO synthesis and subsequent reactions together with metabolic energy production 
contributes to a greater production of reactive oxygen and nitrogen species (RONS). These reactive 
molecules present potential to disrupt cellular function and cause damage to cells particularly in the 
localised area, for example the endothelium. This damage contributes to stiffening of arteries, 
stimulating inflammatory processes described previously and promoting foam cell production (Liu et 
al., 1999). 
2.2.7.2.7 Exercise-Induced Oxidative Stress and Antioxidant Supplementation 
Endurance athletes consume and use large volumes of oxygen during exercise, as well as experiencing 
an up regulation of NO production (Powers, Nelson & Hudson, 2011). These pathways encourage a 
greater production of reactive oxygen and nitrogen species (RONS) such as free radicals which can 
damage cells and lead to oxidative stress. The term oxidative stress refers to an imbalance of oxidants 
and antioxidants in favour of oxidant production (Powers & Jackson, 2008). A free radical is an atom 
that has one or more unpaired electrons, making them unstable and highly reactive. Since electrons 
usually exist in pairs, the unstable free radical donates or accepts an electron from another molecule, 
or alternatively joins onto a nonradical. In each process the nonradical molecule becomes a free 
radical in consequence. Unless the process is terminated, this sequence of events is repeated in a 
chain reaction of radical production, damaging the molecules and cells they reside in (Halliwell, 1991).  
Termination of this sequence is achieved with antioxidants. Many antioxidants become radicals 
themselves, forming part of a cooperative mechanism with other antioxidants that regenerate the 
original antioxidant (Powers, DeRuisseau, Quindry & Hamilton, 2004). The antioxidant defence 
system, which consists of endogenous and exogenous antioxidants, therefore is essential to the 
development of oxidative responses (Powers, Nelson & Hudson, 2011). The major cell bound non-
enzymatic antioxidant in humans is glutathione, whilst superoxide dismutases provide a major source 
of enzymatic antioxidant protection (Powers & Jackson, 2008).  
Low-to moderate levels of ROS have a major role in regulating gene expression, cell signalling 
pathways, glycogen synthesis, and therefore adaptation to exercise training (Powers & Jackson, 2008). 
Usually, a small release of ROS is met with adequate antioxidant defences (Halliwell, 2006). Excessive 
oxidant production can cause irreversible pathological damage, mutation, and negatively affect 
physiological function (Fisher-Wellman & Bloomer, 2009; Murphy, 2009); maintaining a redox balance 
with adequate antioxidant defence is essential for beneficial adaptation and prevention of oxidative 
damage. On the other hand, excessive doses of antioxidant supplementation may induce a reduced 
state, impairing skeletal muscle function and cellular signalling necessary for beneficial adaptations 
(Powers et al., 2004). Redox balance is an environment in which signalling and control in the body is 
not disrupted by excess oxidant production or reductive compounds (Powers & Jackson 2008). The 
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redox balance is demonstrated in figure 8, which is particularly useful in demonstrating the fine line 
between oxidative stress and reductive stress. 
 
 
 
 
 
 
 
 
 
 
 
Davies et al. (1982) are frequently cited as the first evidence that free radicals are produced as a result 
of muscle contraction, and that exercise-induced ROS production has potential to damage body tissue. 
This study inspired extensive research into the area of ROS and tissue damage, including the 
recognition that free radicals may contribute to muscle function and fatigue (Barclay & Hansel, 1991). 
In addition, it has been established that low/basal levels of ROS are essential for normal force 
production and adaptive cellular signalling, yet excess oxidant production compromises force 
production as represented in figure 9 (Powers & Jackson, 2005; Reid, 2001; Seifried et al., 2007). 
Mitochondria have long been presumed the primary source of oxidants during exercise (Boveris & 
Chance, 1973) however, more current research carried out by St-Pierre, Buckingham, Roebuck & 
Brand (2002) considers the rate of mitochondrial ROS production to be significantly lower than 
previously accounted for. Powers & Jackson (2008) propose that the collective findings suggest a 
different predominant source of ROS production, indicating the heart, lungs and white blood cells may 
play a larger role than formerly understood.   
 
 
Figure 8. Illustration of the fine line between redox balance, oxidative stress, and reductive stress 
(Powers et al., 2004). 
Greater oxidant production and inadequate antioxidant defences creates an environment of oxidative stress, 
leading to a chain reaction of oxidised molecules resulting in damage and cellular signalling disruptions. However, 
excessive antioxidants in the body results in a reductive stress environment, also resulting in signalling disruptions.  
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Several, but not all, studies have identified that excessive exercise increases oxidative stress (Kanter, 
Mastaloudis, Leonard & Traber, 2001; Margaritis, Tessier, Richard & Marconnet, 1997; Neaubauer et 
al., 2006). Knez Coombes & Jenkins (2006) state that it is plausible that excessive exercise may advance 
atherogenesis due to oxidative stress and the subsequent LDL oxidation disrupting endothelial 
function. Additionally, the authors suggest the increased mortality rate and CVD risk seen in those 
participating in the most exercise, may be due to an elevated oxidative stress resulting from increased 
activity. This is despite the evidence that a greater antioxidant defence, and therefore enhanced 
protection against oxidative stress, is observed in those accustomed to endurance training (Bloomer 
et al., 2006; Jówko et al., 2011). The associated markers of oxidative stress observed in the 
aforementioned studies have been directly linked with an impairment to the CV system.  
Gross et al. (2005) suggests the process of atherosclerosis may involve the oxidation of LDL particles, 
ROS production, and oxidative damage of cells. Formation of foam cells due to LDL oxidation may 
promote further oxidative damage and further disruption to the blood vessels. This hypothesis has 
previously been supported by Liu et al. (1999) finding an increased susceptibility of LDL oxidation in 
vitro after marathon running. An alternative or contributing mechanism involves the potential for ROS 
to reduce NO bioavailability. The interaction of ROS superoxide (O2-) with NO to form peroxynitrite 
(ONOO-) elicits cellular damage to local areas such as the endothelium. Additionally, ONOO- reduces 
BH4 to its inactive form, therefore reducing its bioavailability as a co-factor for NO production (Sindler, 
Delp, Reyes, Wu & Muller-Delp, 2009). In rodent-based studies, exhaustive exercise has impaired 
Figure 9. Biphasic effect of reactive oxygen species (ROS) on force production of the skeletal muscle 
redrawn from Reid, (2001) by Powers & Jackson (2005). 
1) Unfatigued muscle exposed to reducing agent. 2) Muscle in basal state. 3) Unfatigued muscle exposed to low 
level of oxidants. 4) Detrimental effects of excessive oxidants on muscle force. 
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endothelial function and increased arterial stiffness (Zhao et al., 2013). Interestingly the exercise-
induced attenuation of eNOS expression was reversed by phytonutrient supplementation (Lycium 
barbarum) which had previously been shown to up-regulate NO level (Zhao et al., 2013). Accordingly, 
exogenous antioxidant supplementation may provide an effective strategy to attenuate exercise-
induced oxidative stress and therein reduce the damaging effects on the CV system. Antioxidant 
supplementation can provide some protection, however optimal dosages remain to be elucidated. As 
of yet, there are limited scientific studies which investigate the effect of a multi-nutrient strategy to 
prevent oxidative stress resulting in excessive exercise and the related vascular compromise. 
A large number of ROS can be produced in the body, and different antioxidants can scavenge types of 
free radicals at different biological sites (Hamid, Aiyelaagbe, Usmnan, Ameen & Lawal, 2010; Qin et 
al., 2008). Studies suggest that the use of several antioxidants has multiple potential target sites of 
action rather than overloading few sites with one substrate (Qin, He, Hai, Liang & Liu, 2008). With this 
reasoning, multiple antioxidants should be used to prevent situations of oxidative stress (Qin et al., 
2008). Further supporting this postulation is the evidence of the adverse health effects of high dose 
isolated antioxidant supplementation (Gleeson et al., 2004 and Powers, Ji & Leeuwenburgh, 1999). 
Recent studies have identified an attenuating effect of antioxidant supplementation on exercise-
induced cellular signals and adaptations in both vascular and skeletal muscle (Ji, Cabrera and Vina, 
2006 and Meilhac, Ramachandran, Chiang, Santanam and Parthasarathy, 2001). Antioxidants such as 
vitamin C, E, and polyphenols, may exert pro-oxidant characteristics when intake far exceeds that 
required to obtain redox balance (Scalbert et al., 2005, Ristow et al., 2009, and Nieman et al., 2002). 
Additionally, Gliemann et al. (2013) has demonstrated that in aged men, resveratrol supplementation 
negated the beneficial effects of exercise training on CV health, contrary to prior investigation in 
animal studies (Murase et al., 2009; Dolinsky et al., 2012). With regard to arterial stiffness, it was 
suggested in a recent review of the literature that polyphenol-based interventions, which have effects 
further than redox properties and increase the bioavailability of NO, may be the most effective in 
reducing arterial stiffness (Pase, Grima & Sarris, 2011). 
2.2.7.2.8 Summary: Exercise and Vascular Health  
The above literature demonstrate that moderate exercise is associated with cyclic, transient 
alterations in mechanical and cellular stress, resulting in subsequent long-term remodelling, 
baroreflex adjustments, and increased endothelial function (Hart et al., 2010; Laughlin, Newcomer & 
Bender, 2008). Long-term changes to arterial stiffness and vascular health have been found to be 
predominantly a result of structural adaptation. Excessive exercise training may promote an 
inflammatory environment resulting in reduced elastin and increased collagen in the vascular walls 
resulting in more rigid vessels, which may be further compromised by AGE modification in 
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hyperglycaemic and oxidative stress states. Additionally, short-term changes in arterial compliance 
are predominantly a result of sympathetic tone, cellular alterations and resultant endothelial 
dysfunction and vasoconstriction. Endurance exercise bouts promote oxidative stress via RONS 
production due to elevated oxygen consumption and NO production. Oxidative stress has potential to 
damage the vascular system by means of LDL modification causing endothelial cell damage and 
subsequent foam cell release leading to atherosclerotic plaque accumulation in the blood vessels. 
Alternatively, RONS may elicit damage to vascular cells directly as well as causing reduced 
bioavailability of NO, a potent vasodilator. Antioxidants, in particular phytonutrients and multiple 
antioxidant combinations, have potential to attenuate oxidative stress and subsequent vascular 
disruption and therefore be of value to prolonged endurance exercisers. Excessive amounts of one or 
more antioxidant however may induce a redox imbalance, resulting in pro-oxidant reactions and 
potentially damaging consequences. 
 
2.2.8 Nutritional Factors Influencing Arterial Stiffness 
Nutrition intake prior to, during and post-exercise impacts both performance and recovery. Several 
nutritional factors affect measurements of arterial stiffness. Specifically caffeine, glucose, alcohol, and 
salt consumption have been associated with changes in arterial stiffness and wave reflections. 
(Draaijer et al., 1993; Papaionnou, Karatzi, Papamichael & Lekakis, 2005; Pase Grima & Sarris, 2010; 
van den Elzen et al., 2005; Zieman, Melenovsky & Kass, 2005).  
2.2.8.1 Caffeine 
Caffeine is a widely consumed substance in the world population, especially in athletes for its 
ergogenic effects (Graham et al., 2010). Current evidence provides support for the ability of caffeine 
to influence BP, wave reflections, and arterial stiffness. Indeed, Vlachopoulos, Hirata & O’Rourke 
(2003) showed a significant rise in Aix 30 minutes after caffeine consumption (~7%) which remained 
elevated 3 hours later; though this effect is not adjusted for concomitant HR elevations. Recently, 
caffeinated coffee (80mg caffeine) significantly increased PWV over decaffeinated coffee in a double 
blind crossover study (Karatzis et al., 2005). These data imply that caffeine acutely increases arterial 
stiffness. The effects of caffeine on arterial stiffness are likely due to the interaction with the central 
nervous system and HR (Papaioannou et al., 2005). Adenosine increases throughout wakefulness and 
has been shown to induce sleep and fatigue (Davis et al., 2002). Caffeine is able to cross the blood-
brain barrier where it is suggested to influence CNS stimulation by blocking adenosine receptors (Davis 
et al., 2002). Additionally, the substantial influence of xanthine and theobromine, derivatives of 
caffeine, on the oxidant and antioxidant actions would affect arterial stiffness dependent on the 
conditions (Azam, Hadi, Khan & Hadi, 2003; Powers & Jackson, 2008; Powers, Nelson & Hudson, 2011). 
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2.2.8.2 Glucose 
Endurance athletes are known to and currently encouraged to ingest large amounts of carbohydrate 
and sugar during training periods (Peters 2003).  As discussed previously, AGEs negatively influence 
the structure of arterial walls, stiffening collagen and elastin fibres, as well as compromising 
endothelial function. AGEs are up regulated by increased blood glucose levels, which may at least 
partially explain the accelerated stiffening observed with impaired glucose tolerance and diabetes 
(Goldin, Beckman, Schmidt & Creager, 2006; Henry et al., 2003; Stehouwer, Henry & Ferreira, 2008). 
2.2.8.3 Alcohol 
Discrepancy exists as to the direction between the amount of alcohol consumption and the degree of 
arterial stiffness. Population studies have described a J-shaped relationship between alcohol 
consumption and mortality from CAD and stroke (Corrado, Bagnardi, Zambon & La Vecchia, 2004). 
This finding is supported by cross-sectional studies finding reduced arterial stiffness with light to 
moderate consumption but increased stiffness with heavy alcohol consumption (Sierksma et al., 2004; 
van den Elzen et al., 2005). Speculated beneficial effects refer to increased HDL, enhanced endothelial 
function, and antioxidant potential from partnered beverages such as wine. Detrimental mechanisms 
may involve MMP reduction of elastin, pro-oxidant activity, and pro-coagulant activity (Beilin, 2005). 
2.2.8.4 Salt 
Greater dietary salt intake is associated with an augmented vascular stiffness the reverse is also true 
(Bagrov & Lakatta, 2004; Gates, Tanaka, Hiatt & Seals, 2004). Increase salt stimulates VSMC tone and 
vascular wall composition with abundant collagen production. Additionally, salt interacts with genetic 
polymorphisms which influence endothelial function as well as influencing endothelial function 
directly by diminishing NO bioavailability (Zieman, Melenovsky & Kass, 2005).  
 
2.2.9 SphygmoCor Measurement Techniques for Arterial Stiffness 
2.2.9.1 Pulse Wave Velocity 
Arterial stiffness refers to a loss of elasticity within the arterial walls, which occurs naturally with age 
and arteriosclerosis. When the heart contracts, it generates a pulse wave which travels through the 
circulation; the speed of this pulse relates to the stiffness of the arteries (Laurent et al., 2006). 
Increases to pressure pulse wave velocity (PWV) represent increased arterial stiffening of the central 
arteries, since pulse wave propagation is faster along a stiffer tube (O’Rourke, Staessen, Vlachopoulos, 
Duprez & Plante, 2002). It is important to recognise that pulse wave transmission is different to blood 
flow. The pressure pulse generated by the LV reaches peripheral arteries almost immediately, yet the 
blood ejected by the LV may take several cardiac cycles to reach the same distance. 
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PWV is frequently considered as the ‘gold standard’ method of determining arterial stiffness (Laurent 
et al., 2006). The SphygmoCor apparatus is the most widely used non-invasive and commercially 
available device for determining arterial stiffness and wave reflection calculations (Boutouyrie, Briet, 
Collin, Vermeersch & Pannier, 2009) 
PWV is related to the intrinsic properties of the arterial wall and its relationship can be calculated by 
the Moens-Korteweg equation: 
 
 
Where E = Young’s elastic modulus, h = wall thickness of vessel, r = vessel diameter and ρ = blood 
density (Mackenzie, Wilkinson & Cockroft, 2002; O’Rourke et al., 2002). The technique is relatively 
simple, non-invasive robust and reproducible. Carotid-femoral PWV, measured along the aortic and 
aortic-iliac pathway, is the most clinically relevant as it incorporates the arterial branches which are 
responsible for the majority of the pathophysiological effects of arterial stiffness. Carotid-femoral 
PWV is widely used to demonstrate the predictive value of aortic stiffness for CV events (Laurent et 
al., 2001; Shokawa et al., 2005).  
2.2.9.2 Augmentation index 
Pulse wave analysis readings allow an alternative estimation of aortic arterial stiffness and CBP. Pulse 
wave contours can be created from applanation tonometry measurements taken at the radial artery. 
The validated transfer function then estimates central pulse wave contours which can be used to 
estimate CBP and indices of arterial stiffness. The incident pressure pulse gets reflected back which 
gives the characteristic wave contour. Augmented SBP (AP) due to the naturally occurring wave 
reflections is divided by pulse pressure to give Aix as a percentage (Laurent et al., 2006). 
Although both cfPWV and aortic Aix are markers of aortic arterial stiffness, the two are not mutually 
exclusive and may differ depending on the internal adaptations occurring (Edwards and Lang, 2005). 
PWV gives a regional arterial stiffness measure with influence by the aortic-femoral tract, whereas Aix 
gives an indication of wave reflections in the circulation which can be used to determine arterial 
stiffness. Peripheral, muscular arteries and arterioles serve as the major reflection sites therefore Aix 
is influenced by the function and structure of peripheral arteries.  
2.2.9.3 Validation of SphygmoCor 
2.2.9.3.1 Pulse Wave Velocity 
Carotid-femoral PWV (cfPWV) excludes the proximal segment of the aorta and includes a variable 
length of the iliac and femoral arteries. Wilkinson et al, (2010) suggest the intersecting tangent 
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algorithm should be used to determine transit time from the waveforms, as it has been shown to be 
the more accurate method subjected to less influence by wave contours. The path length should be 
calculated by subtracting the distance from the right common carotid artery and sternal notch from 
the right common femoral artery and sternal notch. Expert consensus has identified that this approach 
gives a truer estimate of the anatomical path length, therefore more physiological values of PWV 
(Laurent et al., 2006; Nichols & O’Rourke, 1998; Sugawara, Hayashi, Yokoi & Tanaka, 2008). More 
recent expert consensus advises using an alternative calculation of 80% of the direct carotid-femoral 
distance in order to provide a more accurate body surface distance estimate in a clinical population 
due to large bellies and breasts (Van Bortel, 2012). However the 80% distance method may be 
redundant in a well-trained endurance population due to the associated reduction in abdominal 
adipose tissue (Helge et al., 2003; Lee et al., 2005; Schütz et al., 2012). It should be ensured that there 
is no significant variation in HR or BP between cfPWV recordings (i.e. haemodynamic stability) which 
can be problematic in a highly trained population whereby sinus arrhythmia is a common occurrence.  
Furthermore, resting bradycardia observed in most athletes could affect wave reflections and 
pressure amplifications as well as impacting PWV assessments (Lantelme, Mestre, Lievre, Gressard & 
Milon, 2002). Therefore, interventions which elicit different HR’s between sessions should be 
interpreted with caution.  
A true aortic PWV (aPWV) can be assessed non-invasively via MRI or invasively by sequential or 
simultaneous recording of pressure/flow waveforms, just above the aortic valve and aortic bifurcation 
with high fidelity pressure sensors/indwelling catheters (Wilkinson et al., 2010). Recent studies have 
shown strong correlations between SphygmoCor cfPWV and invasive procedures; r = 0.59, and 
ultrasound techniques; r = 0.68 (Ring et al., 2014; Vappou, Luo, Okajimi, Di Tullio & Konofagou, 2011). 
Correlations appear to become more scattered in the upper range of results greater than 7 or 8 m·s-1, 
particularly in females. 
2.2.9.3.2 Central Blood Pressures (Generalised Transfer Function) 
The generalised transfer function is applied to derive a central aortic waveform from a peripheral 
arterial waveform recording. Early studies demonstrate that clinically acceptable predictions of central 
arterial pressure and waveforms can be made with the use of a mathematical general transfer function 
from the radial artery pressure wave (Chen et al., 1997; Karamanoglou et al., 1993). The CBP 
estimation by the SphygmoCor system has been validated in various cohorts (Zuo et al., 2010) but the 
most comprehensive study approving the generalised transfer function was conducted by Pauca et al. 
(2001) in 62 patients. Differences in invasively measured, and estimated (from radial) waveforms 
agreed with the requirements of the Association for the Advancement of Medical Instrumentation 
(AAMI). The AAMI criteria for comparison of arterial pressures state that mean values are required to 
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correspond by 5 ± 8 mm Hg or less in a sample of 25 comparisons; for invasive comparisons (White et 
al., 1993). Differences in the study by Pauca et al. (2001) were as follows: systolic (0.0 ± 4.4 mm Hg), 
diastolic (0.6 ± 1.7 mm Hg) pulse (0.7 ± 4.2 mm Hg) and mean arterial pressures (0.5 ± 2.0 mm Hg); 
suggesting a substantial equivalence between estimated and measured aortic waveforms. CBP 
derived from the SphygmoCor system is strongly correlated with invasive procedures (Ding et al., 
2011; Sharman et al., 2006; Zuo et al., 2010), though recent studies suggest derivations may 
underestimate true values (Zuo et al., 2010). Since Aix is a relative quantity, underestimation of CBPs 
should not greatly influence its interpretation, so long as correlations with true CBP’s remain high. 
Indeed studies have noted correlations between Aix (r = 0.97; p < 0.001) between the SphygmoCor 
and invasive procedures (Ring, Eriksson, Zierath & Caidahl, 2014).  
2.2.9.3.3 Factors Influencing Arterial Stiffness Measurements  
Various factors have been associated with altered indices of arterial stiffness such as age, HR, LVED 
and BP. Arterial compliance is diminished with advancing age with particular emphasis on central 
arteries, largely sparing peripheral arteries (Mitchell et al., 2004). It is of great interest that regular 
endurance activity can slow the natural ageing process associated with increasing arterial stiffness 
(DeVan & Seals., 2012; Tanaka et al., 2000).  
Several studies have presented an association between HR and PWV independent of BP (Cunha et al., 
1997; Lantelme et al., 2002). The underlying mechanisms regarding this association are largely 
unknown, however the reduced time available for vessel recoil probably contributes to a reduction in 
vessel compliance (Mangoni, Mircoli, Giannattasio, Ferrari & Mancia, 1996). It is suggested that HR be 
accounted for when interpreting changes in PWV, and gives rise to the need for larger studies to 
attempt correction factors as with Aix@HR75. 
Corrections in Aix for a HR of 75 are based on 2 studies of small numbers of cardiac diseased 
participants (Wilkinson et al., 2000; Wilkinson et al., 2002). Aix was inversely associated with increased 
HR via cardiac pacing, however increasing HR was not associated with changes in arterial stiffness. 
High variations in data were apparent with linear declines in Aix of -0.39% and 5.6% per 10 beats·min-
1 HR increase; respectively. Based on the average of the slopes of these studies an adjustment of 4.8% 
for each 10 beats·min-1 increment was made by the SphygmoCor apparatus for Aix@HR75. The 
responsible mechanism is suggested to involve a shift in the reflected pressure wave from systole to 
diastole due to shortening of LVED (Wilkinson et al., 2002). Recently, Salvi et al. (2013) provided 
evidence to support this mechanism, finding that LVED is a stronger predictor of both PWV and Aix 
than HR. Therefore a more accurate adjustment may involve substituting HR for LVED.  Two important 
points are brought up by these findings; 1) the adjustment of Aix@HR75 is based on few participants 
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with already compromised hearts therefore may not reflect the whole population, 2) LVED may 
represent a more accurate factor to base adjustments of Aix on. 
Aix is directly influenced by changes in BP, in particular SBP and pulse pressure. In stiffer arteries, the 
pulse wave travels at a faster rate, therefore the reflected pulse wave occurs at an earlier point in the 
wave contour (O’Rourke, Staessen, Vlachopoulos, Duprez & Plante. 2002). As a result, the reflected 
wave causes an augmentation during systole rather than during diastole, leading to greater systolic 
BP and pulse pressures (Laurent et al., 2006). 
As a result of these factors, changes in arterial stiffness measurements with concomitant changes in 
HR, LVED, or BP should be interpreted with caution and only large variations should be considered 
significant. Further studies are required to adjust measurement values for correction factors that 
relate more accurately with invasive procedures. Indices without correction factors have value 
regarding the mechanisms, structural or functional, involved with changes in measurements. 
Ultimately, this change results in an altered Aix, which is a ratio of augmented pressure and pulse 
pressure. 
2.2.9.4 Reliability of the SphygmoCor Device 
Reliability refers to the repeatability or consistency of measurements (Drost, 2011). It is essential to 
identify how reliable a measurement technique is in order to decide whether a particular 
measurement is of any value (Bruton, Conway & Holgate, 2000).  There are two types of reliability, 
identified by Baumgarter (1989), relative and absolute reliability. Relative reliability refers to the 
degree to which individuals maintain their ranking over repeated measures, often assessed using 
Pearson’s correlation coefficient. Correlation only identifies how two sets of data vary together, and 
can often be misleading if used as a sole indicator of reliability (Keating and Matyas, 1998). In clinical 
environments it is often necessary to determine whether values obtained are the same, not just 
proportional to each other. Absolute reliability is the degree to which repeated measurements vary 
for individuals, expressed as units of measurement.  
Carotid-femoral PWV is the most widely used index of arterial stiffness and its predictive value has 
been demonstrated above that of classical risk factors in several studies based on different cohorts 
and different geographical locations (Laurent et al., 2006). PWV, independent of the measuring device, 
has been found inherently less reproducible than the measurement of Aix (McCrea, Skulas-Ray, Chow 
& West, 2012; Wilkinson et al., 1998). Wilkinson et al., (1998) found promising results regarding the 
use of SphygmoCor apparatus and pulse wave analysis (PWA) as a reproducible method for 
determining Aix in various patient groups. In this study two investigators measured Aix twice each in 
33 participants and found a high intra and inter-investigator reproducibility determined by Bland-
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Altman plots with small measurement differences of 0.49% and 0.23%; respectively. Additionally, the 
same authors used a similar protocol for cfPWV measurements in 24 participants. The intra and inter-
observer measurement differences of PWV were 0.07m·s-1 and -0.30m·s-1 with Bland-Altman plots 
indicating high reproducibility. For both Aix and PWV there was no significant difference between 
measurements made by different  investigators or between first and second recorded measurements, 
p > 0.05. Furthermore neither indices of arterial stiffness showed trends to vary with the mean value.  
2.2.9.5 Clinical Applicability of PWV and PWA Measurements 
CV events can be predicted with great accuracy using PWV and PWA procedures. Blacher, Asmar, 
Djane, London & Safar (1999) were first to identify PWV as an independent risk factor for CV mortality 
and was strongly associated with atherosclerotic accumulation, albeit in a hypertensive population. In 
this study, a PWV greater than 13 m·s-1 was a strong predictor of CV mortality with high performance 
values; ≥ 60% sensitivity and specificity. Laurent et al. (2001) further support the clinical predictability 
of carotid-femoral PWV in a large study hypertensive populations over an average follow-up 
procedure of 112 months. An odds ratio (OR) of 1.51 was produced for an increase in 5 m·s-1 PWV for 
predicting CV mortality. Regression analysis revealed that in terms of mortality risk, an increase in 
PWV of 5 m·s-1 was equivalent to that of aging 10 years. More recently, increasing PWV has repeatedly 
been associated with CVD and mortality in various geographic, age and health-related populations 
(Cruickshank et al., 2002; Mattace-Raso et al., 2006; Shokawa et al., 2005). The European Society of 
Hypertension support findings from indicating a 50% increase in the risk of a CV event from a PWV of 
12 m·s-1 or greater (Mancia et al., 2009).  
Both aortic Aix and Aix@HR75 have been associated with a higher incidence of CAD in middle-aged 
and older individuals (Weber et al., 2004). Chorinos et al. (2005) and London et al. (2001) also support 
the clinical predictability of Aix in diseased individuals for all-cause mortality.  Further work is 
necessary to establish the predictive value of Aix for younger individuals. Evidence does not appear to 
be unanimous regarding the clinical use of Aix over arterial pressures. In other clinical-based studies, 
Aix fell out of the regression analysis as an independent predictor of clinical outcomes (Pini et al., 
2008; Williams et al., 2006). This may be due to the radial derivation of values in the radial-aorta 
transformation. The inherent inclusion of the degree of peripheral arterial stiffness may obscure the 
aortic transformation. 
Indirect measurements of arterial stiffness provide clinical value irrespective of age; of which, PWV 
provides the greatest independent predictive value of CV events with values greater than 12 m·s-1 
indicative of a high risk. Aix and Aix@HR75 may provide good predictive significance for future CV 
events, although further evidence is required since their robustness has been questioned in several 
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studies. Clinical applicability of the previously discussed arterial stiffness biomarkers in the athletic 
population requires further long-term follow-up investigation. 
 
2.2.10 Summary: Ultra-Endurance, Vascular Health and Protective Theories 
Arterial stiffness reflects the elasticity and function of arterial blood vessels in the body and has been 
adopted as a surrogate marker for CV risk. Moderate activity promotes beneficial vascular adaptations 
whereas habitual prolonged endurance exercise may be associated with detrimental adaptations to 
large and medium sized arteries. Likewise, prolonged endurance exercise may acutely and 
differentially affect arterial stiffness. Importantly, large to medium sized arterial stiffness have been 
shown to increase, whereas smaller peripheral arteries show reduced stiffness in the immediate 
period post-exercise. 
Oxidative stress is a major mechanism responsible for exercise-induced alterations in the physiological 
system. Reducing oxidative stress may ameliorate structural and functional adaptations responsible 
for the transient and long-term impairment to CV health. Therefore antioxidant supplementation, 
particularly of different forms, may provide an appropriate protective strategy for individuals 
performing prolonged endurance exercise. However, excessive antioxidant supplementation may 
negatively influence the beneficial adaptations associated with exercise training. A delicate balance 
must be retained between oxidative stress and antioxidant defence. 
The SphygmoCor apparatus provides a valid and reproducible method of detecting arterial stiffness 
non-invasively by means of regional PWV and wave reflections. Of which, PWV is the best and most 
reliable measure. As CV events are strongly predicted by such measurements they provide an 
appropriate means of assessing the vascular health of various heterogeneous populations. However, 
several nutritional factors should be controlled for prior to measurements being obtained which have 
been shown to transiently and chronically influence arterial stiffness. 
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3.1 Research Design 
This research project was split into 2 studies, study 1 and study 2. Study 1, “physiological profiling of 
the adaptations to endurance training”, adopted a longitudinal research design which studied the 
normal adaptations occurring along a 6 month incremental endurance training period.  Study 2, “the 
influence of athletic status and effects of a long-distance triathlon on markers of arterial stiffness”, 
adopted a non-randomised longitudinal research design which explored the transient and longer term 
effect of an ultra-endurance, ‘ironman’ distance triathlon on markers of arterial stiffness.  
Participants attended the laboratory prior to the study, whereby pre-screening assessments were 
made. Individuals then followed a standardised training programme over a period of 9 months. 
Multiple physiological parameters were measured in 2 month intervals over a 6 month period, i.e. 
months 0, 2, 4 and 6. A subgroup of individuals were recruited to take part in study 2, which began 
testing in month 9, whereby measurements of arterial stiffness were obtained one week prior to a 
long-distance triathlon. This ‘ironman’ distance triathlon consisted of 3.86km swim, 180.25km cycle, 
and 42.2km run. Measurements of arterial stiffness were repeated the day after the event, 7 days 
post-event, and 28 days post-event. A control sample was also collected with repeated measures and 
corresponding time intervals as the triathlon group. 
3.2 Participant Recruitment 
Study 1 participants were recruited via mass advertisement in magazines, social media, email and 
word of mouth. Prior to any pre-screening assessment, potential participants were sent information 
regarding the study design, inclusion/exclusion criteria, and what commitments were to be expected.  
A cohort of participants from study 1 were recruited via email and word of mouth to take part in an 
additional study (study 2). These participants were already set to race in the Barcelona long-distance 
triathlon as part of study 1 criteria. Additionally, a control population were recruited via email and 
word of mouth. All individuals received information regarding participation expectations, study 
design, and inclusion/exclusion criteria. See Appendix 1 and 2 regarding study 2 participant 
information sheets. 
3.3 Anthropometric Measurements  
3.3.1 Height Measurement 
Individuals removed shoes and stood with their feet flat and heels together, with their back to the 
stadiometer (Seca model 214, Hamburg, Germany). The participants were asked to inhale and 
maintain a neutral position whilst looking directly ahead. The horizontal headboard was lowered to 
the top of the participants head and height was measured to the nearest 0.1 cm. 
Chapter Three: General Methods 
52 
 
3.3.2 Body Mass Measurement 
Participants were asked to arrive in appropriate minimal clothing with an empty bladder, and to 
remove excessive clothing and items from pockets prior to measurements. Individuals were then 
asked to step onto the electrical digital scales (Seca model 780, Hamburg, Germany), face forward, 
and remain still whilst the measurement was obtained. Body mass was measured to the nearest 0.1 
kg. 
3.4 Peripheral Blood Pressure 
A British Hypertension Society (BHS) approved automated oscillometric device (Omron MX3 Plus, 
Hoofddorp, The Netherlands) was used to indirectly determine peripheral BP (Coleman, Freeman, 
Steel & Shennan, 2005). The cuff was centred over the brachial artery of the left arm after 5 minutes 
of rest and with the participant seated comfortably. The arm was supported at the level of the heart 
and the automated device was initiated. Participants remained still during the measurement and 
environmental stimulus was kept to a minimum.  A duplicate measurement was obtained after a two 
minute interval and an average of the two measurements was recorded. If a difference of greater than 
5 mmHg occurred a third measurement was obtained.  
3.5 Blood Analysis 
Participant’s finger tips were sterilised using an alcohol wipe and allowed to air dry. A lancet was used 
to pierce the skin on the finger and the surface blood was wiped away. Finger capillary blood was 
collected into 10 μl glass capillary tube (EKF-diagnostic GmbH, Barleben, Germany) which were placed 
in 0.5 ml micro-centrifuge tubes with haemolysing solution (EKF-diagnostic GmbH, Barleben, 
Germany). The sample was gently inverted repeatedly to mix and was allowed to rest for 5 minutes 
before being taken to for analysis using the Biosen lactate analyser (Biosen C-line analyser, EKF-
diagnostic GmbH, Barleben, Germany). 
3.6 Respiratory Analysis 
A mask was fitted to ensure an appropriate size was selected. Gas analysis was achieved through on-
line methods using a breath-by-breath respiratory system (MetaLyzer 3B, Cortex Biophysik GmbH 
Leipzig, Germany) and presented through MetaSoft software (Cortex Biophysik GmbH, Leipzig, 
Germany).  The volume transducer and gas sample line were connected to the mask which allowed 
the respiratory system to calculate respiratory parameters. The mask was tightened prior to the test 
and it was ensured that no expired gas was escaping. To do this the investigator placed a flat hand 
over the volume transducer and the participant was asked to breathe hard through the transducer. 
Last minute standardisation of the MetaLyser device was achieved prior to each test by conducting a 
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clean ambient air measurement with the gas sample line stabilised away from interference such as 
breathing and air conditioning. 
Respiratory equipment was calibrated, allowing for 45 minutes of warming up, on each morning of 
tests according to the manufacturer’s guidelines. Firstly, the barometric pressure sensor was 
measured against a reference barometer and offset value was transferred to the device. Next, a 3 litre 
syringe (series 5570 3L syringe, Hans Rudolph, Kansas, U.S.A.) was used to calibrate the volume 
transducer sensor. Lastly, a two-point gas calibration was executed. Clean ambient air with reference 
concentrations of 20.93% O2 and 0.03% CO2, was used for gas 1 measurement. The gas sample line 
was stabilised away from interference such as breathing and air conditioning during this 
measurement. A known reference concentration of oxygen and carbon dioxide was used as the gas 2 
measurement, with expected reference values input to the device prior to measurement. Oxygen and 
carbon dioxide offsets/factors were assessed and the new values were transferred if they were 
acceptable. 
3.7 Heart Rate during Exercise 
Collection of HR was conducted with the use of an electronic HR monitor via telemetry (Polar FT1, 
Polar Electro, Kempele, Finland). An elastic strap connected to a HR monitor was attached around the 
chest of the participant and was adjusted if until the accompanying watch detected values. The HR 
monitor was dampened with water if necessary to enhance conductivity. 
3.8 Rating of Perceived Exertion  
The 15 point Borg (6-20) rating of perceived exertion (RPE) scale was used to measure the subjective 
intensity of exercise. The RPE scale was explained to participants prior to its use, stating that perceived 
exertion is how hard an individual feels their body is working combining physical stress, effort, and 
fatigue; with reference to all parts of the body. Participants were urged to be as honest as possible. 
3.9 Ergometer Rig 
Participant’s bicycles were supported by a stable rear-axle mount trainer stand (CompuTrainer Pro 
8002, RacerMate, Seattle, Washington). The rear tyre was adjusted to the centre of the load generator 
friction roller which was connected to a laboratory computer and monitor allowing for real-time visual 
feedback for each performance test. Tyres were allowed to warm prior to standardising the 
equipment to 3.73 ± 0.07 kg·m·s-2 and drag factor was set to 100%. A magnetic cadence sensor was 
attached to the chain stay and a magnet was attached to the crank arm to operate cadence. The rig 
was set up to automatically make adjustments in load as the protocol changed. For this reason the 
same cadence would produce different workloads at different points of the protocol. 
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3.10 Study 1 Laboratory Environment 
Testing was performed in the Human Performance Laboratory, College Lane Campus, at the University 
of Hertfordshire. The laboratory was maintained at controlled conditions throughout experimental 
procedures (temperature, 22.4 ± 0.9°C; barometric pressure – range, 97.3-102.3 kPa; humidity – 
range, 21-56%). 
3.11 Data Analysis 
Statistical analysis was performed using the Statistical Package for the Social Sciences Version 21 (SPSS 
Inc., Illinois, United States of America). Graphs and box plots were drawn using Microsoft Excel 2013. 
Data were initially analysed to determine normality or non-normality. Where significant interactions 
were observed, Bonferroni post-hoc tests or Wilcoxon signed rank tests were employed to ascertain 
specific effects. Alpha levels were set at 0.05, and adjusted for multiple comparisons where necessary. 
Detailed descriptions of data analysis procedures are given within specific sections. 
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4.1 Abstract 
INTRODUCTION: There are limited longitudinal data investigating the performance and health-related 
influence of beginning ultra-endurance training. Rather, several cross-sectional studies exist finding 
those performing most exercise may be at an increased risk of CV events. It is important to understand 
the expected physiological adaptations of ultra-endurance training for future participants. This 
understanding will allow individuals to track their progress and add to literature regarding the safety 
of such sports. 
PURPOSE: To assess the development of several physiological factors associated with exercise training 
and to gain a greater insight regarding the changes in cardiac electrical conductance from endurance 
training. 
METHOD: Seventy-six previously recreationally active participants (63 males and 13 females) 
underwent a tailored 6 month endurance training programme, in preparation for an iron-distance 
triathlon. Submaximal and exhaustive cycling tests were performed alongside BF assessments at 
months 0, 2, 4 and 6. Part 1 of this study assessed the data from these tests in a male cohort (n = 55, 
34.9 ± 7.4  yr, 178.3 ± 5.6 cm, 79.4 ± 10.2 kg and 46.6 ± 6.1 ml·kg-1·min-1). Participants were also split 
according to age 18-32 (n = 18), 33-38 (n = 17), and 39-50 (n = 20). Part 2 of this study assessed 12-
lead ECG findings recorded at months 0, 2, 4 and 6, in both male (n = 63) and female (n = 13) 
participants. 
RESULTS: All effects are reported as significant at p < 0.05. Part 1: After 6 months, V̊O2max significantly 
increased by 5.4 ml·kg-1·min-1. Of this change, 65% and 79.6% had occurred after 2 and 4 months, 
respectively. HRmax minimally decreased by 2 beats·min-1 4 months into the programme. Maximal 
cycling power increased by 32 watts; 46.9% and 75% of this change was observed after 2 and 4 
months, respectively. BF percentage decreased by 2.3% and lactate threshold increased by 20 watts. 
There were no significant interactions between time point and age group for any variables. Part 2: ECG 
data revealed that rHR decreased bimonthly by 3 beats·min-1 progressively, up to 9 beats·min-1 at 
month 6. Frontal plane vector loops revealed that QRS axis, P wave axis and T wave axis did not change 
significantly after 6 months of training. QT interval was significantly faster at month 2 than month 4 
and 6 by 18 ms and 38 ms, respectively. Additionally, 13% of participants presented abnormal ECG 
findings on at least 1 occasion. Furthermore, there was a progressive increase in the percentage of 
individuals presenting training-related ECG changes from 68%, 78%, 85% and 87%, at month 0, 2, 4 
and 6, respectively. 
CONCLUSION: Training caused significant changes to related physiological factors. Most known 
training-related adaptations occurred in the initial months of training, with smaller changes as training 
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progressed. Age did not influence the training-related adaptations of variables. Abnormal ECG findings 
increased with the duration into the training programme, as did training-related ECG findings. 
Endurance training may induce bioelectrical patterns of abnormal criteria, reflecting a normal change 
to what was previously thought of as abnormal findings, or pathological manifestations in previously 
healthy individuals. 
 
4.2 Introduction 
The ironman distance triathlon is a relatively new event which requires participants to swim 3.86km, 
cycle 180.25km, and run 42.2km. In recent years, the number of individuals participating in ultra-
endurance events has increased vastly (Hoffman, Ong, & Wang, 2010; Knechtle, Knechtle & Lepers, 
2011). Therefore, a greater number of recreationally active participants are deciding to train for these 
prolonged endurance events. Few longitudinal studies have investigated the pattern of CV and 
performance-related physiological adaptations, which initially occur in recreationally active 
individuals deciding to train for ultra-endurance events. Furthermore, the volume of exercise training, 
and the extent of training-induced adaptations, which is necessary to develop individuals to a level 
whereby they are able to complete such events is not well recognised.  
Multiple physiological adaptations occur with endurance training, resulting in an enhanced capacity 
to perform well. Such adaptations include increased type I muscle fibre recruitment, capillary supply 
to skeletal muscle, enzymatic activity of the electron transport chain, as well as a shift in substrate 
utilisation to fat oxidation over glucose, and a reduction in cellular acidosis (Hawley, 2002; Robergs 
et al., 2004; Venables & Jeukendrup, 2008). Further insight of the physiological adaptations 
occurring in preparation for a long-distance triathlon will help monitor the progress of recreational 
athletes in the early period of endurance training. Further insight would enable appropriate 
estimations of sample size requirements, and the sensitivity of associated parameters for future 
studies in the area.  
Studies have identified an increased relative risk of CV disease (CVD) in those performing most aerobic 
exercise, highlighting the possible adverse effects of exercise (Burr, et al., 2014; O’Keefe et al., 2012; 
Paffenbarger et al., 1986; Quinn et al., 1990; Schnohr, Marott, Lange & Jensen, 2013). For this reason, 
ultra-endurance athletes may represent a group of individuals at an elevated risk of CV events. Hence, 
there is ethical concern that with increasing take-up of recreationally active individuals, more persons 
may be unknowingly putting themselves at risk of damaging consequences. The majority of recent 
intervention studies suggest a purely transient reduction in cardiac health in response to a single bout 
of excessive endurance exercise (La Gerche et al., 2008; Shave et al., 2010). However, epidemiological 
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studies suggest an accumulative detrimental response to long-term involvement in excessive 
endurance exercise (Lee, Pate, Lavie & Blair, 2012; O’Keefe et al., 2012). Those athletes presenting 
training-unrelated abnormalities, representative of underlying heart disease, are at an increased risk 
of SCD and of developing life threatening conditions such as arrhythmias and fibrillations (Corrado et 
al., 2010). Investigating the changes to the electrical activity of the heart over a long-term, high load 
training programme will provide an insight of the bioelectrical adaptations of the ‘athlete’s heart’. 
 
4.3 Aims and Hypotheses 
The aim of the current study was to provide a physiological profiling of the changes expected to occur 
in male participants during the initial 6 months of an endurance training programme. Additionally the 
influence of age on laboratory-based physiological adaptations was investigated. Furthermore, the 
study sought to gain an insight of the changes to the electrical activity of the heart over a long-term, 
high load training programme in male participants and assess the frequency of ECG criteria in male 
and female participants. It was hypothesised that training-related physiological parameters such as 
V̊O2max, lactate threshold, maximal power, HRmax, BF, would change throughout the study period. It 
was also hypothesised that endurance training would influence ECG changes such as rHR, vector loops 
and conduction intervals. It was hypothesised that the prevalence of training-related ECG findings 
would increase and there would be no change in training unrelated ECG findings. The full list of 
hypotheses can be found in chapter 1.4. 
 
4.4 Method 
 4.4.1 Participants 
One hundred and ten individuals were recruited to participate in this study. Participants were 
excluded if they: were aged < 18/> 51 yr, participated in a long-distance event previously, not currently 
training 1-4 days per week, non-recreationally active with V̊O2max <35/>55 ml·kg-1·min-1; male and 
<25/>45 ml·kg-1·min-1; female, or had history of heart abnormalities/hypertension/coronary heart 
disease or diabetes. Fifty-five males were carried through to part 1 of this study for analysis, after 
exclusion criteria, withdrawal and missed appointments were accounted for. Age, height, body mass 
and V̊O2max in the selected participants at the beginning of training was 34.9 ± 7.4  yr, 178.3 ± 5.6 cm, 
79.4 ± 10.2 kg and 46.6 ± 6.1 ml·kg-1·min-1, respectively. These selected participants were also split 
according to age 18-32 yr (n = 18), 33-38 yr (n = 17), and 39-50 yr (n = 20) for analysis purposes. In part 
2 of this study, 50 males were initially assessed for training-induced changes in certain ECG 
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parameters, thought to be related to training (5 males from part 1 of the study were excluded due to 
missing ECG data). Seventy-six participants (male = 63, female = 13) were selected to assess the 
frequency of ECG criteria, regardless of missed appointments. It was deemed necessary to include all 
participants in this part of the study, regardless of whether there was missing data at certain time-
points; this was for the reason that excluding data may have resulted in important findings going 
unnoticed. All participants provided written informed consent along with a letter from their respective 
general practitioners. See appendix 4 for a flow diagram of the study methodology and participant 
attrition. 
 4.4.2 Study Design 
This non-randomised longitudinal study involved a 9 month training protocol in preparation for a long-
distance triathlon involving a 3.86 km swim, 180.25 km cycle, and 42.2 km run; of which, the initial 6 
months involved bimonthly assessments. Individuals meeting the inclusion criteria were invited to 
attend the University of Hertfordshire for pre-screening consisting of anthropometric measurements, 
a 12-lead electrocardiogram (ECG) and a cycling V̊̊O2max test. ECG data was screened by a qualified 
cardiologist and volunteers were excluded if abnormality was found.  
Participants were asked to complete a minimum of 80% of the training sessions of a standardised daily 
training programme, designed for this study by a supervisor (Dr Justin Roberts). This programme 
prescribed relative training intensities dependent on HR zones and/or RPE to elicit an equivalent 
physiological stress among participants (Mann, Lamgerts & Lambert, 2014). Participants completed a 
daily activity diary consisting of training type, session RPE (sRPE) and session volume (mins). Weekly 
training load was quantified in arbitrary units (AU) by the sum of each sessions RPE multiplied by the 
volume in minutes (Foster et al., 2001). Training load was assessed over a 3 week period every 2 
months, incorporating a recovery week, a medium intensity week, and a hard week. The average 
weekly assigned training programme (100%) consisted 1789 AU, 2569 AU, and 2961 AU for month 0 
to 2, month 2 to 4, and month 4 to 6, respectively.  Participant weekly training load increased from 
1948 ± 668 AU (month 0 to 2) to 2628 ± 853 AU (month 2 to 4) and 2921 ± 801 AU (month 4 to 6), as 
shown in figure 10.  
Physiological assessment included 4 testing appointments in a 6 month period of 2 month intervals, 
i.e. months 0, 2, 4 and 6. Participants were asked to arrive at least 2 hours fasted. Each testing 
appointment included: anthropometric measurements, a resting 12-lead electrocardiograph (ECG), 
cycling lactate threshold and V̊O2max tests sequentially. All participants were instructed to abstain from 
caffeine containing substances and alcohol (≥12 h), and told to refrain from exercise training for 24 
hours before the tests. Additionally, participants were asked to complete an approved health screen 
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prior to testing. This protocol was approved by the University of Hertfordshire Health and Human 
Sciences Ethics Committee with delegated ethics authority (protocol number: LS6/9/12SRA multi-
disciplinary investigation in the effects of sustained aerobic training in healthy, recreational individuals 
preparing for a long-distance triathlon).   
 
 
 
 
 
 
 
 
 
 
4.4.3 Experimental Procedure 
Participants were welcomed to the laboratory and undertook multiple physiological tests including; 
anthropometric measurements, resting 12-lead (ECG), cycling lactate threshold and cycling V̊O2max 
tests sequentially. 
4.4.3.1 Body Fat Composition 
Sex, activity level (standard for all participants), height, and age were imputed into the bioelectrical 
impedance scales (Tanita BC418MA, Tokyo, Japan) to be used as part of the equation for body 
composition estimations. Estimated clothing weight was set to 0.3 kg for all measurements and 
participants were asked to step onto the scales and face forward whilst body mass was obtained. 
Participants then grasped the handles holding them with straight arms at an angle to their side. 
Electrical conductivity of segmental parts of the body and total body was detected using the 8 polar 
electrodes on the device. Total body fat (BF) percentage was given to the nearest 0.1% by using an 
in-built formula which has high reliability and high correlation with reference criteria measurements 
of body composition (Aandstad et al., 2014; Kelly & Metcalfe, 2012). The Tanita BC418MA model is 
Figure 10. Training load over 6 month period (24 weeks). Training load in arbitrary units (AU) based 
on intensity (session rating of perceived exertion; sRPE) and volume (minutes) of assigned 
programme (mean ± SD of participants weekly training load). 
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medically approved for use in clinical and university studies and hospitals (Medical Devices Directive 
(MDD) approved, non-automatic weighing instruments (NAWI) Class III). 
4.4.3.2 Electrocardiographic Measurements 
Participants were invited into a separated room and rested in the supine position for 5 minutes. 
Participants were asked to remove any excess chest hair prior to their appointments to ensure 
adequate contact with the skin. Electrode sites were cleansed with alcohol wipes and allowed to dry 
before 30 mm electrodes (Cardiacare Ltd. Essex, United Kingdom) were placed in the standard 12-lead 
ECG formation with cables attached to the electrocardiogram (Custo Med GmbH, Munich, Germany). 
Custo card m software (Custo Med GmbH, Munich, Germany) was interfaced with a laptop and used 
to visually display the measurements. Twelve-lead ECG’s (10 mm = 1mV, 50 mm·s-1) were conducted 
by trained investigators on participants in the rested, supine condition.  
Analysis included the frequency of occurrence of criteria for 20 uncommon, training-unrelated 
conditions as previously described in table 1. Five training-related conditions were assessed for 
frequency of occurrence including sinus bradycardia, first degree atrioventricular (AV) block, 
incomplete RBBB and isolated voltage for LVH as defined by Sokolow and Lyon (1949) criteria (table 
1). ECG’s of the entire population were analysed by computer-generated values with the exception of 
manual interpretation where values were not computed or obvious errors were apparent. 
4.4.3.3 Lactate Threshold Test 
A capillary blood sample was collected after resting ECG’s had been obtained. Participants cycled for 
8 minutes at a set intensity of 40% maximal work output (from pre-screening assessment), using the 
drag factor programme on the CompuTrainer. Participants then began a cycling lactate threshold 
protocol starting at an appropriate intensity for the individual’s ability with drag factor set to 100%. 
Visual performance data was available to the participant during the test including: cadence, power, 
speed, and duration. Athletes were instructed to match real time power with expected load and to 
maintain a consistent cadence throughout, suggested at 90 revolutions per minute (RPM). The 
protocol consisted of 4 minute stages which included a 30 second ‘ramp’ of 15/20 watts, which marked 
the beginning of a new stage. A mask was attached for the full protocol and gas analysis was achieved 
by using the MetaLyzer equipment (chapter 3.6). Respiratory data was analysed from 2-3 minutes 
during each stage. RPE and HR were collected immediately prior to capillary blood samples at 3 
minutes of each stage (chapter 3.7 and chapter 3.8). The investigator terminated the exercise test 
when lactate levels rose substantially above pre-test levels or RER > 1.0 and RPE ≥ 15. The point of 
lactate threshold was termed as the stage before which a direct identification of a ‘break-point’ was 
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observed in the blood lactate accumulation curve (Spurway & Jones, 2007). Power produced during 
this stage was used in the analysis.   
4.4.3.4 Maximal Exhaustion Test 
The V̊O2max protocol consisted of a 10 watt ramp increment every minute starting at one level below 
the lactate threshold power. Performance data was available to the participant during the test 
including: cadence, power, speed, and duration. Athletes were instructed to match real time power 
with expected load and to maintain a consistent cadence throughout, suggested at 90 RPM. 
Participants were instructed to continue with the test until maximal exhaustion. A mask was attached 
for the full protocol and gas analysis was achieved by using the MetaLyzer equipment (chapter 3.6). 
RPE and HR were collected in one minute intervals. Maximal HR and maximal load were observed as 
the participant reached exhaustion. Participants then underwent a 5 minute warm down at an 
undetermined power. Investigators were advised that a test was considered applicable for analysis if 
at least 2 of the following criteria were fulfilled: a levelling off of V̊O2 (no greater than 2.1 ml·kg-1·min-
1 over a 60 second period), as derived from Taylor, Buskirk, and Henschel (1955); a HR within 10 
beats·min-1 of predicted maximum; peak RER values were greater than 1.10; in addition it was 
essential that Borg’s RPE values were ≥ 18. These values were preferred in accordance with the 
majority of previous recent research (Midgley et al., 2007). V̊O2max was averaged over a 60 second 
period in accordance with previous research (Achten, Venebles & Jeukendrup, 2003; Jobson et al., 
2008), and was manually adjusted to avoid automated placement errors and reflect an appropriate 60 
second period that contains the V̊O2plateau. V̊O2max relative to body mass was calculated by dividing the 
maximal volume of oxygen in millilitres by the body mass of the individual, in kilograms. 
4.4.4 Data Analysis 
Statistical analysis was performed using the Statistical Package for the Social Sciences Version 21 (SPSS 
Inc., Illinois, United States of America). Study 1 of the thesis was split into 2 sections with different 
statistical tests conducted for each. The first part of this study focused on the CV and performance-
related physiological measurements obtained in the male population, with secondary emphasis on 
age as a factor. Variables analysed in the first section included V̊O2max relative to body mass, V̊O2max 
absolute, HRmax, maximal cycling power output, BF percentage, and cycling power output at lactate 
threshold. The second part of the results focused on resting 12-lead ECG data obtained over the same 
6 month training period. The variables analysed in this section include resting rHR, QRS complex axis, 
P wave axis, T wave axis, QTc interval and QRS interval. Additionally, descriptive statistics are 
presented for the frequency of occurrence of criteria for non-training-related ECG abnormalities, as 
well as training-related ECG findings. 
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4.4.4.1 Pre-Test Assumptions and Statistical Tests 
4.4.4.1.1 Part 1 – Laboratory-Based Variables  
In order to ensure that parametric test could be run, pre-analysis checks were undertaken. 
Kolmogorov-Smirnov tests of normality were combined with visual analysis of box plots and P-P plots 
to assess the null hypothesis that data for within-subjects analysis was normally distributed (n = 55). 
There was a significant violation to Kolmogorov-Smirnov tests of normality for the power produced at 
lactate threshold, p < 0.05. All other variables remained insignificantly non-normal according to 
Kolmogorov-Smirnov tests. Visual analysis of box plots and P-P plots were again utilised, in this 
instance to assess the distribution of data between age groups. Additionally Shapiro-Wilk tests of 
normality were considered due to the lesser number of participants between age groups (18-32, n = 
18; 33-38, n = 17; and 39-50, n = 20). Slight violations to the Shapiro-Wilk test are discussed in results 
section, however it should be noted that the ANOVA procedure is robust to slight violations of 
normality within a dataset (Field, 2009).  
Levene’s test of equality of error variances was performed on all dependent variables across time 
levels. Levene’s test was found to be significant (p < 0.05), representing a violation to the assumption 
of homogeneity of variance, and is further mentioned in the analysis. Depending on the extent of the 
violation, such situations resulted in a more conservative alpha level of 0.025 (Tabachnick & Fidell, 
2013).  
Mauchly’s sphericity test was used to assess the assumption of sphericity within repeated-measures 
effects. Unless stated otherwise Mauchly’s test was insignificant (p > 0.05), therefore the assumption 
of sphericity was accepted. Greenhouse-Geisser correction for sphericity was used if the estimate of 
sphericity (ε) was < 0.75 and Huyne-Feldt correction was used if the statistic was > 0.75 (Girden, 1992). 
Due to the nature of this study it is unsuprising that Mauchly’s test would be violated. The majority of 
differences in training-related dependent variables are likely to occur within the first periods of 
training for this sample population. 
A two-way mixed measures analysis of variance (ANOVA) was conducted with time as the within-
subjects factor (4 levels; month 0, month 2, month 4, and month 6) and with age as the between-
subjects factor (3 levels; level 1: 18-32 [n = 18], level 2: 33-38 [n = 17], and level 3: 39-50 [n = 20]). Age 
groups were designed to allow for sample sizes to be as equal as possible. Relative V̊O2max, absolute 
V̊O2max, HRmax, maximal cycling power output, and BF percentage were inserted as dependent 
variables. If a main time effect existed Bonferroni corrections for multiple comparisons were used to 
perform pairwise comparisons between all levels of time. Simple main effects were investigated by 
means of Bonferroni comparisons, adjusted for multiple comparisons, on the between-subjects factor 
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at each level of time. Parametric data were reported as mean ± SD. Due to deviations from normality, 
the Friedman test was conducted with cycling power output at lactate threshold as the dependent 
variable. Post hoc comparisons were carried out using Wilcoxon signed-rank tests. Non-parametric 
data were reported as median (interquartile range). 
4.4.4.1.2 Part 2 – Resting Electrocardiograph Variables 
Kolmogorov-Smirnov tests of normality were combined with visual analysis of box plots and P-P plots 
to assess whether data was normally distributed (n = 50). The majority of data severely violated the 
Kolmogorov-Smirnov tests, suggesting a non-normal distribution. For this reason the Friedman test 
was conducted, which does not assume normality in the distribution of data. 
Friedman’s test has been reported as chi-square (χ2), with degrees of freedom (df), and significance 
level; χ2(df) = statistic, p = significance. This analysis reports whether there is an overall difference in 
the dependent variable being investigated. If significance was observed, post hoc analysis with 
Wilcoxon signed-rank test was conducted on the different combinations with a test statistic Z. The 
Bonferroni adjustment for multiple comparisons was undertaken to obtain a new significance level of 
0.008 (0.05/6). In other words, if the p value was larger than 0.008 the result was not statistically 
significant. Median (IQR) values are reported with statistical test statistics.  
 
4.5 Results 
4.5.1 Iron-Distance Performance 
Of the 68 participants who started the iron-distance triathlon in month 9, 56 (82%) crossed the finish 
line. Five participants were unable to start the race and 12 participants did not finish. 
4.5.2 Part 1 – Laboratory-Based Variables 
The results section contains a description of findings for each variable in sequential order. Violations 
within the variable dataset were outlined together with precautions made to control for the 
violations. Within-subject comparisons of time were first identified and, if significant, were followed 
by pairwise comparisons. The interaction effect was then described followed with simple main 
effects to ascertain the locations of significance. Lastly, the main effect of age group on the 
dependent variable was described. See appendix 5 for a full descriptive data of variables. 
4.5.2.1 Cardiorespiratory Fitness 
4.5.2.1.1 Maximal Volume of Oxygen Consumption Relative to Body Mass 
Oxygen consumption was averaged over a 60 second period where values were largest. The volume 
of oxygen consumption, in millilitres, was divided by body mass, in kilograms, of the participant 
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(V̊O2max). Within-subjects tests found a significant main effect of time on relative V̊O2max, F(3, 156) = 
30.45, p < 0.001, ηp2 = 0.37. Pairwise comparisons revealed significant differences between baseline 
(46.6 ± 6.1 ml·kg-1·min-1) and all other months (month 2, 50.1 ± 6.1 ml·kg-1·min-1; month 4, 50.9 ± 5.9 
ml·kg-1·min-1; month 6, 52.0 ± 5.6 ml·kg-1·min-1), p < 0.001. Significant comparisons were not observed 
further than the inclusion of month 0. A significant increase in relative V̊O2max was found between 
month 0 and 2 as demonstrated in figure 11. Mean values remained larger for the duration of the 
training programme, but did not increase significantly more compared to other preceding months. As 
such, in 6 months V̊O2max increased by 5.4 ml·kg-1·min-1. Of this change, 65% and 79.6% had occurred 
after 2 and 4 months, respectively. No significant interaction effects were observed between the level 
of time into training and the age group of participants on relative V̊O2max. This indicates that the effect 
of exercise training on relative V̊O2max did not affect participants of different ages disproportionately. 
There was a significant main effect of age after between subject’s analyses. Pairwise comparisons 
revealed that the youngest age group (18-32 yr) had significantly greater relative V̊O2max values 
compared to the eldest age group (39-50 yr) with a mean overall difference of 5.15 ml·kg-1·min-1, p < 
0.05. 
 
 
 
 
 
 
 
 
 
 
4.5.2.1.2 Absolute Maximal Volume of Oxygen Consumption 
A significant main effect of time was observed for the dependent variable absolute V̊O2max, F(3, 156) = 
23.31, p < 0.001, ηp2 = 0.31. Bonferroni pairwise comparisons revealed significant differences between 
baseline (3.675 ± 0.454 L·min-1) and all other months (month 2, 3.946 ± 0.549 L·min-1; month 4, 3.999 
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Figure 11. Comparison of maximal volume of oxygen consumption (V̊O2max) relative to body weight 
between levels of time (mean ± SD). Data represents all male participants who underwent a 
progressive training programme over the course of the study. 
a. significantly different from month 0, p < 0.001. 
Chapter Four: Study 1 
66 
 
± 0.506 L·min-1; month 6, 4.035 ± 0.464 L·min-1), p < 0.001. No significantly different comparisons were 
observed past the inclusion of month 0. An interaction effect of time and age group was not significant, 
F(6, 156) = 1.00, p = 0.44, ηp2 = 0.04. These results, shown in table 4, suggest that absolute V̊O2max 
increased significantly from baseline and took the same trend through the training programme 
irrespective of age. Between-subjects analysis showed a non-significant effect of age group, F(2, 52) = 
1.19, p = 0.31, ηp2 = 0.04. This result suggests absolute V̊O2max was statistically similar between age 
groups. The statistical inferences are similar to that observed for relative V̊O2max, described above, in 
that significant differences are only observed when comparing baseline values. 
4.5.2.1.3 Cycling Power produced at Lactate Threshold 
Power at lactate threshold was not analysed as part of the mixed measures ANOVA or with a repeated 
measures only ANOVA due to the large deviation of normality. Kolmogorov-Smirnov tests of normality 
revealed a highly significant violation to the assumption of normality at month 0, D(55) = 0.20, month 
2, D(55) = 0.21, month 4, D(55) = 0.17, and month 6, D(55) = 0.25; p < 0.001. Additionally, power at 
lactate threshold violated the Shapiro-Wilk assumption of normality test for ages 18-32 at month 0; 
W(18) = 0.772, p < 0.05, month 4; W(18) = 0.87, p < 0.05, and month 6; W(18) = 0.80, p < 0.05. Values 
for power at lactate threshold for ages 33-38 were significantly non-normal at month 6, W(17) = 0.89, 
p < 0.05. The null hypotheses that data was non-normally distributed for ages 39-50 was rejected at 
month 0; W(20) = 0.887, p < 0.05, and month 6, W(20) = 0.86, p < 0.05. 
Within-subjects analysis of cycling power produced at lactate threshold was conducted with the 
Friedman’s test. There was a statistically significant difference in power production χ2(3) = 35.63, p < 
0.001, as shown in figure 12. Median (IQR) power was 160 watts (140 to 170 watts), 160 watts (140 
to 180 watts), 180 watts (160 to 180 watts) and 160 watts (160 to 180 watts) at month 0, 2, 4 and 6, 
respectively. Wilcoxon signed-rank test were performed with Bonferroni multiple comparisons 
adjustment to obtain a new significance level of 0.008 (0.05/6). Wilcoxon signed-rank tests revealed 
significant differences between month 0 and month 4 (Z = -4.39, p < 0.001), and month 6 (Z = -4.58, p 
< 0.001), despite no differences in median values at month 0 and month 6. Additionally, significant 
differences were observed between month 2 and month 4 (Z = -3.95, p < 0.001).  
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4.5.2.1.4 Maximal Power Output during Cycle Test 
Maximal power was defined as the load, in watts, at which individuals could not cycle any longer 
during a continually increasing maximal test. A significant main effect of time on maximal power was 
found, F(3, 156) = 44.04, p < 0.001, ηp2 = 0.46. Pairwise analysis revealed differences between all 
possible comparisons. Maximal power at month 0 was lowest compared with month 2, 4 and 6 (274 ± 
36 watts vs. 289 ± 38 watts, 298 ± 38, and 306 ± 37 watts, respectively; p < 0.001) as presented in 
figure 13. Maximal power at month 2 was significantly lower than month 4, p < 0.005, and month 6, p 
< 0.001. Likewise, power at month 4 was significantly lower than month 6, p < 0.05. Overall, maximal 
cycling power increased by 32 watts; 46.9 and 75% of this change was observed after 2 and 4 months, 
respectively. 
No significant time and age group interaction was observed, F(6, 156) = 0.83, p = 0.55, ηp2 = 0.03. 
Similarly, no significant between-subjects effect was found for age group on maximal power produced, 
F(2, 52) = 0.84, p < 0.44, ηp2 = 0.03.  
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Figure 12. Comparison of cycling power output at lactate threshold during 6 months of a training 
programme in a male sample.  
Upper box, upper 75% of values; lower box, lower 25% of values; middle/thick line, median; highest 
whisker, maximal value; lower whisker, minimum value.  
a. significantly different from month 0, p < 0.001. 
b. significantly different from month 2, p < 0.001. 
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4.5.2.1.5 Maximal Heart Rate 
HR was continually observed during a progressively increasing cycle test to obtain a maximal value. 
Equal variance in HRmax between time-points was not accepted. Mauchly’s test of sphericity was 
significant therefore the assumption of equal variances between time-points was rejected, χ2 (5) = 
16.00, p < 0.05. To correct for this violation Huyne-Feldt adjustment for degrees of freedom was 
adopted ε = 0.90. Analysis showed a significant main time effect of HRmax, F(2.71, 141.06) = 4.40, p < 
0.05, ηp2 = 0.08. Bonferroni pairwise comparisons revealed a significant difference of 2 beats·min-1 
between month 0 and month 4 only (184 ± 9 beats·min-1 vs. 182 ± 9 beats·min-1, p < 0.05). Comparisons 
of HRmax at month 0 with month 2 (183 ± 9 beats·min-1) and month 6 (182 ± 9 beats·min-1) remained 
statistically insignificant, p > 0.05. Means are presented in table 4. No significant interaction effect of 
time and age was found, F(5.43, 141.06) = 8.18, p = 0.78, ηp2 = 0.02. 
Between-subjects analysis revealed a significant main effect of age, F(2, 52) = 5.50, p < 0.05, ηp2 = 
0.18. Pairwise comparisons identified a statistically significant difference between the means of HRmax 
in the youngest age group (18-32 yr) and the eldest age group (39-50 yr), mean difference 8 ± 3 
beats·min-1 , p < 0.05. HRmax was greater overall in the younger group compared with the eldest group 
of participants. 
Figure 13. Comparison of maximal power output during a cycle test between different levels of time 
(mean ± SD). Data represents all male participants who underwent a progressive training 
programme over the course of the study. 
a. Significantly different from month 0, p < 0.001. 
b. Significantly different from month 2, p < 0.005. 
c. Significantly different from month 2, p < 0.001. 
d. Significantly different from month 4, p < 0.05. 
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4.5.2.1.6 Body Fat 
Average total BF percentage was hypothesised to decrease in the sample as the training programme 
progressed. Pre-test assumptions were violated for Mauchly’s test of sphericity, χ2 (5) = 35.25, p < 
0.001, indicating the differences between time-points were unequal. As a result of this violation, 
degrees of freedom were corrected using Greenhouse-Geisser method, ε = 0.72. Within-subjects 
ANOVA tests found a significant effect of time on BF percentage, F(2.12, 112.94) = 20.00, p < 0.001, 
ηp2 = 0.28. A significant difference was observed between baseline (month 0: 18.6 ± 5.7%) and month 
2 (17.7 ± 5.3%, p < 0.005), month 4 (17.1 ± 5.1%, p < 0.001), and month 6 (16.3 ± 5.4%, p < 0.001) as 
presented in table 4. Similarly, significant differences were observed between month 2 and month 6 
(p < 0.005). BF percentage approached significance between month 4 and month 6 (p = 0.05). In 6 
months of endurance training, BF percentage decreased by 2.3%; 46.9% and 75% of this change was 
observed after 2 and 4 months, respectively. 
There was no significant interaction effect of time and age, F(4.34, 112.94) = 0.57, p = 0.70, ηp2 = 
0.021. Likewise the main effect of between-subjects factor, age group, was insignificant, F(2, 52) = 
2.38, p = 0.10, ηp2 = 0.08. The results suggest BF percentage decreased significantly over time and 
that age did not significantly affect the decrease in BF percentage. 
 
Table 4. Maximal oxygen consumption, maximal heart rate and body fat percentage  
Measurement Age Category Month 0 Month 2 Month 4 Month 6 
Absolute V̊O2max 
(L·min-1) 
18 to 32 yr 
33 to 38 yr 
39 to 50 yr 
Total 
 
3.666 ± 0.399 
3.855 ± 0.523 
3.529 ± 0.403 
3.676 ± 0.454 
3.867 ± 0.487 
4.103 ± 0.575 
3.885 ± 0.579 
a 3.946 ± 0.549 
3.928 ± 0.467 
4.077 ± 0.512 
3.998 ± 0.550 
a  3.999 ± 0.506 
3.981 ± 0.411 
4.173 ± 0.431 
3.968 ± 0.530 
a 4.035 ± 0.464 
Maximal Heart 
Rate (beats·min-1) 
18 to 32 yr 
33 to 38 yr 
39 to 50 yr 
Total 
 
189 ± 9 
182 ± 6 
181 ± 9 
184 ± 9 
187 ± 10 
182 ± 6 
180 ± 8 
183 ± 9 
187 ± 9 
180 ± 7 
179 ± 9 
a 182 ± 9 
187 ± 10 
181 ± 9 
178 ± 8 
182 ± 9 
Body Fat (%) 18 to 32 yr 
33 to 38 yr 
39 to 50 yr 
Total 
 
16.5 ± 4.9 
18.3 ± 5.9 
20.7 ± 5.6 
18.6 ± 5.7 
15.9 ± 5.1 
17.3 ± 5.3 
19.6 ± 5.3 
a 17.7 ± 5.3 
15.4 ± 4.5 
16.7 ± 5.4 
18.8 ± 5.1 
a 17.1 ± 5.1 
14.9 ± 5.0 
15.8 ± 5.8 
17.8 ± 5.1 
a b 16.3 ± 5.4 
V̊O2max = maximal volume of oxygen consumption; yr = years 
Age category, 18 to 32 (n = 18); 33 to 38 (n = 17); 39 to 50 (n = 20). a significantly different form month 0; b 
significantly different from month 2. 
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4.5.3 Part 2 - Resting 12-lead Electrocardiographic Variables 
The ECG data used in statistical analysis over the 6 month training period included resting rHR, QRS 
complex axis, P wave axis, T wave axis, QTc interval and QRS interval. This data reflects the male 
population of participants, from which full data was available at every appointment (n = 50). 
Additionally, the frequency of occurrence of criteria for non-training-related ECG abnormalities and 
training-related ECG findings were assessed in male and female participants (n = 76; M = 63, F = 13). 
A greater number of participants were selected since all ECG appointments were considered to 
avoid the loss of important findings. 
4.5.3.1 Resting Heart Rate 
It was predicted that rHR would decrease throughout the training programme. There was a statistically 
significant difference in rHR depending on the time-point at which measurements were obtained, χ2(3) 
= 23.42, p < 0.001. Post hoc analysis with Wilcoxon signed-rank tests was conducted with Bonferroni 
correction applied. rHR values at month 0, 2, 4 and 6 were 59 beats·min-1 (52 to 65 beats·min-1), 56 
beats·min-1 (48 to 61 beats·min-1), 53 beats·min-1 (47 to 61 beats·min-1) and 50 beats·min-1 (47 to 58 
beats·min-1), respectively as shown in figure 14. There was a significant difference in rHR between 
month 0 and month 2 (Z = -3.07, p < 0.008), month 4 (Z = -3.68, p < 0.001), and month 6 (Z = -4.52, p 
< 0.001). Significance was not observed between other combinations of time-points.  
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Figure 14. Comparison of resting heart rate (rHR) values obtained by a 12-lead 
electrocardiogram at several time-points during a training programme. 
Upper box, upper 75% of values; lower box, lower 25% of values; middle line, median; highest 
whisker, maximal value; lower whisker, minimum value.  
a. significantly different from month 0 (start of training programme), p < 0.001. 
a a 
a 
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4.5.3.2 Frontal Plane ECG Vector Loop  
The summative direction of the electrical conductance from the QRS complex, P wave, and T wave of 
the frontal plane were obtained during 12-lead ECG analysis. There was no statistically significant 
difference in QRS complex axis any time-points of the training programme, χ2(3) = 4.95, p = 0.18.  
Median QRS axis values at month 0, 2, 4 and 6 were 52° (44 to 62°), 52° (35 to 65°), 53° (40 to 61°), 
and 55° (42 to 62°), respectively. Similarly, no significant differences were observed between time-
points for P wave axis direction (χ2(3) = 1.75, p = 0.63), and T wave axis direction (χ2(3) =  1.30, p = 
0.73).  
4.5.3.3 Electrical Conduction Intervals  
There was a statistically significant difference in QTc interval depending on the time into the training 
programme, χ2(3) = 25.13, p < 0.001. QTc was 409 ms (393 to 424 ms) at month 0, 422 ms (404 to 444 
ms) at month 2, 404 ms (388 to 420 ms) at month 4, and 384 ms (402 to 418 ms) at month 6. Wilcoxon 
signed-rank tests revealed a significant difference between month 2 and month 4 (Z = -3.42, p < 0.008), 
and month 6 (Z = -3.86, p < 0.001). This indicates that QTc was longer at month 2 in comparison to 
month 4 and month 6, as displayed in figure 15. Likewise, there was no significant difference in QRS 
interval between time-points as identified by the Friedman’s test, χ2(3) = 4.17, p = 0.24.  
 
 
 
 
 
300
350
400
450
500
550
Month 0 Month 2 Month 4 Month 6
Q
T 
in
te
rv
al
 C
o
rr
ec
te
d
 f
o
r 
H
ea
rt
 R
at
e 
o
f 
6
0
 b
ea
ts
·-1
(m
s)
Time
Figure 15. Comparison of QT interval corrected for a heart rate of 60 beats·-1 by Bazzetts 
formula. Values were obtained using a 12-lead electrocardiogram at several time-points during 
a training programme. 
Upper box, upper 75% of values; lower box, lower 25% of values; middle line, median; highest 
whisker, maximal value; lower whisker, minimum value.  
b. significantly different from month 2, p < 0.001. 
b 
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4.5.3.4 Group 1, Training-Unrelated Electrocardiographic Abnormalities 
Two-hundred and ninety three 12-lead ECG tracings were obtained from 77 individuals. A total of 34 
abnormal ECG findings were identified in 10 participants. This suggests that 13% of individuals 
displayed abnormal training-unrelated ECG criteria on at least 1 time-point. The frequency and 
distribution of training-unrelated ECG findings are presented in table 5. 
ECG criteria was not fulfilled at any stage for T wave inversion, ST segment depression, complete left 
or right bundle branch block (BBB), left atrial enlargement (LAE), (RVH), ventricular pre-excitiation, 
short QT interval, profound bradycardia, premature ventricular arrhythmias and atrial 
tachyarrhythmias. Six participants (a, d, e, q, g, x) were found to have abnormal ECG criteria fulfilled 
only at one time-point for a condition, indicating a potential abnormality or lead placement error. 
Potential lead placement errors are noted when necessary. 
Pathologically deep Q waves (> 3mm depth) were observed in participant “a” at month 2, which were 
not preceded at month 0 and did not persist at month 4 or 6. QRS complex axis was similar at month 
0, 2, 4, and 6 (28°, 33°, 29° and 25° respectively) therefore the occurrence of a deep Q wave is unlikely 
to be due to an extreme rotation of the heart. 
Participant “d” presented criteria for right atrial enlargement (RAE; high pointed P wave, ≥0.25 m, in 
leads II and II or V1) at month 4 which was not present at month 0 or month 2 and did not persist to 
month 6, although displayed borderline RAE. The criteria for RAE was also fulfilled in participant “c” 
at month 2 and month 6 and was borderline at both months 0 and 4. Long QT interval was also 
identified for participant “c” at month 4 and 6 but not at month 0 or 2, though almost fulfilled criteria 
at month 0 (QTc = 467 ms). 
Participant “b” was recognised as having left axis deviation (LAD), intraventricular conduction delay, 
first degree atrioventricular block, and early repolarisation in several ECG tracings. LAD was a 
consistent finding throughout the bimonthly ECG analysis (figure 16). Criteria for intraventricular 
conduction delay was almost satisfied at month 0 (QRS duration = 118 ms) and was fulfilled from 
month 2 to month 6. 
LAD was observed at month 0, 2 and 6 for participant “w”. Criteria for LAD was not met at month 4, 
although a QRS axis of -28° was close to fulfilling the condition. Likewise, LAD criteria was seen in only 
1 of the 4 ECG tracing’s for participant “q”. Criteria was not fulfilled at month 0, was almost met at 
month 2, and exceeded criteria at month 4 but not at month 6 (28°, -25°, -45°, and 2° respectively). 
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Month 0 
Month 2 
Month 4 
Month 6 
LAD in participant “r” 
QRS axis  =  - 65° 
QRS axis  =  - 64° 
QRS axis  =  - 71° 
QRS axis  =  - 59° 
Normal QRS axis 
QRS axis  =  92° 
QRS axis  =  89° 
QRS axis  =  88° 
QRS axis  =  92° 
Figure 16. Frontal plane vector loop of left axis QRS deviation (LAD) in participant “r”; left side, and 
an example of a normal QRS axis of a healthy athletic individual. 
QRS axis is considered to have a LAD if the mean electrical axis of ventricular contraction lies between -
30° and -90°. A normal QRS axis for endurance trained individuals usually lies between -30 and 120°. Past 120° 
a QRS axis is considered to have a right axis deviation (RAD). 
Note: P and T wave axis are similar between individuals. 
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RAD was observed in one participant (g) at month 6 which was combined with extreme p wave and t 
wave axis deviation, none of which were found in previous months.   
One participant (“e”) displayed criteria for intraventricular conduction delay at month 6 only, and for 
right atrial enlargement at month 4 only. QRS duration was borderline for intraventricular conduction 
delay in the months leading to month 6 for participant “e”.  
Long QT interval was observed in participant “x” at month 0 but was not observed in subsequent ECG 
tracings for the same participant. rHR was 88 beats·min-1 at month 0 for participant “x”, resulting in 
an exaggerated QTc. Indeed rHR reduced to 68, 67 and 67 beats·min-1 (month 2, 4 and 6 respectively). 
It is supposed that the 1 case of right axis deviation (“g”) may have been erroneous as a result of 
incorrect lead placement. P, QRS, and T axis were all deviated at month 6 with this subject but were 
normal in previous ECG’s. An epsilon wave appeared at month 2 in participant “r” and was continually 
found in subsequent ECG’s for this individual (figure 17). 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B 
C D 
Figure 17. Epsilon wave in participant “r”, depicted as a small negative deflection just beyond the 
QRS complex in V1 highlighted by a red circle. 
A, month 0; B, month 2; C, month 4; D, month 6. 
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4.5.3.5 Group 2, Common Training-Related Electrocardiographic Findings 
Frequency and distributions of training-related ECG findings are presented in table 6. At the start of 
the training programme 68.1% of participants displayed a training-related ECG finding. The most 
common finding was sinus bradycardia, defined by a HR below 60 beats·min-1, among all time-points. 
The percentage of participants with training-related ECG findings increased at month 2, 4 and 6 
(77.9%, 85.1%, and 87.1% respectively). The percentage of female participants presenting training-
Table 5. Frequency and distribution of group 1, abnormal ECG criteria. 
 Month 
Abnormal ECG finding 
0 
(n = 72) 
2 
(n = 77) 
4 
(n = 74) 
6 
(n = 70) 
Fr
eq
u
en
ci
es
 
T wave inversion     
ST segment depression     
Q wave abnormality  a   
CLBBB     
CRBBB     
Intraventricular conduction delay  b b b, e 
LAE     
RAE  c d, e c 
LAD b, w b, w b, q b, w 
RAD    g 
RVH     
Ventricular pre-excitation     
Long QT interval x  c c 
Short QT interval     
Epsilon wave  r r r 
Profound bradycardia     
Premature ventricular arrhythmias     
Atrial tachyarrhythmias      
     
Frequency of abnormalities: TOTAL 3 6 7 8 
% of participants showing ≥ 1 ECG abnormality 4.2% 6.5% 8.1% 8.6% 
Frequency of abnormalities: Male 1 (n = 59) 5 (n = 64) 7 (n = 61) 7 (n = 57) 
% of Males showing ≥ 1 ECG abnormality 3.4% 6.3% 8.2% 8.8% 
Frequency of abnormalities: Female 2 (n = 13) 1 (n = 13) 0 (n = 13) 1 (n = 13) 
% of Females  showing ≥ 1 ECG abnormality 7.7% 7.7% 0% 7.7% 
Note: Alphabetised participant identification. Month 0 ECG data was not available for participant e and g.  
Those with long QT interval were below the cut-off value for unequivocal long QT. 
CLBBB, Complete left bundle branch block; CRBBB, complete right bundle branch block; LAE, left atrial 
enlargement; LAE, right atrial enlargement; LAD, left axis deviation; RAD, right axis deviation; RVH, right 
ventricular hypertrophy; M, male; F, female. 
“a”, “b”, “c”, “d”, “e”, “g”, “q”  and “r” were male participants. 
“w” and “x”, were female participants. 
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related findings did not change throughout the 6 month period. The total frequency of training-related 
findings increased during the 6 month training period from 64 at month 0, to 88 at month 2, and to 
98 at month 4 and 6. Seven female participants displayed a rHR below 60 beats·min-1 (sinus 
bradycardia) at month 0 which remained throughout to month 6. Only 1 other training-related finding 
was observed in the female population which was first degree AV block. Criteria for first degree AV 
block was found at month 0 and month 6 for this participant.  
Table 6. Frequency and distribution of group 2, training-related ECG findings. 
 Month 
ECG finding 
0  
(n = 72) 
2  
(n = 77) 
4 
(n = 74) 
6  
(n = 70) 
Fr
eq
u
en
ci
es
 Sinus bradycardia 38 47 51 52 
First degree AV block 5 8 8 8 
Early Repolarisation 12 17 20 21 
Incomplete RBBB 7 7 7 6 
Isolated voltage criteria for LVH 2 9 12 11 
     
Frequency of training-related findings: TOTAL 64 88 98 98 
% of participants showing ≥ 1 training-related 
findings 68.1% 77.9% 85.1% 87.1% 
Frequency of training-related findings: Male 56 (n = 59) 81 (n = 64) 91 (n = 61) 90 (n = 57) 
% of Males showing ≥ 1 training-related findings 71.2% 82.8% 91.8% 94.7% 
Frequency of training-related findings: Female 8 (n = 13) 7 (n = 13) 7 (n = 13) 8 (n = 13) 
% of Females showing ≥ 1 training-related findings 53.8% 53.8% 53.8% 53.8% 
Note: AV, atrioventricular; RBBB, right bundle branch block; LVH, left ventricular hypertrophy. 
 
 
 
 
4.6 Discussion 
4.6.1 Part 1 
4.6.1.1 Maximal Volume of Oxygen Consumption 
The present study confirms the hypothesis that endurance training over a 6 month period would 
increase V̊O2max. These results confirm the findings of multiple previous studies (Isawaki et al., 2003; 
Jones & Carter, 2000), showing that in this investigation, 6 months endurance training increased 
V̊O2max by 5.4 ml·kg-1·min-1. Of this change, 65% and 79.6% had occurred after 2 and 4 months, 
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respectively. This finding supports the suggestion that large adaptations occur at the beginning of a 
training programme, followed by smaller adaptations with enhanced endurance ability (Isawaki et al., 
2003; Scharhag-Rosenberger, Meyer, Walitzek & Kindermann, 2009). The extent of increases to V̊O2max 
from endurance training depend on various factors including the initial fitness of the study population, 
the duration, intensity and frequency of training sessions, as well as the duration and intensity of the 
training programme (Jones & Carter, 2000). Changes in relative V̊O2max are understandably heavily 
influenced by body weight reductions, however the present study also revealed similar results 
regarding absolute V̊O2max. Absolute V̊O2max increased by 0.36 L·min-1 after 6 months of training, and 
was also only significantly different from baseline throughout the study.  
Differences in V̊O2max of 5.15 ml·kg-1·min were observed between the youngest and eldest age groups, 
consistent with other investigations (Kasch et al., 1999; Tanaka et al., 2000). Previous data has 
observed losses of 5.8 to 6.8% per decade (Kasch et al., 1999). Multiple mechanisms may be 
responsible for the age associated decline in V̊O2max including, a decrease in exercise training stimulus, 
changes in body weight, and physiological determinants such as HRmax and stroke volume (Tanaka & 
Seals, 2003). Differences in body weight is likely the major factor of the age-related differences in this 
study since absolute V̊O2max was not found to be different between groups.  
4.6.1.2 Lactate Threshold 
The hypothesis that lactate threshold would be augmented due to endurance training was accepted. 
Lactate threshold significantly increased by month 4 and month 6 compared to the start of the training 
period, although median values were only greater at month 4. The intensity at which lactate threshold 
occurs has been identified as a powerful predictor of endurance performance (Jones & Carter, 2000). 
A major influencing factor is due to the coinciding cellular acidosis with lactate production; reducing 
its accumulation delays active muscular fatigue (Robergs et al., 2004). 
Due to the nature of the outcome goal of the training programme designed for the present study 
participants (success in an iron-distance triathlon), there was a greater emphasis on lower HR zones 
and greater durations of exercise. Therefore, aerobic energy pathways were specifically targeted, and 
hence greater increases to lactate threshold were expected. Contrary to this, maximal power output 
rose progressively throughout the programme discussed in chapter 4.6.1.3. The training programmed 
was designed relative to individual’s HR zones and perceived exertions, rather than absolute to 
training speeds.  Nonetheless, it is possible that the programme did not provide sufficient stimulus for 
adaptation for those of a greater athletic status at the start, compared to their more sedentary 
counterparts. This is reflected by the lessening of the interquartile range displayed for lactate 
threshold power in figure 12.  
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Changes noted in physiological parameters over the training period in the current study, represent a 
cohort of individuals in whom the response to training may differ. It has been previously found that 
the training response regarding one parameter, is not necessarily followed by the same training 
response of other parameters (Scharhag-Rosenberger et al., 2012; Vollaard et al., 2009). Due to the 
existence of responders and non-responders to endurance training, caution should be applied when 
transferring the data from the current study to other individuals starting endurance training. Future 
studies should provide percentages or frequencies of the extents of physiological adaptations in order 
to categorise responders and non-responders. 
4.6.1.3 Maximal Power Output 
Maximal cycling power output progressively increased throughout the training period in the present 
study. Six months of endurance training increased maximal power output by 32 watts. Unlike other 
factors, muscle power was the only variable to increase significantly over each bimonthly test. 
Enhancing an athlete’s anaerobic work capacity is suggested to benefit the individual’s ability to 
respond to sections of a race that are above the average work output (Fukuba & Whipp, 1999; Jones 
& Carter, 2000). With increasing intensities, there is an increased reliance on oxygen-independent 
energy pathways (Bassett & Howley, 2000). For this reason, exercise training with a focus on improving 
endurance performance, should aim to increase the rate of energy production from aerobic as well as 
oxygen-independent pathways, match ATP production with hydrolysis, minimise cellular disturbances, 
increase efficiency, and improve fatigue resistance (Hawley, 2002). Maximal power represents an 
outcome variable which is impacted by these components, and therefore should be considered during 
endurance training. A more specific analysis of the anaerobic processes may have been to investigate 
the actual power increase past V̊O2max attainment (Bassett & Howley, 2000).  
4.6.1.4 Maximal Heart Rate 
Endurance training reduced HRmax by 2 beats·min-1 at month 4, however results were insignificant by 
month 6. This is a lesser response to that seen in previous studies; Isawaki et al. (2003) for example, 
observed reductions of 9 beats·min-1 within 3 and 6 months of endurance training compared to 
baseline. Discrepancies between training-induced responses may be due to methodological 
differences such as variations in training stimuli. Additionally, the population used in the present study 
were already recreationally active prior to participation. Many previous studies have observed 
differences in sedentary, untrained individuals undergoing a training period (Isawaki et al., 2003; 
Zavorsky, 2000). Whyte et al. (2008) and Boyette et al. (2013) suggest the decrease in HRmax is not due 
to high vagal tone, but can be explained by sinoatrial node remodelling. The results of the present 
study agree with previous investigations, finding a reduction in HRmax of 8 beats·min-1 in those of the 
eldest age group compared with the youngest individuals. Multiple studies have shown advancing age 
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to be associated with a decrease in HRmax at just under a rate of 1 beat·min-1 per year (Gellish et al., 
2007; Hawkins et al., 2001).  
4.6.1.5 Body Fat 
Average BF decreased as a result of endurance training by 2.3%, again with the majority of change 
occurring within the first 2 months of training. This finding supports the hypothesis that BF is reduced 
with endurance training. The rise in training load undertaken by participants likely caused an increased 
metabolic demand with associated shifts in substrate utilisation from glucose to fat stores. In turn, 
calorific output is elevated and greater fatty acid oxidation occurs (Bruce et al., 2006, Venables & 
Jeukendrup, 2008). Although adipose tissue may be reduced as a result of endurance training, 
intramuscular triglycerides have been shown to be augmented in endurance trained individuals 
(Goodpaster, He, Watkins & Kelley, 2001; Kiens, 2006; Tarnopolsky et al., 2007). This finding is 
considered an endurance specific training response, allowing greater accessibility to highly dense fuel 
stores in active muscle fibres (Tarnopolsky et al., 2007). Therefore, global BF composition values as 
used in the current study do not represent specific changes in the body. In this context, BF percentage 
may be a flawed measurement. Separate measurements of intramuscular triglyceride and adipose 
triglycerides would give a greater representation of the physiological adaptations occurring in 
response to training. 
Regardless of age-related differences in relative V̊O2max and HRmax, training-related adaptations were 
not influenced by age. This implies that endurance training stimulates similar adaptations in older 
aged individuals and younger individuals. With further analysis of the time response, perhaps 
differences would be observed reflecting variations in the upper limit of adaptations. For example, it 
has been speculated that maximal cardiac training responses, and subsequent full expression of the 
athlete’s heart, occur when training is undertaken during growth and development (Zadeh et al., 
2014). 
 
4.6.2 Part 2 
4.6.2.1 Resting Heart Rate 
The current study found that rHR was slower by 9.0 beats·min-1 after 6 months of endurance training. 
Therefore, the hypothesis that endurance training would reduce rHR can be accepted. This finding is 
a common change found with multiple previous studies. For example, 6 months of endurance training 
has been followed with reductions of 2.7 to 9.0 beats·min-1 in rHR (Scharhag-Rosenberg et al., 2009; 
Wilmore et al., 1996). The mechanisms underlying this adaptation are multifactorial including the 
autonomic nervous system, sinoatrial remodelling, cardiac hypertrophy, baroreflex resetting and 
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individual’s genetic predispositions (Corrado et al., 2010; Matelot, Schnell, Kervio, Du Boullay & Carré, 
2013).  
4.6.2.2 Frontal Plane Vector Loop 
The hypothesis that QRS axis would significantly change in response to endurance training was 
rejected. Likewise no significant changes were observed with P wave axis and T wave axis. Previous 
studies have shown that endurance training results in increased LV wall thickness and LV dilation 
(Ellison et al., 2011; Mihl, Dassen & Kuipers, 2008). Recently, it was shown that the left and right 
ventricle develop differently in response to endurance training. Zadeh et al. (2014) showed that in the 
first 6-9 months of endurance training, the LV responds with concentric remodelling, followed 
thereafter with eccentric remodelling, restoring the mass to volume ratio. Conversely, the RV 
responds to endurance training with eccentric remodelling throughout. Measurements of average 
electrical directions are likely influenced by changes in weight, as a consequence of lead placement 
variations. Therefore potential axis deviations may be masked or obscured by weight reductions. It is 
also possible that the lack of change in QRS axis may reflect the increased reliance on the right 
ventricle with prolonged endurance exercise (La Gerche et al., 2008; La Gerche et al., 2012). These 
findings provide evidence of similar remodelling of the left and right chambers of the heart. 
4.6.2.3 Electrical Conduction Intervals 
QTc increased, albeit insignificantly from month 0 to month 2, where it was significantly longer than 
month 4 and month 6. rHR on the other hand significantly decreased after 2 months of the training, 
and remained lower 6 months into the training programme. Furthermore, QRS interval remained 
unchanged throughout the study. It is recognised that HR is directly correlated with QT interval, 
hence the use of Bazzett’s formula correcting QT for HR (Corrado et al., 2010). Together, this 
information indicates that the initial adaptation of a reduced rHR does not confer similar responses 
to the QTc or QRS interval. The reduction in QTc, observed from month 2 to month 4, may be a 
result of a prolonged adjustment of the electrical conduction of the heart to a reduced rate of 
contraction.  
4.6.2.4 Group 1 and Group 2 ECG Findings 
The frequency of group 1 training-unrelated ECG findings increased over 2 fold throughout the 6 
month period. 8.6% of participants presented at least one training-unrelated finding at month 6, 
compared to 4.2% at month 0 of the study. Recent investigation has found an increased prevalence of 
both training-related and training-unrelated ECG findings in elite endurance trained athletes 
compared to non-endurance athletes (Brosnan et al., 2014). Likewise, both groups of changes were 
more prevalent in elite endurance athletes than the frequencies observed previously in competitive 
mixed discipline athletes (Papadakis et al., 2011). In elite endurance athletes, the frequency of at least 
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one training-unrelated finding was as high as 29.9%, compared with findings of less than 10% in 
competitive athletes, which is more comparable to the current study. The increased frequency of 
training-unrelated ECG findings throughout the current study, with progressive training load 
elevations, supports the suggestion that some changes are not exclusively training-unrelated as 
previously thought. Brosnan et al. (2014) have suggested that group 1 abnormal changes may actually 
be non-pathological and related to endurance exercise have been those of right ventricle association, 
such as RVH and right precordial T wave inversion (Brosnan et al., 2014). It could not be implied from 
the current study which group 1 findings were related to endurance exercise due to the lack of 
incidences, likely because of insufficient participants. Although suggestive of pathological adaptations, 
without further clinical investigation with cardiac imaging or echocardiographic measurements, 
underlying CV disease cannot be assumed. The occurrence and subsequent disappearance of certain 
ECG criteria for abnormal findings may represent a normal morphology of the heart at a particular 
stage of exercise-induced cardiac adaptation. Alternatively pathological findings may indicate an 
increased risk of a cardiac event during the period whereby the electrical activity of the heart is 
compromised. 
In regards to normal training-related ECG changes, sinus bradycardia was the most prevalent, followed 
by early repolarisation patterns. Incidences of isolated voltage criteria for LVH increased substantially 
from 2 participants at month 0 to 11 participants at month 6. The overall percentage of individuals 
presenting training-related findings increased from 68.1% to 87.1% from month 0 to month 6. 
Interestingly, the percentage of females presenting training-related changes did not change over the 
course of the study, therefore the increased prevalence of findings was solely contributed by male 
participants. Additionally, only one female presented findings of group 1 abnormal ECG findings 
throughout, indicating the increased prevalence of training-unrelated findings was due to the male 
population. However, male participants far outweighed the participation of female participants in this 
study, therefore results cannot be generalised. Nonetheless, pre-menopausal females also have a 
lower incidence of CV disease than males (Deschamps & Murphy, 2009). Oestrogen has been 
suggested the responsible factor, and has been shown to alter gene expression and non-genomic 
pathways which activate signalling pathways for cardioprotection (Murphy & Steenbergen, 2007). 
Such pathways include eNOS bioavailability and mitochondrial biogenesis. Literature is scarce 
regarding the cardiac specific influence of oestrogen, although the data from the current study provide 
evidence that females are less likely to undergo changes to the electrical conductance of the heart. 
Lack of adaptation to the electrical conductance may not be advantageous to sporting performance, 
but it may decrease the likelihood of undergoing pathological remodelling. 
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4.6.3 Methodological Issues 
4.6.3.1 Part 1 Limitations 
The training programme used was progressive over time, with the specific goal of attaining a level of 
fitness that would allow individuals to complete an iron-distance triathlon. It is true that the training 
programme designed contained components of high intensity training and functional, strength 
training therefore is not entirely specific to endurance training. Variability in training programmes 
between studies means caution should be made when comparing physiological adaptations. 
Furthermore, participants were included for analysis if they met the total training load requirements, 
assessed by volume and intensity. As such, participants not complying with the set training 
programme, performing sessions of low volume and high intensity, may have been deemed as 
performing the same unit of training load as those performing typical high volumes with lower 
intensities. This would stimulate alternative physiological processes, contributing to individual 
variation in the adaptive responses incurred over the course of the study. 
Participants recruited for this study were required to train for 9 months prior to an iron-distance 
triathlon. However due to a change in study design, CV and associated measurements relevant to this 
study were only collected until 6 months of training. For this reason, the influence of tapering prior to 
the race, an integral technique for competitive athletes, was not considered. Nevertheless, previous 
long-term investigations have found most improvements to endurance capacity over the first 3 to 6 
months of training (Scharhag-Rosenberg, 2009). As with the present study, most adaptations occurred 
at the beginning of the training, with diminishing responses as training progressed. Therefore, it is 
unlikely that substantial changes occurred in the final 3 months of training. The study design was 
changed to assess other parameters, such as time-trial performance, which subsequent studies will 
use to identify ultra-endurance performance predictor variables. 
The continuous step protocol used to obtain lactate threshold had large incremental steps in power 
output for each stage. Therefore, the actual power produced at lactate threshold may be largely 
obscured. Additionally, at the first testing procedure, approximations were made as to which power 
load was suitable for each participant. As a result, lactate threshold curves often contained very few 
or numerous stages, resulting in offset lactate thresholds due to lactate kinetics. The maximal lactate 
steady state (MLSS) may provide a better assessment of endurance performance due to the steady 
state nature, however would not reflect lactate kinetics (Faude et al., 2009). On the other hand, using 
such a protocol as the MLSS would have required a far greater time commitment from participants 
and investigators. 
The percentage V̊O2max at lactate threshold may have given a more indicative parameter for the 
assessment of endurance ability. V̊O2max alone has previously been shown to increase and 
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subsequently level off over the beginning months of training, whereas V̊O2max at lactate threshold 
continues to change over time (Bassett & Howley, 2000).Though this finding may provide a greater 
mechanistic insight to the specific physiological adaptations which occur, the use of power production 
at lactate threshold as used in the current study, provides an outcome variable integrating other 
important physiological factors. 
Though bioelectrical impedance assessments of body composition show high correlation with 
reference methods such as dual-energy X-ray absorptiometry (DEXA) scanning, measurement errors 
are not eradicated (Völgi et al., 2008). Impedance varies as a result of water distribution and quantity 
within the body. The distribution of water in the body is vulnerable to intra-day variability as a result 
of food and drink intake as well as exercise. Therefore, although it was urged that participants 
maintained uniform conditions prior to repeat measurements, inter-day fluctuations are unavoidable 
to an extent. However, the reliability of the bioelectrical impedance method has been repeatedly 
approved in test-retest methods in various population samples (Aandstad, Holtberget, Hageber, 
Holme & Anderssen, 2014; Kelly & Metcalfe, 2012). Additionally, body composition measurements 
should not be compared directly with values from other studies using different techniques. Knechtle 
et al. (2011) demonstrated significantly larger values of fat and skeletal muscle mass compared with 
anthropometric equations in an ultra-endurance athletic sample. 
4.6.3.2 Part 2 Limitations 
QTc has been criticised for its applicability to the athletic population. Since QT is corrected for R-R 
interval to quantify QTc there is a heavy reliance on HR at the time of the ECG. In normal, healthy 
individuals 450ms in males and 460ms in females, is likely to distinguish a long QT interval (Viskin, 
2009). This value is increased in the criteria used in this study allowing for elevated values in the 
athletic population and to increase specificity (Drezner, 2012). The majority of QTc values were similar 
and realistic throughout the bimonthly ECG tracings with the exception of some spurious values which 
were frequently deviated due to a different HR at the time of the ECG. 
Family and personal history are important considerations when investigating 12 lead ECG findings. As 
such, this information was considered as part of the pre-screening procedure. Additionally, symptoms 
such as chest pain and syncope provide important insight together with ECG findings regarding the 
development of CVD. Throughout the study period, participants were not asked if they were 
experiencing related symptoms. Providing this information would have enabled further understanding 
of the CV adaptation to prolonged endurance training. Another limitation to this study is that although 
an attempt was made to display information in relative terms, such as percentages, the low number 
of female participants highly obscures the information. The low number of female participants means 
that a potentially small frequency of observed findings will unnaturally exaggerate the relative 
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percentage of occurrences. Additionally, this limited cohort of female participants can not reflect the 
female population appropriately. 
It would have been appropriate to analyse 12-lead ECG’s immediately or shortly after measurements 
were obtained in order to assess other factors which might have been influencing results, such as 
hyperkalaemia, hypercalcaemia and acidosis. Additionally, assessing ECG’s earlier would have allowed 
the identification of individuals potentially at risk from SCD prior to the ultra-endurance exercise. 
Referring such individuals and undergoing further clinical investigations, such as the use of 
echocardiography and imaging techniques, would have given a greater insight into developments and 
associated conditions. Furthermore, the identification of criteria reflecting pathological conditions 
may have been exaggerated in the current study. Despite the simplicity of use regarding electrode 
placement of the 12-lead ECG, it is possible that the contribution of relatively inexperienced 
investigators jeopardised accurate results. Although pre-participation screening was conducted by a 
cardiologist who was aware of the similar manifestations of the athletic and pathologic heart, false 
positive detection is still a concern (Corrado et al., 2010). This same cardiologist was not available to 
interpret ECG data used in the data analysis. Moreover, the investigator responsible for identification 
of abnormal ECG patterns did not have certification in the field of cardiac physiology. All learning was 
conducted through the use of books, research articles and online courses. For this reason, human 
error should be considered as a limitation and interpretation should be made with caution. 
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4.7 Conclusion 
This study demonstrates that 9 months endurance training is suitable to produce an acceptable rate 
of completion for an iron-distance triathlon event (82% success in those who competed).  Additionally, 
this study provides data on physiological adaptations expected to occur in response to an endurance 
type training programme in previously recreationally active male individuals. Over 6 months V̊O2max 
increased by 5.4 ml·kg-1·min/0.36 L·min-1, maximal power increased by 32 watts, rHR decreased by 9 
beats·min-1, HRmax decreased by 2 beats·min-1 and BF decreased by 2.3%. Median lactate threshold 
values increased by 20 watts at month 4 but not at 6 months; nonetheless, interquartile ranges were 
greater at month 6. Regardless of age-related differences in V̊O2max and HRmax, age did not influence 
the training-related adaptations. The majority of training-related adaptations were greatest in the 
initial periods of endurance training from month 0 to month 2 or 4. Likewise, the prevalence of both 
training-related and unrelated ECG findings increased most from month 0 to month 2 and 4. 
Additionally, males were more likely to undergo bioelectrical cardiac changes than female 
participants. This adds further weight to the debate regarding the potentially damaging effects of 
endurance training. Prospective evaluations should conduct further clinical examination on 
participants displaying abnormal ECG criteria to confirm or exclude pathological origin.
Key points: 
 Nine months of endurance training is sufficient training period to allow recreationally 
active individuals complete an ironman-distance triathlon. 
 In previously recreationally active individuals, most known training-related adaptations 
occur within the initial months of training. Subsequent changes are smaller as the time in 
to training progresses. 
 Age differences only existed for relative V̊O2max (5.15 ml·kg-1·min) and HRmax (8 beats·min-
1). Nevertheless, training-related adaptations were not influenced by age. 
 QRS axis is not altered with endurance training, suggestive of similar left and right 
ventricular adaptation. 
 Group 1 training-unrelated findings were more frequent as the training period progressed. 
 Training-related and training-unrelated bioelectrical cardiac changes were more prevalent 
in males than females. 
 The increased prevalence of abnormal ECG criteria implies either i) certain abnormal 
findings are not necessarily training-unrelated as previously thought and may still reflect 
normal bioelectrical patterns, or ii) endurance training induces pathological 
manifestations of the heart in individuals previously thought to be healthy. 
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5.1 Introduction 
It is important in research to determine the reliability of a procedure being used. Perfect reliability, no 
random variation and no systematic variation, is very rare in most clinical research (Bruton, Conway 
& Holgate, 2000). Usually, reliability testing is conducted to assess the instrumental reliability, 
observer reliability, and variable reliability (Bruton et al., 2000). The most common form of reliability 
testing is retest reliability, which refers to the reproducibility of values when you conduct the 
measurement twice on the same individual in the same condition (Hopkins, 2000).  
The reliability and validity of the SphygmoCor device have been previously discussed in chapter 2.2.9. 
Nonetheless, reliability of equipment may jeopardised by several factors including, observer 
experience and equipment damage. SphygmoCor measures of arterial stiffness were assessed for test-
retest reliability prior to the main investigation. PWV and Aix and Aix@HR75 were measured on two 
separate occasions. 
5.2 Pilot Study 1: Reliability of Pulse Wave Velocity Measurements 
5.2.1 Method 
Eight normotensive participants were recruited for this pilot study (female, n = 2 and male, n = 6). 
Descriptive participant characteristics are presented in table 7. Resting peripheral BP measurements 
were obtained from the left arm after 10 minutes of seated rest as in chapter 3.4. The participant was 
asked to rest for a further 10 minutes in the supine position while the equipment was set up as 
outlined below. PWV was obtained and the procedure was duplicated immediately after the first 
measurement was competed. All measurements were conducted by the same investigator. 
 
Table 7. Descriptive characteristics of pilot study 1 participants (n = 8). 
Participant Characteristic Mean ± SD 
Age (yr) 35.8 ± 16.5 
Height (cm) 175.4 ± 8.8  
Body Mass (kg) 71.8 ± 14.2 
Resting Heart Rate (beats·min-1) 60 ± 7 
Peripheral Systolic Blood Pressure (mmHg) 122 ± 13 
Peripheral Diastolic Blood Pressure (mmHg) 67 ± 7 
 
5.2.2 SphygmoCor CVMS Measurements 
Arterial Stiffness was measured non-invasively via applanation tonometry using the SphygmoCor 
equipment (SpygmoCor, AtCor Medical, Sydney, Australia). The device was calibrated for brachial BP 
prior to measurements along with anthropometric data including height and body mass. A high fidelity 
tonometer was applied with gentle pressure over the artery so that it was only partially occluded. The 
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tonometer was adjusted until a satisfactory and repeatable waveform was being captured, and was 
held stable throughout data capture. The data acquisition box was interfaced with a laptop installed 
with SphygmoCor CVMS software (AtCor Medical, Sydney, Australia) to display visual information.  
All participants were asked to abstain from caffeine and alcoholic substances (>12 hrs), food (3 hrs) 
and exercise (12 hrs) prior to their appointments. Testing was conducted in laboratory controlled 
conditions at temperature, 21 ± 1°C; barometric pressure – range, 97.3-102.3 kPa; humidity – range, 
21-56%. 
5.2.2.1 Pulse Wave Velocity Measurements 
Participants were instructed to lie in the supine position and rest for 5-10 minutes prior to data 
acquisition. During this time the sites for carotid and femoral artery pulse on the right side of the body 
were palpated and suitable sites were identified and marked. Distance was measured from the 
suprasternal notch to the distal site, femoral artery, and from the suprasternal notch to the proximal 
site, carotid artery of the right side of the body (Seca, 201 ergonomic circumference measuring tape, 
Hamburg). Electrode sites were cleansed with alcohol wipes, allowed to dry, and three 30 mm 
electrodes (Cardiacare Ltd. Essex, United Kingdom) were placed according to the SphygmoCor manual 
recommendations, see figure 18. Cables were attached to the electrodes and the SphygmoCor device. 
Carotid and femoral artery sites were cleansed with an alcohol wipe and allowed to dry. Using the 
tonometer, pulse waves were obtained transcutaneously at the carotid and femoral artery of the right 
side sequentially for a 12 second acceptable period. Data was obtained for at least 2 minutes at each 
site before processing to allow familiarisation of the conditions. 
5.2.2.2 Carotid and Femoral Artery Measurements 
For carotid artery assessment, the patient lay on the bed in the supine position with the absence of a 
pillow. The patients head was tilted slightly backwards and to their left. The operator felt for the 
position of the strongest pulse at the right carotid artery and placed the tonometer directly over the 
skin of this point. The operator was sitting behind the patient with a solid platform to rest the forearm 
during the measurement. For the femoral assessment, the patient remained supine on the bed with 
their right knee slightly flexed and thigh rotated away from the body. Right sided femoral pulse was 
felt midway between the anterior superior iliac spine and the front of the pubic bone. The tonometer 
was placed directly over the point of the skin where the pulse was strongest until an adequate reading 
was obtained. Latex gloves were worn for the duration of the femoral artery assessment. 
PWV was measured using the intersecting tangent algorithm using the foot-to-foot velocity method 
from a minimum of 3 waveforms, as presented in figure 19 (Chiu et al., 1991). An ECG trace was 
obtained concurrent to the pulse wave recording and the time delay (Δt or transit time) was measured 
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between the feet of the two waveforms. PWV was calculated as PWV = D (meters) / Δt (seconds), 
where D equals the proximal distance (suprasternal-carotid) subtracted from the distal distance 
(suprasternal-femoral). Measurements were repeated if the standard deviation of the time 
differences was greater than 10% or if rHR varied by greater than 5 beats·min-1. 
 
 
 
 
 
 
 
 
 
5.2.2.3 Data Analysis 
Paired samples t-tests were conducted to examine differences between measurement 1 and 
measurement 2. Significance was determined by an alpha level of p < 0.05. Repeatability coefficient 
(CR) was used to present measurement error over the two tests using the following formula as 
recommended by the British Standards Institution (1979):  
 
 
 
Linear regression was conducted on the difference between measurement 1 and 2 and the mean 
values of measurement 1 and 2. The hypotheses was tested that the mean difference coefficient was 
0. 
5.2.3 Results  
On average, PWV was not significantly different in measure 1 (5.6 ± 1.0) than to measure 2 (5.8 ± 0.9), 
t(7) = -1.618, p > 0.05. Pearson’s correlation was 0.96 (p < 0.001). The test-retest coefficient of 
variation was 18% for measurement 1 and 16% for measurement 2.  The estimated repeatability 
Figure 19. Measurement of carotid-femoral pulse 
wave velocity (PWV) with the foot to foot method. 
Figure 18. Three-cable 
electrocardiograph (ECG) 
configuration on SphygmoCor 
equipment. 
Where ‘d’ is the difference between two measurements, and ‘n’ is sample size (Bland and Altman, 1986). 
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coefficient was 0.7 m.s-1. Linear regression revealed no significance for the test that the coefficient for 
the mean difference was not 0, t = -0.94, p = 0.38, indicating no proportional bias. In addition, Bland-
Altman plots indicated good reproducibility of PWV, 100% within 2 standard deviations (figure 20).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.2.4 Discussion 
PWV measurements were obtained one after the other in 8 participants with the same investigator. 
The reliability of these intra-investigator measurements were examined in preparation for their use 
within a prospective main study. Bland-Altman plots indicated a high reproducibility for PWV. 
Repeatability coefficient represents the value below which the difference between 2 measurements 
will lie with 95% probability. In this study, an estimated repeatability coefficient of 0.7 m.s-1 means we 
can expect the absolute difference between two future measurements made by one investigator on 
one participant to be no greater than 0.7 m.s-1 on 95% of occasions. The acceptance of the null 
hypothesis that the coefficient of the mean difference between measurements was 0, indicates there 
was no proportional bias. In other words, no trend was observed where there are more points above 
Figure 20. Bland-Altman plot from repeated measures of pulse wave velocity (PWV) showing the 
extent of intra-observer variability.  
Mean difference = 0.18 m.s-1; lower 95% = - 0.48 m.s-1; upper 95% = 0.83 m.s-1. 
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or below the mean difference line. This suggests there is a high level of agreement for PWV 
measurements. The Pearson’s correlation value of 0.96 represents a high correlation between the 
test-retest measurements. 
 
5.3 Pilot Study 2 - Reliability of Pulse Wave Analysis Measurements 
5.3.1 Method 
Thirteen normotensive participants were recruited for this pilot study (female, n = 1 and male, n = 12). 
Descriptive statistics of this sample are presented in table 8. Resting peripheral BP was obtained from 
the left arm after 10 minutes of seated rest. The SphygmoCor equipment was set up to record PWA 
as outlined below. The procedure for PWA was duplicated immediately after the first measurement 
was completed. All measurements were conducted by the same investigator. 
Table 8. Descriptive characteristics of pilot study 2 participants (n = 13). 
Participant Characteristics Mean ± SD 
Age (yr) 30.9 ± 13.3 
Height (cm) 177.1 ± 5.7 
Body Mass (kg) 76 ± 11.5 
Resting Heart Rate (beats·min-1) 59 ± 11 
Peripheral Systolic Blood Pressure (mmHg) 113 ± 6 
Peripheral Diastolic Blood Pressure (mmHg) 65 ± 6 
 
5.3.2 SphygmoCor CVMS Measurements 
Arterial Stiffness was measured non-invasively via applanation tonometry using the SphygmoCor 
equipment (SpygmoCor, AtCor Medical, Sydney, Australia). The device was calibrated for brachial BP 
prior to measurements along with anthropometric data including height and body mass. A high fidelity 
tonometer was applied with gentle pressure over the artery so that it was only partially occluded. The 
tonometer was adjusted until a satisfactory and repeatable waveform was being captured, and was 
held stable throughout data capture. The data acquisition box was interfaced with a laptop installed 
with SphygmoCor CVMS software (AtCor Medical, Sydney, Australia) to display visual information.  
All participants were asked to abstain from caffeine and alcoholic substances (>12 hrs), food (3 hrs) 
and exercise (12 hrs) prior to their appointments. Testing was conducted in laboratory controlled 
conditions at temperature, 21 ± 1°C; barometric pressure – range, 97.3-102.3 kPa; humidity – range, 
21-56%. 
5.3.2.1 Pulse Wave Analysis Measurements 
The participant remained in the seated position with the left arm relaxed at heart level. The skin site 
was cleansed with an alcoholic wipe and left to dry before the tonometer was placed perpendicular 
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to the strongest pulse at the radial artery of the left arm. After at least 2 minutes of data acquisition a 
12 second recording was processed and the corresponding aortic pressure waveform was generated 
from the in-built transfer function. Aix was defined as a percentage of augmentation pressure (AP) 
divided by aortic pulse pressure (aPP). Aix was corrected for a HR of 75 beats·min-1 (Aix@HR75). 
SphygmoCor software adjusts for this manipulating Aix at an inverse rate of 4.8% for each 10 
beats·min-1 increase in HR (Stoner, Young & Fryer, 2012; Wilkinson et al., 2000; Wilkinson et al., 2002). 
In compliance with the SphygmoCor operator manual, parameters determined from a left ventricular 
ejection duration (LVED) value outside the range of 200-450 ms were disregarded. Additionally, results 
were only accepted if operator index was greater than 75%, as suggested in the manufacturer’s 
recommendations. Operator index refers to the number calculated from the quality control indices 
including average pulse height, pulse height variation, diastolic variation, and shape variation.  
5.3.2.2 Data Analysis 
As in part 1 of the pilot study, paired samples t-tests were conducted to examine differences between 
measurement 1 and measurement 2, of Aix and Aix@HR75. Significance was determined by an alpha 
level of p < 0.05. Repeatability coefficient (CR) was used to present measurement error over the two 
tests using the following formula as recommended by the British Standards Institution (1979):  
 
 
 
Linear regression was conducted on the difference between measurement 1 and 2 and the mean 
values of measurement 1 and 2. The null hypotheses was tested that the mean difference coefficient 
was significantly different to 0. 
5.3.3 Results 
On average, Aix was not significantly different in measure 1 (15.2 ± 12.1%) than to measure 2 (15.8 ± 
10.6%), t(12) = -0.50, p = 0.63. Likewise, Aix@HR75 was not significantly different between 
measurements (7.9 ± 14.2% vs. 7.7 ± 12.8%), t(12) = 0.14, p = 0.89. Pearson’s correlation was 0.93 for 
Aix and 0.96 for Aix@HR75; p < 0.001. The test-retest coefficient of variation was not calculated since 
the type of data was interval.  The estimated repeatability coefficient was 8.5% for Aix and 7.4% for 
Aix@HR75. The average quality control operator index score was 95 ± 6%. Linear regression revealed 
no significance for the test that the coefficient for the mean difference was not 0, t = -1.23, p = 0.24 
for Aix and t = -1.29, p = 0.23 for Aix@HR75. In addition, Bland-Altman plots indicated good 
Where ‘d’ is the difference between two measurements, and ‘n’ is sample size (Bland and Altman, 1986). 
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reproducibility of Aix, 100% within 2 standard deviations (figure 21), as well as Aix@HR75, 92% within 
2 standard deviations (figure 22). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21. Bland-Altman plot from repeated measures of augmentation index (Aix) showing the 
extent of intra-observer variability. 
Mean difference = 0.6%; lower 95% = - 7.9%; upper 95% = 9.1%. 
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Figure 22. Bland-Altman plot from repeated measures of augmentation index corrected for a 
heart rate of 75 beats·min-1 (Aix@HR75) showing the extent of intra-observer variability.   
Mean difference = 0.2%; lower 95% = - 7.5%; upper 95% = 7.2%. 
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5.3.4 Discussion 
PWA procedures were conducted twice consecutively in 13 participants. Aix and Aix@HR75 were 
obtained and the reliability of intra-investigator measurements were examined. In line with previous 
research, Bland-Altman plots indicated a high reproducibility for Aix and Aix@HR75 (Papaionnou et 
al., 2007). An estimated repeatability coefficient of 8.5% for Aix means we can expect the absolute 
difference between two future measurements made by one investigator on one participant to be no 
greater than 8.5% on 95% of occasions. An estimated repeatability coefficient of 7.4% for Aix@HR75 
confers similar assumptions. These values are considerable and may reflect inexperienced use with 
equipment. One measure to account for the large repeatability coefficient may be to increase the 
operator index acceptance level from 75% in this study, to 90%. This adjustment would allow for a 
tighter regulation of data provided by the SphygmoCor equipment. 
The acceptance of the null hypothesis that the coefficient of the mean difference between 
measurements was 0 indicates there was no proportional bias. In other words, no trend was observed 
where there are more points above or below the mean difference line. This suggests there is a high 
level of agreement for PWV measurements.  
 
5.4 Overall Pilot Testing Conclusion 
All of the measurements of arterial stiffness obtained by the SphygmoCor equipment showed 
adequate reliability. The hypothesis for proportional bias was rejected for all techniques. PWV appears 
a more reliable method of arterial stiffness measurement than Aix or Aix@HR75. These methods were 
considered suitable for use in the next phase of study with the knowledge that within-subject 
repeatability is adequate. However, the aforementioned repeatability coefficient values should be 
considered in the main section of the study when making conclusions regarding arterial stiffness. One 
method to adjust for this would be to consider a greater minimum operator index for pulse wave 
analysis measures, for example 90%. 
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6.1 Abstract 
INTRODUCTION: Repetitive episodes of arterial shear stress provide a stimulus that promotes vascular 
adaptations through endothelium-dependent remodelling. Longer exposure to stimuli, such as during 
endurance exercise, may compromise the vascular system. The mechanisms are likely due to shear 
stress, oxidative stress and inflammatory processes having an influence on endothelial function and 
aortic elasticity.  
PURPOSE:  To provide an insight to the vascular response to ultra-endurance training and an ultra-
endurance event, and to determine whether antioxidant supplementation influences the arterial 
stiffening response to prolonged exercise. 
METHODS: Eleven athletes (TRI; age: 34.3 ± 8.7yr; weight: 73.9 ± 10.3 kg) and 10 recreational control 
participants (NOTRI; age: 26.5 ± 7.1 yr, weight: 72.7 ± 5.6 kg) were assessed on 4 occasions with 
identical time intervals. Additionally, n = 5 TRI participants received antioxidant & anti-inflammatory 
supplementation for 12 weeks (S) whilst n = 6 received no supplementation (NS). Carotid-femoral 
pulse wave velocity (PWV), and pulse wave analysis (PWA) procedures were measured 7 days prior 
(T1) to an iron-distance triathlon. This consisted of a 3.86km swim, 180.25km cycle, and 42.2km run. 
Repeated measurements were obtained 12 to 18 hours post-triathlon (T2), 7 days post-triathlon (T3), 
and 28 days post-triathlon (T4). The NOTRI group did not participate in the triathlon. Data presented 
as mean ± standard deviation.  
RESULTS:  All effects are reported as significant at p < 0.05. Average triathlon race time was 786 ± 
63mins. PWV was significantly greater in TRI than NOTRI at T2 and T3 (T2; 6.1 ± 0.4m·s-1 vs. 5.5 ± 
0.6m·s-1 and T3; 6.3 ± 0.7m·s-1 vs. 5.6 ± 0.6m·s-1), but not at T1 or T4 (T1; 5.9 ± 0.6m·s-1 vs 5.6 ± 0.8m·s-
1 and T4; 6.0 ± 0.6m·s-1 vs 5.8 ± 0.8m·s-1). No significant differences were observed for Aix or 
Aix@HR75. No significant differences in PWV, Aix or Aix@HR75 were observed in TRI alone between 
time-points. No significant time or group interactions were revealed for PWV, Aix or Aix@HR75 in S 
and NS between time-points. 
CONCLUSION: The elevation of PWV but not Aix or Aix@75 in the TRI group is likely due to the different 
response to shear stress and acute systemic inflammation of large and small arterial vascular beds. 
Importantly, all measurements were statistically similar levels at the final time-point; suggesting only 
a short-term elevation of arterial stiffness. This response was not substantial enough to elicit a change 
in arterial stiffness markers in the triathletes compared against themselves over time-points. Prior 
antioxidant supplementation did not provoke a differential response in arterial stiffening from ultra-
endurance exercise. 
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6.2 Introduction 
Substantial evidence supports the concept that habitual exercise has CV health benefits contributing 
to an overall reduction in risk of SCD and cardiac events (Corrado, Migliore, Basso & Thiene 2006; 
Warburton, Nichol and Bredin, 2006). Prolonged endurance training on the other hand has been 
associated with unfavourable CV risk factors (Schwartz et al., 2014, O’Keefe et al., 2012; Vlachopoulos 
et al., 2010). Indirect arterial stiffness indices such as PWV and wave reflections including Aix are 
powerful independent predictors of CV events and mortality (Laurent et al., 2006). Therefore, elevated 
arterial stiffness measurements represent an increased CV risk. In the chronic setting, it has been 
indicated that ultra-endurance athletes may present an elevated arterial stiffness than recreationally 
active individuals (Burr et al., 2014; Vlachopoulos et al., 2010).  
Growth of ultra-endurance events and participants competing in prolonged endurance exercise has 
increased in recent years (Hoffman, Ong, & Wang, 2010; Knechtle, Knechtle & Lepers, 2011), therefore 
the need to assess the health consequences of such events has become more important. Acute 
exercise transiently elevates the risk of SCD (Corrado, Basso, Rizzoli, Schiavon & Thiene, 2003). Despite 
rising participation and evidence of transiently compromised CV heath, the acute and long-term 
responses to prolonged excessive exercise that are implicated in the transient period are not fully 
understood. Studies investigating the acute effect have indicated an increased large artery stiffness 
and reduced wave reflections, suggestive of enhanced peripheral artery compliance. The time 
response of arterial distensibility to an ultra-endurance bout have not yet been investigated, however 
as with the heart, it is not inconceivable to expect prolonged changes (La Gerche et al., 2008; Neilan, 
Yoerger et al., 2006). Research examining the area of ultra-endurance has typically focused on elite or 
long-term performers, however the recent increases in participation and thus sub-elite athletes allow 
the investigation of the responses in previously unexperienced athletes. It is probable that the 
associated stressors and outcomes of participation manifest differently in experienced and 
unexperienced individuals. 
One of the suspected primary mechanisms regarding arterial stiffening with particular reference to 
prolonged exercise involves an up-regulation of oxidative stress (Gross et al., 2005; Sindler et al., 
2009). Oxidative stress influences long-term, structural mediators of arterial stiffening as well as short-
term, functional mechanisms. Antioxidant strategies may attenuate this oxidative stress and 
subsequent arterial stiffening (Qin et al., 2008; Zhao et al., 2013).  
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6.3 Aims and Hypotheses 
The purpose of this study was to provide an insight to the CV response to ultra-endurance training 
and an ultra-endurance event, and to determine whether antioxidant supplementation influences 
the arterial stiffening response to prolonged exercise. The primary null hypothesis was that PWV, 
Aix, Aix@HR75, rHR, SBP, DBP and LVED would not differ between ultra-endurance trained and 
recreationally active controls at baseline. The secondary null hypothesis predicted that PWV, Aix, 
Aix@HR75, rHR, SBP, DBP and LVED would not change in the short or longer period post long-
distance triathlon event. Thirdly, the null hypothesis predicted no differences in PWV, Aix, 
Aix@HR75, rHR, SBP, DBP and LVED between antioxidant supplemented and non-supplemented 
individuals at any time-point pre and post-event. 
 
6.4 Method 
 6.4.1 Participants 
A total of 33 healthy individuals were recruited to take part in this study with 21 participants 
completing the protocol. Twenty athletes were originally recruited from study 1 of an adjunct larger 
scale study, and were previously signed up to compete in a long-distance triathlon in Barcelona 
consisting of a 3.86 km swim, 180.25 km cycle, and 42.2 km run. Only 11 athletes were able to 
complete the study largely due to failure to complete the long-distance event. Of these, 5 participants 
were receiving supplementation (S), and 6 were receiving no supplementation (NS). Twelve week 
supplementation consisted of a multi-nutrient formula, an essential fatty acid formula, an antioxidant 
formula, and a probiotic formula (Biocare Ltd., Birmingham, United Kingdom). See appendix 6 for full 
supplementation information. Thirteen participants were recruited to act as a control population who 
did not receive supplementation and did not complete the triathlon. Ten control participants were 
taken forward to analysis due to withdrawal. Control volunteers were considered ‘recreationally 
active’, completing no more than 4 exercise sessions per week. Participant information can be found 
in table 9. Inclusion criteria required that participants be aged between 18 and 51 years, have no 
history of heart abnormalities, hypertension, coronary heart disease or diabetes, have not previously 
completed a long-distance event, and are not taking any medication. Written informed consent was 
obtained prior to the study and a health screen was provided before each appointment. Upon initial 
arrival, participants were given a verbal brief regarding the study design, what was to be expected 
from them, and to ensure they understood the commitment and testing procedure sufficiently. 
Participants were excluded if they: were aged <18/>51 years, participated in a long-distance event 
previously, not currently training 1-4 days per week, or had history of heart 
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abnormalities/hypertension/coronary heart disease or diabetes. All participants provided written 
informed consent along with a letter from respective general practitioners. 
 6.4.2 Study Design 
This longitudinal study employed a non-randomised repeated measures experimental design to 
examine the short and longer term effects of prolonged exercise on human vasculature. Additionally 
it was sought to identify if nutritional supplementation influenced the vascular response to prolonged 
exercise. This protocol was approved by the University of Hertfordshire health and human sciences 
ethics committee with delegated ethics authority (protocol number: aLMS/PG/UH/00139 the 
influence of ultra-endurance exercise on the CV and related physiological systems). 
6.4.3 Experimental Procedure 
Arterial stiffness measures were obtained 7 days prior to the previously mentioned long-distance 
triathlon in the athletic population (T1). These measurements were repeated 12-18 hours post-event 
(T2), 7 days post-event (T3), and 28 days post-event (T4). Measures were also repeated with the same 
time intervals on a different group of ‘recreational’ individuals. Height, body mass and peripheral BP 
were obtained as in chapter 3.3 and 3.4. Appendix 7 shows the flow diagram of the method used in 
this study. 
6.4.4 SphygmoCor CVMS Measurements 
Arterial Stiffness was measured non-invasively via applanation tonometry using the SphygmoCor 
equipment (SpygmoCor, AtCor Medical, Sydney, Australia). A high fidelity tonometer was applied with 
gentle pressure over the artery so that it was only partially occluded. The tonometer was adjusted 
until a satisfactory and repeatable waveform was being captured, and was held stable throughout 
data capture. The data acquisition box was interfaced with a laptop installed with SphygmoCor CVMS 
software (AtCor Medical, Sydney, Australia) to display visual information.  
Where possible, participants were booked in at the same time of the day to control for natural diurnal 
variance. Additionally, participants were asked to eat a similar meal prior to each testing appointment. 
All participants were asked to abstain from caffeine and alcoholic substances (>12 hr), food (3 hr) and 
exercise (12 hr) prior to their appointments. Testing points 7 days pre (T1), 7 days post (T3), and 28 
days post-event (T4) were conducted in laboratory controlled conditions at temperature, 21 ± 1°C; 
barometric pressure – range, 97.3-102.3 kPa; humidity – range, 21-56%. Measurements for the 
triathlon group at 12-18 hr (T2) post-event were completed in a different environment due to logistical 
reasons, at temperature 21 ± 1°C. To avoid inter-observer error all the measurements were conducted 
by the same investigator. Systematic errors and bias were minimised by using the same equipment on 
each participant.  
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Firstly, PWA measurements were conducted, providing values for: Aix, Aix@HR75, aortic systolic and 
diastolic BP, and LVED, as in chapter 5.3.2. Waveforms were only accepted if the operator index 
reached 90% or greater, for reasons observed in pilot study 2.  Next, PWV and rHR were obtained in 
the same arrangement as chapter 5.2.2. 
6.4.5 Genova Diagnostics 
Participants were instructed to follow the standardised instructions for the collection of bodily 
samples required for the ‘optimal nutrition evaluation’ (ONE) (Genova Diagnostics, Surrey, United 
Kingdom). Participants were required to overnight fast (8 hrs) and collect their first morning urine 
sample into the sterile cup provided. Participants were responsible for transferring the urine into the 
3 collection tubes provided via pipette and were asked to freeze the samples for a minimum of 2 hours 
before shipping. Instructions were available to participants both in hardcopy and online format. 
Samples were sent to Genova Diagnostics for processing within 24 hours of collection. Further 
information can be found in the appendix 8. Lipid peroxide, 8-hydroxydeoxyguanosine (8-OHdG), and 
glutathione requirement were assessed in the TRI groups (NS and S). The ONE feedback document 
consisted of urinary lipid peroxide values given as microliters per gram of creatinine (µmol·g 
creatinine-1). 8-OHdG were measured in micrograms per g of creatinine (µg·g creatinine-1). Glutathione 
requirement was given in scale format (figure 23). Therefore, each major tick represented an 
incremental score of 1 (0 to 10) for analysis purposes.  
 
 
 
 
 
 
 
 
 
 
6.4.6 Data Analysis 
Statistical analysis was performed using the Statistical Package for the Social Sciences Version 21 (SPSS 
Inc., Illinois, United States of America). Pre-test checks were conducted prior to statistical analysis to 
assess for violations of assumptions. These include the Shapiro-Wilk tests of normality, with visual 
analysis of histograms, box plots and P-P plots, Levene’s test of equality of variances, and Mauchly’s 
sphericity test. Two mixed measures analysis of variance (ANOVA) models were conducted and are 
Figure 23. An example of the visual feedback regarding glutathione requirement values from the 
optimal nutrition evaluation (ONE).  
Urinary samples were collected and dispatched for analysis by participants. Glutathione requirement 
was determined via urinary analysis in an external laboratory by Genova Diagnostics. The green area 
reflects a normal score, yellow area indicates borderline requirement, and the red area indicates a high 
need. Major tick marks represent an incremental score of 1 for analytical purposes, with 0 representing 
the lowest score and 10 representing a maximal score. X indicates the score for the individual. 
Chapter Six: Study 2 
101 
 
described separately in part 1 and part 2 of the results section. Independent samples t-tests were 
performed on baseline variables to demonstrate whether the groups were matched at baseline or not. 
The first two-way mixed measures ANOVA (part 1) used time as within-subjects factor (4 levels; T1: 7 
days pre-event, T2: 12 to 18 hours post-event, T3: 7 days post-event, and T4: 28 days post-event) and 
with condition as between-subjects factor (2 levels; TRI: athletes participating in iron-distance 
triathlon, and NOTRI: recreationally active participations, tested with equal variance between time-
points as TRI group). In the second two-way mixed measures ANOVA (part 2) time was again used for 
within-subjects comparisons. In this section only the TRI participants were used for data analysis with 
group (2 levels; NS: non-supplementation group, and S: supplementation group) as the between-
subjects factor. 
Within-subjects analysis investigated the main time effect on the dependent variables as well as the 
interaction effect of the within-subjects factor (time) and the between-subjects factor (condition or 
group). If a main time effect existed Bonferroni comparisons were used to perform pairwise 
comparisons between all levels of time. Significant interactions were followed with simple main 
effects using Bonferroni comparisons on the between-subjects factor at each level of time. Main 
effects were also conducted for the between-subjects factor. Adjustments for multiple comparisons 
were made for pairwise analysis, accounting for the number of potential hypotheses within each test. 
Correcting for the total amount of hypotheses within the study would have created an alpha level 
extremely conservative. This procedure would significantly reduce the chance of a type I error, but 
also increase the risk of a false negative significance occurring. 
 
6.5 Results 
6.5.1 Pre-Test Assumptions 
Shapiro-Wilk tests of normality were conducted for assessment of the distribution of data along with 
visual analysis of histograms and P-P plots. No large deviations from normality were observed, and 
since most comparison procedures perform well under small deviations from normality it was deemed 
appropriate to use parametric tests (Field, 2009). The ANOVA is particularly robust to slight violations 
of normality within a dataset (Field, 2009). 
Levene’s test of equality of error variances was performed on all dependent variables across time 
levels. The assumption of homogeneity of variance was met if Levene’s test accepted the null 
hypothesis that error variance was equal across groups. Significance (p < 0.05) in Levene’s test, 
representing a violation to the assumption of homogeneity of variance, is mentioned in text. 
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Depending on the extent of the violation, such situations resulted in a more conservative alpha level 
of 0.025 (Tabachnick & Fidell, 2013).  
Mauchly’s sphericity test was used to assess the assumption of sphericity within repeated-measures 
effects. Unless stated otherwise Mauchly’s test was insignificant (p > 0.05), therefore the assumption 
of sphericity was accepted. Greenhouse-Geisser correction for sphericity was used if the estimate of 
sphericity (ε) was < 0.75 and Huyne-Feldt correction was used if the statistic was > 0.75 (Girden, 1992). 
 
6.5.2 Part 1: Triathletes vs. Recreationally Active 
Part 1 of this study used a 4 by 2 mixed measures ANOVA with time as the within-subjects factor (4 
levels) with between-subjects comparisons made between TRI (athletes participating in iron-distance 
triathlon) and NOTRI (recreationally active participants not participating in triathlon) conditions. 
Arterial stiffness biomarkers, rHR, aortic BP, and LVED were inserted into the ANOVA as dependent 
variables. Full descriptive data can be found in appendix 9. 
6.5.2.1 Baseline Comparisons 
Table 9 presents the baseline participant characteristics between conditions. An independent sample 
T-test was conducted for age, height and body mass between TRI and NOTRI conditions at T1. A 
significant difference in age was found at baseline between TRI and NOTRI conditions, t(19) = 2.23, p 
= 0.04. Significant differences were not observed for height, t(19) = -0.91, or body mass, t(19) = 0.33; 
p > 0.05. 
Table 9. Baseline study 2 participant characteristics between conditions.  
 TRI (n = 11) NOTRI (n = 10)  
Age (years) 34.4 ± 8.7 26.5 ± 7.1 p < 0.05 
Height (cm) 174.5 ± 7.4 177.0 ± 5.3 p = 0.25 
Body mass (kg) 73.9 ± 10.3 72.7 ± 5.6 P = 0.29 
TRI = triathlete participants; NOTRI = recreationally active participant; yr = years; cm = centimetre; kg = 
kilogram. 
 
6.5.2.2 Arterial Stiffness Biomarkers – Pulse Wave Velocity 
Within-subject analysis found no significant main time effect on PWV, F(3, 57) = 0.697, p = 0.56, ηp2 = 
0.04. Likewise no significant interaction was observed for time and condition for PWV, F(3, 57) = 1.610, 
p = 0.20, ηp2 = 0.08. This finding indicates that TRI and NOTRI participants were not affected differently 
over time. 
Between-subjects analysis found a significant effect in PWV between TRI and NOTRI conditions, F(1, 
19) = 4.46, p < 0.05, ηp2 = 0.19. Simple effects analysis was conducted with Bonferroni adjustment for 
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multiple comparisons. TRI and NOTRI conditions were compared across each level of time. A 
significant difference in PWV was found at T2 (F(1, 19) = 9.24, p < 0.05, ηp2 = 0.33) and T3 (F(1, 19) = 
6.228, p < 0.05, ηp2 = 0.25 (figure 24). These results indicate that PWV was significantly greater in 
those who competed in the triathlon than participants who did not, at 12 to 18 hours post-event (T2: 
6.1 ± 0.4m·s-1 vs. 5.5 ± 0.6m·s-1, respectively) and 7 days post-event (T3: 6.3 ± 0.7m·s-1 vs. 5.6 ± 0.6m·s-
1 respectively). There were no significant differences between TRI and NOTRI 7 days pre-event or 28 
days post-event (T1: 5.9 ± 0.6m·s-1 vs 5.6 ± 0.8m·s-1 and T4: 6.0 ± 0.6m·s-1 vs 5.8 ± 0.8m·s-1). Average 
PWV remained stable between time-points in NOTRI (maximal change 0.2m·s-1) and TRI (maximal 
change 0.4m·s-1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.5.2.3 Arterial Stiffness Biomarkers – Augmentation Index 
Levene’s test of equality of error variances was violated at T3, F(1, 19) = 5.44, p = 0.03. Owing to this 
violation, an alpha level of 0.025 was accepted. There was not a significant main effect of time on Aix, 
F(3, 57) = 2.74, p = 0.05, ηp2 = 0.13. There was no significant interaction effect of time and condition 
for Aix, F(3, 57) = 1.493, p = 0.226, ηp2 = 0.07. This suggests that TRI and NOTRI participants were not 
affected differently across any level of time as presented in figure 25 (T1: 14.6 ± 12.1% vs. 10.0 ± 
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Figure 24. Comparison of pulse wave velocity (PWV) values between both conditions TRI (n = 11) 
and NOTRI (n = 10) across 4 time-points (mean ± SD). 
TRI = triathlete participants; NOTRI = recreationally active participants; T1 = 7 days pre-event; T2 = 12-18 
hours post-event; T3 = 7 days post-event; T4 = 28 days post-event (in respect to TRI group). Time-points reflect 
equal variance for NOTRI group conducted at a later period. * significant difference between conditions, p < 
0.05. 
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10.4%; T2: 9.2 ± 9.5% vs. 12.7 ± 7.6%; T3: 6.1 ± 12.7% vs. 7.9 ± 7.9%; T4: 11.2 ± 10.0% vs. 12.2 ± 8.2%; 
respectively, p < 0.05). Aix decreased from T1 to T3 by 8.5% in the TRI group, almost a 3 fold reduction, 
however was non-significant as previously mentioned. Between-subjects analysis found no significant 
main effect of condition on Aix, F(1, 19) = 0.01, p = 0.91, ηp2 = 0.00.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6.5.2.4 Arterial Stiffness Biomarkers – Augmentation Index Corrected for a Heart Rate of 75 
beats·min-1  
Analysis of within-subjects effects found no significant main time effect, F(3, 57) = 0.90, p = 0.14, ηp2 
= 0.09, and no significant interaction of condition and time, F(3, 57) = 0.168, p = 0.917, ηp2 = 0.01. The 
results displayed in figure 26 suggest Aix@HR75 did not significantly differ between conditions across 
any time-point (T1: 5.5 ± 10.6% vs. 5.5 ± 9.8%; T2: 6.3 ± 6.9% vs. 5.8 ± 7.6%; T3: 1.6 ± 10.3% vs. 2.9 ± 
8.1%; T4: 3.8 ± 9.8% vs. 5.4 ± 6.9%; respectively, p > 0.05). A very large variation in findings is 
represented by the SD’s in figure 26 ranging into negative values, a normal finding for low wave 
reflections. Similarly, between-subjects analysis found no significant differences in TRI or NOTRI 
conditions for Aix@HR75, F(1, 19) = 0.03, p = 0.86, ηp2 = 0.00. 
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Figure 25.  Comparison of augmentation index values (Aix; AP/PP) between TRI (n = 11) and NOTRI 
(n = 10) across 4 time-points (mean ± SD, p > 0.05). 
TRI = triathlete participants; NOTRI = recreationally active participants; T1 = 7 days pre-event; T2 = 12-18 
hours post-event; T3 = 7 days post-event; T4 = 28 days post-event (in respect to TRI group). Time-points 
reflect equal variance for NOTRI group conducted at a later period.  
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6.5.2.5 Other Cardiovascular Measurements - Resting Heart Rate  
Within-subjects analysis displayed no significant main time effect, which suggests the values for rHR 
were in general similar across levels of time, F(3, 57) = 1.85, p = 0.15, ηp2 = 0.09. An interaction effect 
of condition and time on HR was found to be significant, F(3, 57) = 10.28, p < 0.001, ηp2 = 0.35. 
Bonferroni pairwise comparisons displayed a significant difference in rHR between TRI and NOTRI at 
T2, 69 ± 9 beats·min-1 vs. 56 ± 11 beats·min-1, F(1, 19) = 6.57, p < 0.05, ηp2 = 0.29 but not at T1 (56 ± 7 
vs. 63 ± 13 beats·min-1, p = 0.13), T3 (65 ± 8 vs. 60 ± 8 beats·min-1, p = 0.2) or T4 (58 ± 9 vs. 61 ± 10 
beats·min-1, p = 0.60). Figure 27 presents values for rHR for TRI and NOTRI participants over the 4 time 
levels. 
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Figure 26. Comparison of augmentation index corrected for a heart rate of 75 beats·min-1 
(Aix@HR75) between TRI (n = 11) and NOTRI (n = 10) across 4 time-points (mean ± SD, p > 0.05). 
TRI = triathlete participants; NOTRI = recreationally active participants; T1 = 7 days pre-event; T2 = 12-18 
hours post-event; T3 = 7 days post-event; T4 = 28 days post-event (in respect to TRI group). Time-points 
reflect equal variance for NOTRI group conducted at a later period.  
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6.5.2.6 Other Cardiovascular Measurements - Aortic Systolic Blood Pressure  
Mauchly’s test indicated that the assumption of sphericity had been violated, χ2(5) = 11.43, p = 0.04. 
Owing to this violation, degrees of freedom were corrected using Greenhouse-Geisser correction, ε = 
0.69. Within-subjects analysis found no significant effect of time, F(2.06, 38.19) = 1.35, p = 0.27, ηp2 = 
0.07. Similarly, an interaction effect of time and condition remained statistically insignificant, F(2.06, 
38.19) = 1.04, p = 0.38, ηp2 = 0.05. There was no significant main effect of condition, indicating aSBP 
values for TRI and NOTRI participants were in general the same, F(1, 19) = 1.25, p < 0.05, ηp2 = 0.06 
(table 10). 
6.5.2.7 Other Cardiovascular Measurements - Aortic Diastolic Blood Pressure 
Levene’s test of equality of error variances was violated at T1, F(1, 19) = 7.54, p < 0.05, and at T2, F(1, 
19) = 8.69, p < 0.05. As a result a more conservative alpha level of 0.025 was accepted. There was no 
significant main effect of time on aDBP, F(3, 57) = 1.91, p = 0.14, ηp2 = 0.09 or interaction effect 
between time and condition, F(3, 57) = 1.22, p = 0.31, ηp2 = 0.06. This indicates that aDBP of different 
levels of time did not differ according to whether participants were in the TRI or NOTRI condition 
(table 10). Between-subjects effects found no overall significant difference between TRI and NOTRI 
conditions, F(1, 19) = 1.33, p > 0.05, ηp2 = 0.07, indicating aDBP was similar between athletes 
participating in the triathlon and recreationally active individuals.  
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Figure 27. Comparison of resting heart rate (rHR) between TRI (n = 11) and NOTRI (n = 10) 
conditions across 4 time-points (mean ± SD). 
TRI = triathlete participants; NOTRI = recreationally active participants; T1 = 7 days pre-event; T2 = 12-18 
hours post-event; T3 = 7 days post-event; T4 = 28 days post-event (in respect to TRI group). Time-points 
reflect equal variance for NOTRI group conducted at a later period.  
* significance between TRI and NOTRI, p < 0.05. 
 
* 
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6.5.2.8 Other Cardiovascular Measurements - Left Ventricular Ejection Duration  
A significant main time effect was found for LVED, F(3, 57) = 2.82, p < 0.05, ηp2 = 0.13, with a linear 
contrast, F(1, 19) = 10.40, p < 0.005, ηp2 = 0.35. Additionally, within-subject analysis found a significant 
time and group interaction, F (3, 57) = 6.45, p < 0.005, ηp2 = 0.25, indicating that LVED was affected 
by the different conditions across different levels of time (table 10). Simple main effects using 
Bonferroni adjustment for multiple comparisons was used to clarify the effect of condition. Analysis 
found a significant difference between TRI and NOTRI conditions at T3, F(1, 19) = 4.60, p < 0.05, ηp2 = 
0.20. This suggests that LVED was similar between TRI and NOTRI conditions pre-event (T1: 316 ± 20 
ms vs. 301 ± 21 ms) and 12 to 18 hours post TRI only event (T2: 298 ± 21 ms vs. 311 ± 21 ms). LVED 
was significantly shorter for TRI compared with NOTRI at 7 days post-event (T3: 290 ± 17 ms vs. 305 ± 
17 ms) but not at 28 days post TRI only event (T4: 302 ± 20 ms vs. 296 ± 21 ms). Between-subjects 
effects of condition was insignificant, F(1, 19) = 0.09, p = 0.77, ηp2 = 0.01 indicating LVED was similar 
between athletes participating in the triathlon and recreationally active individuals. 
 
Table 10. Descriptive statistics of additional cardiovascular measurements 
between conditions. 
Measurement Time-Point TRI (n = 11) NOTRI (n = 10) 
aSBP  (mmHg) T1 – 7d Pre 
T2 – 12-18h Post 
T3 – 7d Post 
T4 – 28d Post 
 
109 ± 12 
103 ± 8 
108 ± 10 
103 ± 9 
103 ± 11 
103 ± 11 
102 ± 8 
101 ± 7 
aDBP (mmHg) T1 – 7d Pre 
T2 – 12-18h Post 
T3 – 7d Post 
T4 – 28d Post 
 
73 ± 6 
70 ± 7  
74 ± 6 
70 ± 7 
70 ± 11 
67 ± 11 
67 ± 9 
67 ± 8 
LVED (ms) T1 – 7d Pre 
T2 – 12-18h Post 
T3 – 7d Post 
T4 – 28d Post 
 
302 ± 20 
290 ± 17 
*298 ± 21 
316 ± 20 
296 ± 21 
305 ± 17 
311 ± 21 
301 ± 21 
TRI = triathlete participants; NOTRI = recreationally active participant; aSBP = aortic systolic blood pressure; 
aDBP = aortic diastolic blood pressure; LVED = left ventricular ejection duration.  
* significant difference compared with NOTRI at level of time (p < 0.05). 
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6.5.3 Part 2: Supplementation vs. Non-supplementation 
Part 2 of this study used a 4 by 2 mixed measures ANOVA with time as the within-subjects factor (4 
levels) and with comparisons made between and NS and S groups (non-supplementation group and 
supplementation group, respectively) using TRI participants only (athletes participating in iron-
distance triathlon). Arterial stiffness biomarkers, rHR, aortic BP, and LVED were inserted into the 
ANOVA as dependent variables. 
6.5.3.1 Baseline Comparisons 
Table 11. shows the baseline participant characteristics between NS and S groups (NS: no 
supplementation and S: supplementation). Independent samples t-tests were conducted for baseline 
(T1) age, height and body mass between groups as reflected in table 11. Age was statistically non-
significant between groups t(9) = -1.35, p = 0.21. Likewise, no significant differences between groups 
were observed for height, t(9) = -1.07, p = 0.31, or body mass, t(9) = 0.33, p = 0.75. Additionally, V̊O2max 
values for NS and S participants were not significantly different, t(9) = 0.19, p = 0.85, along with race 
performance, t(9) = 1.07, p = 0.31. 
 
Table 11. Baseline participant characteristics between groups.  
 TRI (n = 11)  
 NS 
(n = 6) 
S 
(n = 5) 
 
Age (years) 31. 2 ± 7.9 38.0 ± 8.9 p = 0.21 
Height (cm) 172.3 ± 8.5 177.0 ± 5.1 p = 0.31 
Body mass (kg) 70.8 ± 10.6 77.6 ± 9.6 p = 0.75 
Relative V̊O2max (ml·kg-1·mins-1) 51.0 ± 7.1 50.2 ± 6.5 p = 0.85 
Race Performance (dec mins) 804.7 ± 65.3 764.2 ± 59.1 p = 0.31 
NS = non-supplementation group; S = supplementation group; yr = years; cm = centimetre; kg = 
kilogram; relative V̊O2max = maximal volume of oxygen uptake per kilogram of body mass per minute; 
dec mins = decimal minutes. 
 
 
There were no significant differences observed between NS and S for urinary markers of oxidative 
stress and antioxidant reserve capacity pre-event (table 12). Independent samples t-tests were 
conducted for pre-event oxidative stress biomarkers including: urinary lipid peroxides t(8) 0.02, p = 
0.98 and 8-hydroxydeoxyguanosine (8-OHdG) t(8) = -0.14, p = 0.90. Additionally, glutathione 
requirement scores were not significantly different between groups t(9) = -0.72, p = 0.49. 
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Table 12. Comparison of urinary oxidative stress biomarkers and antioxidant reserve 
capacity obtained pre-race. 
 TRI (n = 11)  
 NS 
(n = 6) 
S 
(n = 5) 
 
Lipid peroxides (µl·g creatinine-
1) 
5.75 ± 1.61 5.75 ± 1.87 p = 0.98 
8-OHdG (µg·g creatinine-1) 10.83 ± 2.48 11.00 ± 1.41 p = 0.90 
Glutathione Requirement Score 2.51 ± 2.95 3.60 ± 2.07 p = 0.49 
NS = non-supplementation group; S = supplementation group; 8OHdG = 8-hydroxydeoxyguanosine. 
Glutathione requirement was scored from 0 to 10 for each participant. 
 
6.5.3.2 Arterial Stiffness Biomarkers - Pulse Wave Velocity  
The null hypothesis was tested that there would be no difference in PWV between time-points, and 
there would be no difference between those receiving antioxidant supplementation and those not 
receiving supplementation.  Analysis showed no significant main time effect for PWV, F(3, 27) = 1.20, 
p = 0.33, ηp2 = 0.12, indicating the results were in general the same across time-points (T1: 5.9 ± 0.6 
m·s-1, T2: 6.1 ± 0.4 m·s-1, T3: 6.3 ± 0.7 m·s-1, 6.0 ± 0.6 m·s-1; p < 0.05). Similarly, no significant 
interactions were observed for group across time levels for PWV values, F(3, 27) = 0.39, p = 0.76, ηp2 
= 0.04 suggesting that values of PWV of different levels of time were similar between participants 
(figure 28). Between-subjects analysis displayed an insignificant difference in PWV between groups, 
F(1, 9) = 0.15, p = 0.71, ηp2 = 0.02. Figure 29 shows the individual deviation of PWV values from pre-
event (T1) to various time-points post-event. PWV remained less than 8 m.s-1 for all participants. 
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Figure 28. Comparison of pulse wave velocity (PWV) in TRI participants NS (n = 6) and S (n = 5) 
across 4 time-points (mean ± SD, p > 0.05). 
NS = non-supplementation group; S = supplementation group; T1 = 7 days pre-event; T2 = 12-18 hours 
post-event; T3 = 7 days post-event; T4 = 28 days post-event (in respect to TRI group). Time-points reflect 
equal variance for NOTRI group conducted at a later period.  
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6.5.3.3 Arterial Stiffness Biomarkers - Augmentation Index  
Levene’s test of equality of error variances was violated at T1, F(1, 9) = 5.95, p = 0.04 and T3, F(1, 9) = 
7.96, p = 0.02 and as such, an alpha level of 0.025 was accepted. Within-subject analysis revealed a 
non-significant main time effect on Aix, F(3, 27) = 3.06, p  = 0.05, ηp2 = 0.25. ANOVA results revealed 
no significant interaction effect of time and group factors, F(3, 27) = 1.39, p = 0.27, ηp2 = 0.13. Results 
show that Aix at different time-points were similar between groups and time alone did not have a 
significant effect (figure 30). Between-subject analysis found no significant difference between groups 
for Aix, F(1, 9) = 0.29, p = 0.6, ηp2 = 0.03. Figure 31 shows the individual deviation of Aix values from 
pre-event (T1) to various time-points post-event. 
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Figure 29. Change in pulse wave velocity values (PWV) for individual participants of NS (n = 6) and 
S (n = 5) compared with baseline values (mean ± SD, p > 0.05).  
NS = non-supplementation group; S = supplementation group; T1 = 7 days pre-event; T2 = 12-18 hours 
post-event; T3 = 7 days post-event; T4 = 28 days post-event.  
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Figure 30. Comparison of augmentation index (Aix) in TRI participants NS (n = 6) and S (n = 5) across 
4 time-points (mean ± SD, p > 0.05). 
NS = non-supplementation group; S = supplementation group; T1 = 7 days pre-event; T2 = 12-18 hours 
post-event; T3 = 7 days post-event; T4 = 28 days post-event. 
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Figure 31. Change in augmentation index (Aix) for individual participants of NS (n = 6) and S (n = 
5) compared with baseline values (mean ± SD, p > 0.05).  
NS = non-supplementation group; S = supplementation group; T1 = 7 days pre-event; T2 = 12-18 hours 
post-event; T3 = 7 days post-event; T4 = 28 days post-event.  
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6.5.3.4 Arterial Stiffness Biomarkers - Augmentation Index Corrected for a Heart Rate of 75 
beats·min-1  
Levene’s test was significant for Aix@HR75 at T1, (F(1, 9) = 15.24, p = 0.004), T3 (F(1, 9) = 5.75, p = 
0.04) and T4 (F(1, 9) = 14.8, p = 0.004). This finding suggests there was a violation to the assumption 
of equality of error variances and therefore, a more conservative alpha level of 0.005 was accepted. 
Within-subjects analysis established no significant main time effect on Aix@HR75, F(3, 27) = 1.80, p = 
0.17, ηp2 = 0.17. The time and group interaction effect was non-significant, F(3, 27) = 0.58, p = 0.06, 
ηp2 = 0.06 indicating that Aix@HR75 did not differ between S and NS groups at different time levels 
before and after the triathlon as shown in figure 32. Between-subjects analysis found no significant 
differences in group for Aix@HR75, F(1, 9) = 0.21, p = 0.67, ηp2 = 0.02. 
 
 
6.5.3.5 Other Cardiovascular Measurements - Resting Heart Rate  
Levene’s test of equality of error variances was violated at T2, F(1, 9) = 5.86, p = 0.04. Due to this 
violation, an alpha level of 0.025 was accepted for between groups analysis with time level T2. Analysis 
of within-subjects tests revealed a significant main effect of time on rHR, F(3, 27) = 11.39, p < 0.001, 
ηp2 = 0.56. Pairwise comparisons identified significant differences between T1 and T2, (55.5 ± 6.9 
beats·min-1 vs. 68.6 ± 9.4 beats·min-1 respectively, 19% increase, p < 0.001) and T2 and T4 (58.4 ± 8.5 
beats·min-1, 18% reduction, p < 0.005) as presented in figure 33. In addition, differences between T1 
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Figure 32. Comparison of augmentation index corrected for heart rate (Aix@HR75) in TRI 
participants NS (n = 6) and S (n = 5) across 4 time-points (mean ± SD, p > 0.05). 
NS = non-supplementation group; S = supplementation group; T1 = 7 days pre-event; T2 = 12-18 hours 
post-event; T3 = 7 days post-event; T4 = 28 days post-event. 
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and T3 (64.6 ± 8.1 beats·min-1) approached significance with an elevation of 14%, p = 0.06. A significant 
time and group interaction existed, F(3, 27) = 4.12, p < 0.05, ηp2 = 0.31. This would suggest that rHR 
values for S and NS interacted differently after the triathlon event. Bonferroni pairwise comparisons 
did not find a significant difference between groups among time levels however values for rHR 
approached significance at T2; 64 ± 5 vs. 74 ± 11; TRI and NOTRI respectively, p = 0.06). Between-
subjects analysis found no significance between groups, F(1, 9) = 0.06, p = 0.94, ηp2 = 0.001.  
 
 
 
6.5.3.6 Other Cardiovascular Measurements - Aortic Systolic Blood Pressure 
There was a significant main effect of time on aSBP, F(3, 27) = 3.43, p < 0.05, ηp2 = 0.28. After 
adjustment for multiple comparisons, Bonferroni pairwise analysis did not find significance between 
time-points, p > 0.05. There was no significant main effect of group, F(1, 9) = 0.03, p = 0.87, ηp2 = 0.003 
indicating that values of aSBP were affected by triathlon performance as indicated by time levels but 
not enough to be significant (table 13). Additionally, supplementation did not have an influence on 
aSBP across levels of time. 
Figure 33. Comparison of resting heart rate (rHR) in TRI participants NS (n = 6) and S (n = 5) across 
4 time-points (mean ± SD). 
NS = non-supplementation group; S = supplementation group; T1 = 7 days pre-event; T2 = 12-18 hours 
post-event; T3 = 7 days post-event; T4 = 28 days post-event.  
* significantly different from T1, p < 0.001. 
# significantly different from T4, p < 0.005. 
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6.5.3.7 Other Cardiovascular Measurements - Aortic Diastolic Blood Pressure 
Levene’s test of equality of error variances was violated at T1, F(1, 9) = 5.86, p = 0.04 and as such, an 
alpha level of 0.025 was accepted for between groups analysis. Within-subjects analysis found no 
significant main effect of time, although the F statistic approached significance, F(3, 27) = 2.738, p = 
0.06, ηp2 = 0.23. Similarly, the time and group interaction for aDBP also approached significance, F(3, 
27) = 2.93, p = 0.05, ηp2 = 0.25. There was no significant main effect of group, F(1, 9) = 0.09, p = 0.77, 
ηp2 =  0.10, indicating supplementation did not significantly affect aDBP through time levels (table 13). 
6.5.3.8 Other Cardiovascular Measurements - Left Ventricular Ejection Duration 
There was a significant main effect of time on ED, F(3, 27) = 5.21, p < 0.05, ηp2 = 0.37. Bonferroni 
pairwise comparisons did not reveal specific differences between levels of time after adjustment for 
multiple comparisons. There was no significant interaction effect of time and the groups on ED, 
indicating values from NS and S participants were in general the same, F(3, 27) = 1.17, p = 0.34, ηp2 = 
0.12 (table 13).  
Table 13. Descriptive statistics of additional cardiovascular measurements between groups. 
  Triathletes  
Measurement Time-Point NS 
(n = 6) 
S 
(n = 5) 
Overall  
(n = 11) 
aSBP (mmHg) T1 – 7d Pre 
T2 – 12-18h Post 
T3 – 7d Post 
T4 – 28d Post 
 
110 ± 12 
105 ± 6 
106 ± 10 
101 ± 10 
108 ± 12 
100 ± 10 
110 ± 11 
107 ± 9 
109 ± 12 
103 ± 8 
108 ± 10 
103 ± 9 
aDBP (mmHg) T1 – 7d Pre 
T2 – 12-18h Post 
T3 – 7d Post 
T4 – 28d Post 
 
72 ± 4 
73 ±7 
75 ± 6 
69 ± 9 
74 ±8  
67 ± 6 
73 ± 5 
71 ± 5 
73 ± 6 
70 ± 7  
74 ± 6 
70 ± 7 
LVED (ms) T1 – 7d Pre 
T2 – 12-18h Post 
T3 – 7d Post 
T4 – 28d Post 
 
322 ± 15 
309 ± 18 
291 ± 22 
304 ± 19 
 
308 ± 24 
284 ± 16 
287 ± 10 
301 ± 23 
302 ± 20 
290 ± 17 
298 ± 21 
316 ± 20 
NS = non-supplementation group; S = supplementation group; aSBP = aortic systolic blood pressure; aDBP = 
aortic diastolic blood pressure; LVED = left ventricular ejection duration.  
 
 
 
6.6 Discussion 
6.6.1 Arterial Stiffness in Endurance Trained and Recreationally Active Individuals 
A major finding in this investigation was that indices of arterial stiffness were similar at baseline 
between endurance-trained and recreationally active participants. There was no difference in PWV 
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between ultra-endurance trained and recreationally active controls despite significant differences in 
the confounding factor, rHR. This finding contributes to the limited span of literature concerning ultra-
endurance athletes and arterial health. Previous investigations have observed differences in large 
artery compliance between ultra-endurance athletes and recreationally active individuals. Burr et al., 
(2013) observed a significant reduction in large artery compliance, but non-significant differences 
between small artery compliance in habitual ultra-marathon runners, compared with age-matched 
recreationally active controls. Similar results were observed in marathon runners with different 
measurements; Vlachopoulos et al. (2010) observed no difference in Aix, and a significantly elevated 
PWV in marathoners; 0.56 m·s-1 above recreationally active controls. On the other hand, Radtke et al. 
(2013) found comparable results to the present study, whereby no significant differences in brachial-
ankle PWV were observed between recreational, marathon, and ultra-endurance athletes.  
Methodological issues exist in deriving aortic stiffness from pulse waves of peripheral limbs due to the 
inherent contribution of peripheral arteries in the estimation (Laurent et al., 2006; Rowley et al., 
2011). Data from our study comply with others finding a non-existent difference in peripheral artery 
compliance, assessed in this study by wave reflections, between habitual endurance athletes and 
recreationally active individuals (Burr et al., 2014; Knez et al., 2008; Radtke et al., 2013; Vlachopoulos 
et al., 2010). The current findings give evidence that 9 months of ultra-endurance training does not 
provide significantly different arterial stiffness differences from recreationally active individuals. This 
would indicate that contrary to epidemiological and previous longitudinal studies, ultra-endurance 
training is not a stimulus for unfavourable adaptation of the CV system, specifically arterial compliance 
(O’Keefe et al., 2012; Schwartz et al., 2014).  
6.6.2 Cardiovascular factors affecting Arterial Stiffness Measurements  
In agreement with other studies in the area, the current study found that SBP and DBP did not differ 
between ultra-endurance trained and physically active controls (Burr et al., 2014). However 
controversy exists as to whether excessive endurance training may elevate SBP (O’Keefe et al., 2012; 
Vlachopoulos et al., 2012). Additionally, in the current study rHR and LVED were not significantly 
different between ultra-endurance trained and recreationally active controls at baseline. Therefore, 
similarities in arterial stiffness measurements between conditions remained unaffected by other CV 
factors such as CBP, rHR and LVED.  
 
6.6.3 Arterial Stiffness in Response to an Ultra-Endurance Exercise Bout 
Another important finding in this investigation relates to changes in arterial stiffness in response to 
ultra-endurance exercise. Trained participants competing in an iron-distance triathlon had 
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significantly greater arterial stiffness than recreationally active individuals in the short period 
following the race, which did not exist prior to, or 28 days post-event. The finding of differences in 
PWV, but not Aix or Aix@HR75 in this short period, indicates that those who participated in the 
exercise were subjected to a low level increase in regional large and medium artery stiffening. 
Nevertheless, it is necessary to note that the triathletes experienced almost a 3-fold decrease in mean 
Aix values 7 days post-event, which was not equivalent in the control group. Importantly PWV did not 
exceed the European Society of Hypertension’s clinical threshold value of 12 m·s-1 for CV mortality risk 
in any individuals of this study (Mancia et al., 2009). However, according to current criteria, no 
participants presented a serious CV risk, although triathletes may have been exposed to an increased 
risk of CV events in the short period after ultra-endurance exercise.  
Differential responses in PWV and Aix likely originate in the methodological calculation of arterial 
stiffness. Aix is derived from wave reflections at the radial artery which is heavily influenced by 
peripheral arteries and arterioles, whereas PWV gives a regional stiffness of the aortic-femoral tract 
(Laurent et al., 2006). There are also differential physiological responses to exercise in peripheral 
arteries and large to middle sized arteries. Peripheral arteries are likely to be more heavily influenced 
by nitric oxide (NO) production than central arteries (Joannides et al., 1995). However, Sugawara et 
al. (2004) found that nitric oxide synthase (NOS) inhibition has no effect on the decrease of middle 
sized arterial stiffness post-exercise.  
The augmented PWV, indicative of large arterial stiffening, observed between triathletes and 
recreationally active conditions was not great enough effect to elicit a significant increase between 
time-points when the triathlon group were treated separately. Indeed, the maximal PWV increase of 
0.4 m.s-1 for triathletes was observed between 7 days pre-event and 7 days post-event. However, pilot 
testing (chapter 5.2) revealed that differences up to 0.7 m.s-1 between 2 testing sessions can be 
expected. Significant alterations have been found recently by Burr et al., (2012) who identified a 
reduction large artery compliance, indicative of an augmented arterial stiffening in response to an 
ultra-endurance footrace. Recently, only 40 minutes of downhill running has been found to induce 
delayed elevations to PWV (and muscle soreness) which peaked 2 days post-exercise, and remained 
elevated 3 days post-exercise (Burr Boulter & Beck, in press). It is not unusual for long-distance 
triathlons to contain substantial components of eccentric exercise, as with downhill running. Eccentric 
exercise can elicit a delayed onset of muscular soreness (DOMS) which has previously been associated 
with similar delayed increases in PWV and inflammatory markers (Barnes, Trombold, Dhindsa, Lin & 
Tanaka, 2010). Lack of change in wave reflections, derived from the radial artery, pre and post-exercise 
is not an uncommon finding in response to endurance exercise, and may even be reduced post-event 
(Burr et al., 2012; Burr et al., in press; Vlachopoulos et al., 2010). Previous investigations have 
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observed significant reductions in Aix immediately post-endurance exercise from 12.2 ± 12.5% to -5.8 
± 11.1%, with large and similar standard deviations to the present study (Vlachopoulos et al., 2010). 
Arterial stiffness and therefore CV risk remained unaffected by ultra-endurance exercise in this study. 
The current study is the first, to our knowledge, to investigate arterial stiffness further than 1 day of 
ultra-endurance exercise, and indicates that an excessive exercise bout does not cause long-term 
alterations in arterial stiffness. An insignificant low level elevation in large artery stiffness was 
observed which was largest 7 days post-exercise than 1 day and 28 days post-exercise. Therefore, this 
study implies there is no serious elevations to CV risk after ultra-endurance exercise. However, 
differences in markers of artery stiffness between conditions warrants further study with more 
participants and more frequent testing appointments. 
6.6.4 Cardiovascular factors affecting Arterial Stiffness Measurements  
Functional CV variables were assessed concomitantly with arterial stiffness measurements to gain an 
understanding of mechanisms and identify factors influencing arterial stiffness measurements. Central 
SBP and DBP did not differ between any time-points within the triathletes, indicating no long-term 
changes in BP. However, a reduced SBP may have been observed in the immediate period post-
exercise if measurements were obtained earlier, as identified by Halliwill et al. (2013) and 
Vlachopoulos et al. (2010). Additionally, rHR was elevated only at 1 day post-event (13 beats·min-1 
increase from baseline), though remained elevated 7 days later (9 beats·min-1 increase from baseline). 
This may be partially explained by a sustained cardiac baroreflex resetting from prolonged exercise, 
complex central nervous system (CNS) patterns, and a compensatory response for metabolic 
requirements (Hart et al., 2010; Laforgia, Withers & Gore, 2006; Raine et al., 2001; Sala-Mercado et 
al., 2006). LVED was not significantly different between time-points. No significant differences were 
observed in arterial stiffness between time-points, though elevations in rHR may be at least partially 
responsible for slight changes in arterial stiffness measures. The combination of rHR being different 
between triathletes and controls 1 day post-event, and dissimilar LVED 7 days post-event, could 
potentially explain the differences in PWV between conditions at these time-points. Changes to 
systolic ejection rate and duration influence the extent of vessel recoil during diastole, affecting the 
level of arterial compliance (Salvi et al., 2013). Since significant alterations in arterial stiffness were 
not observed within triathletes, cardiac function may predominantly affected in the short period post-
ultra-endurance exercise, reducing the pressure within the arteries. 
6.6.5 Potential Mechanisms of Action for Arterial Stiffness Response to Ultra-Endurance 
Exercise 
Possible explanations for increased large artery stiffness due to a bout of excessive exercise include 
functional and structural mechanisms. It is conceivable that the prolonged rather than cyclic 
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inflammatory responses to excessive exercise may stimulate detrimental structural remodelling, 
contributing to long-term arterial stiffness. Sustained shear stress and oxidative stress induced by 
prolonged endurance exercise may induce fibrotic changes, decrease arterial wall elasticity, and 
promote pro-atherogenic phenotypes and plaque accumulation (Laughlin, Newcomer & Bender, 2008; 
O’Keefe et al., 2012; Schwartz et al., 2014). These harmful changes are associated with an increased 
risk of CV events and SCD, therefore it is important to understand whether ultra-endurance athletes 
are predisposed to such conditions (O’Keefe et al., 2012). Conversely, transient responses of arterial 
stiffness are likely mediated by functional alterations such as impaired endothelial function and 
adjusted sympathetic vascoconstrictor tone (Dawson et al., 2008; Failla et al., 1999; Sinder, Delp, 
Reyes, Wu & Muller-Delp, 2009). Elevated RONS production and oxidative stress caused by increasing 
metabolic reactions may induce endothelial dysfunction. Likely mechanisms responsible include 
reduced NO bioavailability due to RONS production, such as superoxide (O2-) and subsequent 
peroxynitrite (ONOO-), as well as the reduction of NO cofactor tetrahydrobiopterin (BH4) 
bioavailability (Sinder, Delp, Reyes, Wu & Muller-Delp, 2009). Sympathetic tone is elevated with 
exercise which is in part as a response of the metaboreflex, which increases cardiac output and the 
release of vasoconstrictive substances, mediating blood flow distribution (Boushel, 2010; Davies et al., 
2007; Sala-Mercado et al., 2006). Sustained arterial and cardiac catecholamine exposure such as 
norepinephrine as well as increased sympathetic tone likely influences arterial stiffness by increasing 
HR, resulting in overall shortening of the cardiac cycle. Vessel recoil may then be shortened during 
diastole therefore restricting the extent of arterial compliance (Heffernan, et al., 2013; Salvi et al., 
2013).  
It was originally speculated that participants in the current study, with no previous ultra-endurance 
exposure, would present amplified findings of arterial stiffness post-event compared with other 
studies using experienced ultra-endurance athletes. This reasoning was formed due to the enhanced 
inflammatory response and oxidative stress protection observed in those habituated to endurance 
exercise (Bloomer et al., 2006; Jówko et al., 2011); though the training period alone may be adequate 
to elicit similar adaptations. Additionally the basis was formed on the assumption that multiple 
previous exposure to ultra-endurance exercise bouts would have elicited most structural and 
functional adaptations, specifically the CV system, resulting in a lessened response (Neilan, Jannuzi et 
al., 2006; Sahlén et al., 2009). However, the opposite may also hold true, in that repeated exposure 
may result in an elevated vulnerability for detrimental vascular effects. Excessive exercise such as 
several ultra-endurance bouts may accelerate atherosclerosis (Knez et al., 2008; Mastaloudis et al., 
2001). Shear stress induced arterial remodelling, in the presence of atherosclerosis may become 
uncontrolled and contribute to plaque vulnerability (Schwartz et al., 2014; Silver & Vita, 2006). This 
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would result in a greater arterial stiffening response than would potentially be seen in a healthy vessel, 
without atherosclerotic plaque accumulation. The lack of arterial stiffening response post-event in the 
current study provides evidence against our postulation. Further investigation is warranted to 
compare a single excessive exercise bout in those with and without previous exposure to ultra-
endurance exercise  
6.6.6 Supplementation in Response to an Ultra-Endurance Exercise Event 
The present study indicates that ingestion of multiple supplements with antioxidant and anti-
inflammatory properties prior to ultra-endurance exercise did not influence markers of arterial 
stiffness. Urinary biomarkers of oxidative stress and glutathione obtained pre-event were not 
influenced by a 12 week supplementation with multiple exogenous antioxidants. It was suggested that 
increasing exogenous antioxidant availability would increase the endogenous antioxidant reserve 
(measured in this study as urinary glutathione levels), and reduce oxidative stress experienced during 
the event (Bloomer, Goldfarb & Mckenzie, 2006; Mastaloudis et al., 2004). In turn, it was hypothesised 
that this would provide a protective mechanism to the endothelial cells of the vasculature. 
Supplementation did not attenuate or augment markers of arterial stiffness before or after the event. 
This finding could be a result of inadequate oxidative stress however previous literature has provided 
significant associations between ultra-endurance and increased RONS production (Neubauer, Konig & 
Wagner, 2008; Knez, Jenkins & Coombes, 2007). Our study implies that antioxidant supplementation 
is unnecessary and redundant in protecting exercise-induced arterial stiffness, largely due to the 
absence of arterial stiffening within all triathletes. Furthermore the lack of differences in SBP, DBP, 
rHR or LVED between intervention groups throughout the study supports the absence of CV effect of 
the supplementation strategy employed. Future implications on exercise-induced arterial stiffness of 
whole food antioxidant strategies with polyphenols should be investigated further. 
6.6.7 Methodological Issues and Future Research 
Due to the heterogeneity of the sample and lack of current understanding regarding the changes in 
arterial stiffness following prolonged endurance exercise, this study aimed to provide an insight for 
more substantial subsequent investigations. Previous research has found that white European men 
had an Aix on average 7.8% lower than women (Wojchiechowska et al., 2006). However, a possible 
differential effect of sex on the results of the current study could not be inferred due to the disparity 
in distribution of male and female participants. Additionally, the large scale study by Wojchiechowska 
et al. (2006) identified a non-linear increase in Aix with age. This suggests samples with wide age 
dispersions, as adopted in the current study, may have very different values. Furthermore exercise-
induced adaptations have been shown to differ among young and older individuals. Peripheral arteries 
are suggested to be more affected in younger individuals, whereas larger elastic arteries are involved 
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in older individuals (McDonnell et al., 2013). Unfortunately, the sample size in the current study was 
not large enough to offer a substantial insight into this differentiation. A more homogenous sample 
would have added specificity to the study but would not have reflected the whole population.  
According to the recent expert document by Van Bortel et al. (2012) regarding cfPWV, it is advised 
that investigators should take the mean of 2 measurements in a single session.  A third measurement 
should be obtained if PWV differs by greater than 0.5m·s-1, whereby the investigator should then use 
take the median value to avoid outliers. This procedure was not conducted in the present study which 
followed procedures for a single measurement within quality control parameters. Following the recent 
consensus would have resulted in more precise measurements and would have reduced the risk of 
investigator errors/type I errors. Furthermore, the SphygmoCor equipment is an apparatus 
predominantly used in the clinical environment, mainly with already diseased individuals including 
renal disease, hypertension, hyperlipidaemia, and hypercholesterolemia (Mattace-Raso et al., 2006; 
Pauca et al., 2001; Wilkinson et al., 2010). Its use in the athletic population has not currently been 
validated, and its reproducibility in said individuals has not been investigated.  
Another limitation of the present study was that hydration status and plasma volume were not 
assessed. These factors have been found to influence cardiac efficiency, stroke volume, and 
subsequent BP and arterial stiffness indices (Di lorio, Nazzaro, Cucciniello & Bellizzi, 2010). 
Nevertheless, it is likely that the time for recovery before measurements were taken allowed 
adequate replenishment of hydration. In addition, obtaining measures of oxidative stress post-
exercise and recruiting larger numbers of participants would contribute to the understanding of 
underlying mechanisms with the use of correlational analysis. 
Studies in this area of research would benefit from knowledge of nutritional and training practices, as 
well as further assessment of race information. Nutrition intake prior to, during and post-race would 
impact performance, and recovery. Specifically caffeine, glucose, alcohol, and salt consumption have 
been associated with changes in arterial stiffness and wave reflections, these food stuffs were not 
considered (Draaijer et al., 1993; Papaionnou, Karatzi, Papamichael & Lekakis, 2005; Pase Grima & 
Sarris, 2010; van den Elzen et al., 2005; Zieman, Melenovsky & Kass, 2005). Additionally, impaired 
glucose tolerance was not assessed which enhances the production of AGEs, altering the mechanical 
properties of arterial stiffness (Henry et al., 2003). Though the current study observed no significant 
differences in race duration, race intensity was not considered. Presumably increasing exercise 
intensity would influence measures of arterial stiffness (Sharman et al., 2005), which warrants further 
research. Furthermore, although triathletes followed the same training protocols prior to the race, 
training practices post-event were undetermined which should be controlled for in future research. It 
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is also possible that triathletes made notable lifestyle changes in the period post-event which could 
interact with arterial stiffness measurements, therefore future studies should attempt to control for 
this factor. 
The influence of alcohol on parameters measured in this study was not entirely controlled for. Light 
to moderate levels of alcohol consumption provides a cardioprotective effect, however irregular 
consumption of large volumes (binge drinking) elicits harmful influences to the CV system and arterial 
stiffness (Beilin, 2002; Murray et al., 2002). Therefore, it was urged for participants in this study to 
refrain from alcohol ingestion prior to measurements. However, it is more than likely that at least 
some triathletes felt the need to become intoxicated post-event due to the sense of enormousness of 
achievement. Hence post-event measurements may be unfairly influenced. 
Non-invasive measurements of arterial stiffness, as used in this study, are calculated using models of 
the circulation. Therefore, such methods increase the possibility for estimation errors. However, 
invasive procedures are far more unfeasible in field-based studies given the methodological challenges 
for example the cost and location of equipment. Additionally, during pulse wave analysis the 
calculation of Aix@HR75 is corrected for HR based on relatively little evidence (Wilkinson et al., 2000; 
Wilkinson et al., 2002), despite LVED better predicting changes in the gold standard measurement 
PWV (Salvi et al., 2013). 
Future investigations should examine the dose response of exercise to arterial stiffness indices and 
equally to investigate the associated time response to different doses and intensities of exercise. 
Furthermore, examining arterial stiffness measurements prior to involvement in ultra-endurance 
exercise, and after consecutive annual time-points would provide more valuable evidence for the 
exercise dose debate. This could have been achieved in the present study by attaining arterial stiffness 
measurements at the beginning of the training programme (month 0 rather than month 9), and 
comparing changes to a control population of recreational or sedentary controls; both of which 
populations should be considered. In addition, the accumulative effects of prolonged endurance 
exercise should be assessed in relation to vascular health. Multi-day ultra-endurance events provide 
an opportunity to investigate this, with potentially inadequate recovery periods in comparison to the 
present study. 
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6.7 Conclusion 
In light of recent cross sectional and epidemiological investigations, a longitudinal study was deemed 
necessary to assess the causal relationship between ultra-endurance event participation and the 
health of the vascular system. The evidence from this preliminary study suggest an iron-distance 
triathlon does not cause long-term negative impact to the arteries in non-elite athletes. Additionally, 
antioxidant and anti-inflammatory supplementation did not influence arterial stiffness. 
This pilot study aimed to provide insight to the CV response to ultra-endurance training and an ultra-
endurance event, with specific emphasis on arterial stiffness. A supplementary aim was to determine 
whether antioxidant supplementation influenced the arterial stiffening response to this prolonged 
exercise. No differences were observed regarding arterial stiffness indices between endurance trained 
and recreationally active individuals prior to ultra-endurance exercise exposure. The preliminary 
results, however, showed a delayed central arterial stiffening may occur one day and one week 
following a single day ultra-endurance event. Importantly, all measurements were found to be similar 
one month post-event; implying only a transient exercise-induced elevation to arterial stiffness. The 
mechanisms involved in this response likely include a combination of both functional and structural 
pathways which require further elucidation. It is possible that the more immediate arterial stiffening 
post-exercise is associated with the ventricular dysfunction observed in some individuals, in particular, 
the vulnerability of the right ventricle to dysfunction post-exercise due to the contribution of 
increased afterload. The effect of the change was very small and remained far clear of clinical cut-off 
values and so is unlikely to contribute significantly to an increased CV risk for the general population. 
It should be noted, that when the triathlon group were treated separately no significant differences 
were observed between time-points. Additionally, 12-weeks of prior antioxidant and anti-
inflammatory supplementation provides no additive protection against changes in arterial stiffening 
above natural strategies. Accordingly, contrary to current speculation, this study provides evidence to 
suggest there is no causal relationship between a single-day ultra-endurance event and long-term 
arterial stiffening. For individuals rarely participating in such events, this evidence is reassuring and 
contradicts several cross-sectional analyses of myocardial scarring and atherosclerotic plaque 
accumulation in the endurance athlete. This novel study is the first to our knowledge to investigate 
arterial stiffness in individuals participating in their first ultra-endurance event. 
The finding of short-term arterial stiffness post-event gives warrant to future studies to investigate 
the accumulative influence of prolonged exercise. Multi-day ultra-endurance events could highlight 
this and so should be identified as a focus for further investigation, although the lower intensity of 
such events is likely to attenuate this response. Additionally, the intensive training during the period 
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leading to an ultra-endurance event, should not be ignored in future studies, particularly in those with 
CV risk factors. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Key points: 
 No difference in arterial stiffness between ultra-endurance trained and recreationally 
active individuals at baseline. 
 The increase in arterial stiffness observed in the short period after ultra-endurance 
exercise likely returns to baseline within1 month after the event. 
 Antioxidant supplementation is unnecessary and redundant in protecting exercise-
induced arterial stiffness, largely due to the absence of arterial stiffening within all 
triathletes. 
 Further research should investigate the potential accumulative influence of prolonged 
exercise, for example, multi-day ultra-endurance events as well as the intensive 
training period leading to the event. 
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7.1 General Conclusion 
The health benefits of exercise to the CV system are proven, whereas the potential risks of exercise 
are theoretical. As such, no clear link exists between “excessive” exercise and CV damage. 
Nonetheless, evidence from cross-sectional studies suggest there is a potentially damaging effect of 
long term ultra-endurance participation. The lack of longitudinal investigation, however, regarding the 
physiological adaptations occurring from recreational activity to ultra-endurance participation limit 
these findings. Accordingly, the aim of this study was to examine the longitudinal cardiovascular-
related physiological changes over an incremental training period in recreationally active individuals. 
Additionally, it was aimed to investigate the difference in arterial stiffness in relation to athletic status. 
Finally, this was the first study to examine arterial stiffness after an iron-distance triathlon in 
individuals previously unaccustomed to ultra-endurance exercise.  
Nine months of endurance training was a sufficient training period to allow recreationally active 
individuals to complete an ironman-distance triathlon. Normal changes over 6 months of triathlon-
specific endurance training included enhancements to cardiorespiratory fitness and other training-
related parameters. Although much is known of the athlete’s heart, few studies have highlighted the 
change regarding the electrical patterns of the heart in adaptation to an intensive training programme, 
particularly in those previously unaccustomed to such exercise. The current study provides 
information of such changes with reference to time-frames. The frequency of sinus bradycardia 
findings increased most over the 6 month period relative to other criteria, followed by isolated voltage 
criteria for LVH and early repolarisation. High volumes of endurance training induced ‘abnormal’ ECG 
changes in a minority of individuals, as well as the more recognised training-related changes of the 
‘athlete’s heart’. It is important to ascertain whether these findings occur due to an accumulative 
pathophysiological cascade of events or, more likely, whether they occur secondary to ongoing 
adaptations of the athlete’s heart. Understanding this phenomenon will provide useful monitoring 
information for new ultra-endurance athletes and contribute to the excessive exercise dose debate. 
Given that the extent of cardiac adaptations is strongly associated with training hours and fitness it 
can be expected that those participating in ultra-endurance exercise are those most likely to show an 
overlap in training-related ECG changes and those associated with pathology. Importantly, in the 
current study, relatively few individuals displayed abnormal ECG characteristics, despite participating 
in an intensive long-term training programme. 
Preliminary evidence for transiently increased arterial stiffness was found post iron-distance triathlon. 
However, no evidence was found to expect long-term changes in arterial stiffness post-event. 
Additionally antioxidant supplementation prior to the event was unnecessary in protecting against 
exercise-induced arterial stiffness, but likely provides benefits to other systems. It is unlikely that the 
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extent of arterial stiffening after prolonged exercise would place individuals at high risk of CV event, 
however it does give an indication of the direction of change. Moreover, the evidence displayed in the 
current study is reassuring for current ultra-endurance athletes and prospective athletes alike due to 
the lack of long-term arterial stiffness changes due to such events with adequate recovery. 
In conclusion, this study demonstrates that in previously recreationally active individuals undertaking 
intensive exercise training, relatively few individuals undergo cardiac remodelling resulting in 
abnormal electrical conduction similar to pathological disease. This abnormal remodelling may relate 
to a pathological condition or more likely, normal extensive remodelling of the athlete’s heart. 
Furthermore, it is suggested that first participation in an iron-distance triathlon results in no long-term 
arterial stiffening. The safety of individuals participating in sport is paramount, and although most 
ultra-endurance athletes are not competing to improve health per se, knowledge of the risks involved 
should be provided for all athletes. The beneficial impact of exercise on various physiological and 
psychological systems of the human body are proven. The potentially unfavourable risks of exercise 
on cardiovascular health remain predominantly theoretical and limited to those with pre-existing 
conditions, yet require further research.  It is understood that the potential risks involved with exercise 
would affect a minority of individuals, even to the extent of ultra-endurance, and is likely accountable 
to genetics, illness, underlying risk factors, drugs and training/ recovery mismatch. For these reasons, 
exercise should be promoted for all until significant evidence provides information to disagree with 
current consensus. Individuals are encouraged to listen to the body’s stress signals and not engage in 
strenuous activity during these periods, whilst those with CV risk factors or involved with drugs should 
consult a specialist to undergo both pre-participation screening and monitoring. 
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Appendices 
Appendix 1: Study 2 Participant Information Sheet for Triathletes 
 
UNIVERSITY OF HERTFORDSHIRE 
 
ETHICS COMMITTEE FOR STUDIES INVOLVING THE USE OF HUMAN PARTICIPANTS 
(‘ETHICS COMMITTEE’) 
 
 
FORM EC6: PARTICIPANT INFORMATION SHEET 
 
 
 
Title of Research 
 
The Influence of Ultra-Endurance Exercise on the Cardiovascular and Related Physiological 
Systems. 
 
Introduction 
 
 You are being invited to take part in a research study.  Before you decide whether to 
do so, it is important that you understand the research that is being done and what your 
involvement will include.  Please take the time to read the following information carefully and 
discuss it with others if you wish.  Do not hesitate to ask us anything that is not clear or for any 
further information you would like to help you make your decision. Please do take your time to 
decide whether or not you wish to take part.  Thank you for reading this. 
 
What is the purpose of this study? 
 
 Participation trends in ultra-endurance events have increased several fold in the past 
decade. As such, there has been an increased interest in providing scientific research in the 
area. An important aspect of this research is the health benefits/disadvantages that occur as 
a consequence of participating in an extreme endurance event and also the accumulative 
effect of excessive training. In addition, limited research focuses on individuals who undertake 
longer distance events from a relatively 'novice' or 'recreational' background. The heart is of 
particular interest to healthcare practitioners due to the problems that are associated with 
pathological functioning and exercise such as exercise-induced sudden cardiac death.  
 Emerging data has suggested that excessive endurance training may induce 
pathologic structural remodelling of the heart and large arteries in a small subgroup of 
individuals (Mastaloudis et al., 2001). Epidemiological studies have identified an increased 
relative risk of cardiovascular disease, hypertension, and risk of death in those participating in 
the most aerobic exercise indicative of a detrimental, accumulative, effect of excess exercise 
over time (Quinn et al., 1990; Paffenbarger et al., 1986). However, it has been suggested that 
these responses may in fact be mitigated in ultra-endurance athletes as a result of exercise-
induced adaptations (Knez et al., 2006). This statement is supported by many studies 
presenting a transient cardiovascular dysfunction post ultra-endurance exercise, however, 
Neilan, et al. (2006) recently found a more prolonged dysfunction in a small number of 
subjects. 
 As you are aware, we are currently undertaking a longitudinal research study to 
investigate the effects of habitual endurance training on a UK cohort of recreationally active 
individuals who will be taking part in their first iron-distance triathlon (which involves a 3.8km 
swim, 180km cycle, and 42.2km run, in succession in one day). The study has previously been 
granted ethical approval for Phase 1 (protocol number: LS6/9/12SRA multi-disciplinary 
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investigation in the effects of sustained aerobic training in healthy, recreational individuals 
preparing for a long-distance triathlon). During Phase 1, you have been monitored for a 
number of parameters ranging from cardiovascular and physiological variables, immunological 
status, nutritional and bone mineral density variables, psychological ‘mental toughness’, 
functional movement and biomechanical assessment. 
 The aim of the forthcoming study will be to investigate the cardiovascular and cardiac-
related response to completing an ironman distance triathlon; including the short-term and 
more long-term consequences. Several aspects will be considered including nutrition, 
supplementation, training, sleep, and where available the use of clinical feedback such as 
oxidative stress, inflammation, and hormonal function (through the use of Genova Diagnostics 
kits which has received ethical approval (Study 1: protocol number: LMS/SF/UH/00010 The 
influence of Dietary Intake on Functional Nutrition Biomarkers and Exercise Performance in 
Recreationally Trained Individuals. Study 2: protocol number: LMS/SF/UH/00011 The Effect 
of Alpha Lipoic Acid and Probiotic Supplementation on Gastrointestinal Permeability, 
Endotoxemia and Exercise Performance in recreationally Trained Individuals).  
Aims of project 
The key aims of the project include: 
1. To investigate the effects of prolonged endurance exercise on cardiovascular and 
cardiac-related variables in multiple subgroups. 
2. To investigate the effects of dietary intake and prolonged endurance exercise on 
cardiovascular and cardiac-related variables. 
3. To investigate the relationship between various diagnostic biomarkers and 
cardiovascular/cardiac-related variables over a period of prolonged endurance 
exercise. 
 
Do I have to take part? 
 
 It is completely up to you whether or not you decide to take part in this study.  If you 
do decide to take part you will be given this information sheet to keep and be asked to sign a 
consent form.  Agreeing to join the study does not mean that you have to complete it.  You 
are free to withdraw at any stage without giving a reason.  A decision to withdraw at any time, 
or a decision not to take part at all, will not affect the rest of the treatment/care that you receive. 
 
What will happen to me if I take part? 
 
If you decide to take part in this study you will be asked to: 
 
1. Attend the University of Hertfordshire 1 week prior to the race to carry out non-invasive 
assessments of the cardiovascular system which includes the following 
measurements: 
 12 lead electrocardiogram (ECG)  
 Pulse wave analysis, using SphygmoCor 
 Pulse wave velocity, using SphygmoCor 
 
2. Less than 16 hours post-event (ie. the next day) you will be asked to attend a location 
in Cayella, nearby to the race finish, whereby pulse wave analysis and pulse wave 
velocity measurements will be carried out. 
 
3. 1 week post-event you will be asked to attend the University of Hertfordshire for 
another cardiovascular assessment which repeats (1) above. 
 
4. 4 weeks post-event you will be asked to attend the University of Hertfordshire for one 
last cardiovascular assessment which repeats (1) above. 
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Each session you attend will take around 30 minutes of your time. 
 
Preparation 
 Please avoid alcoholic substances and caffeinated substances such as coffee/tea, 
chocolate and energy drinks 12 hours prior to your appointment. 
 Please refrain from exercising 12 hours prior to your appointment. 
 Provide the investigator with current medication and/or supplementation on each 
occasion. 
 
What is electrocardiography (ECG) and what is required of me? 
 ECG is a non-invasive procedure used to record the electrical activity of the heart over 
a short period of time.  
 
During the procedure  
 You will be asked to lie down and an investigator will clean several areas of your upper 
body. Small patches called electrodes will be attached to these areas which will be 
connected by cables to the ECG apparatus. 
 You are required to remain still during the procedure which should not take long. 
 When the procedure is finished the wires will be disconnected by the investigator and 
you will be free to remove the electrodes. 
 
What is SphycmaCor and what is required of me? 
 A SphygmaCor is a tool used to provide a comprehensive yet non-invasive 
assessment of the cardiovascular system. By recording various pulse waveforms and using 
several equations the equipment is able to calculate various important cardiovascular 
parameters. 
 
Pulse Wave Analysis (PWA) 
Pulse waveforms are obtained through a measurement taken at the 
wrist. Central blood pressures among other parameters are then 
calculated using several carefully designed equations. 
During the procedure  
 Your peripheral blood pressure will be obtained prior to the 
procedure. A cuff will be placed around your arm which will 
inflate fairly quickly, then deflate at a slower rate. 
 You will be asked to sit with your arm resting on a stable 
surface with your palm facing upwards. 
 The investigator will place a tonometer (probe) over the lower part of your wrist until 
an acceptable 10 second reading has been obtained. 
 
Pulse Wave Velocity (PWV) 
PWV is used to estimate arterial stiffness by 
measuring the velocity of the blood pressure 
waveform between two superficial artery sites. 
Pulse waveforms are obtained through 
measurements taken at the carotid and femoral 
site. A 3 cable ECG will be recorded 
simultaneously to act as a timing reference.  
During the procedure  
 Your peripheral blood pressure will be 
obtained prior to the procedure. A cuff 
will be placed around your arm which will 
inflate fairly quickly, then deflate at a slower rate. 
 
 
Femoral Pulse 
 
Carotid Pulse Site 
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 You will be asked to lie face up on a stable surface. 
 Three electrodes will be placed on your chest which will be connected by cables to the 
SphygmoCor equipment. 
 The investigator will place a tonometer (probe) over the carotid artery until an 
acceptable 11 second reading has been obtained. (See diagram above for site 
location.) 
 The investigator will place a tonometer (probe) over the femoral artery until an 
acceptable 11 second reading has been obtained. (See diagram above for site 
location.) 
 
In addition, you will be asked to keep a record of training sessions over the 4 week period after 
the race. A template for this will be provided. 
 
What are the possible disadvantages, risks or side effects of taking part? 
 
Electrocardiography (ECG) 
 Participants may be required to shave the chest area where electrodes are will be 
placed. You may experience slight discomfort upon removal of the electrodes. No electricity 
is sent through the body, so there is no risk of shock.  
 
SphygmoCor 
 There should be no pain associated with the use of this equipment, if there is any 
discomfort please inform the investigator.  
 
Exercise Training/ Race Performance – as part of undertaking this study, you have already 
entered the 2013 Barcelona Challenge Triathlon, which is an ultra-distance event. You are 
already undertaking progressive endurance training under the guidance of an Accredited 
Sport and Exercise physiologist, where the risks of exertional fatigue, musculoskeletal injury 
and soreness have been previously outlined, and you have been made aware that you 
undertake such training at your own liability and responsibility. Such risks are minimized if you 
adhere to the progressive nature of the training, and discuss any concerns with the lead 
researcher. 
 
In entering the race you have already agreed to the terms and conditions outlined by the race 
director, including rules and regulations for competing in this event. Participation in this event 
is undertaken at your own liability and responsibility as previously outlined at the beginning of 
Phase 1. Competing in an ultra-endurance race is both physically and mentally challenging, 
and carries the risk of fatigue, dehydration, exhaustion, gastrointestinal distress, nausea, 
dizziness, collapse and musculoskeletal injury. However, the potential for these risks have 
been reduced in that all participants are recreationally trained, and by October 2013 will be 
specifically race trained (so long as you maintain the training programme). All participants will 
be covered by medical services provided during and immediately after the race event. All 
participants will have signed a race event waiver to this effect. 
 
What are the possible benefits of taking part? 
 
 By participating in the exercise training appropriately you will benefit in terms of 
suitable preparation for the 2013 Barcelona Challenge Triathlon. All participants will also 
benefit in terms of personal knowledge of the test data once analysed. Participants will be 
debriefed post study and if requested will receive feedback in terms of cardiovascular 
function. If necessary participants will be advised to take further action with their general 
practitioner. 
 
How will my taking part in this study be kept confidential? 
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 The information that is obtained during the study will follow ethical and legal practice 
and handled in strict confidence. The information obtained, however, will be used for statistical 
analysis with your right to privacy retained. All information will be anonymised; that is, all 
figures and numbers will not be traceable to you and personal details will be removed. All data 
you provide will be stored on a password protected computer. 
 
What will happen to the results of the research study? 
 
 If you agree to take part, your results will be stored on a password protected computer 
and disk drive, with your name and other details removed. All paper data will be locked in a 
filing cabinet in a room which will be locked when it is not being occupied by a member of the 
research team at University of Hertfordshire. Hopefully, we expect that the data will be 
published in a scientific journal. On publication of results it will not be possible to identify 
individual participants and all personal data will be destroyed upon completion. 
 
Who has reviewed this study? 
 
 This research study has been reviewed by an independent group of people, called a 
Research Ethics Committee, to protect your interests. This study has been reviewed and given 
a favorable opinion by the Hertfordshire University Ethics Committee. The study design and 
suitability has been discussed with Dr. Michael Roberts and Dr. Justin Roberts. 
 
Who can I contact if I have any questions? 
 
 If you would like further information or would like to discuss any details personally, 
please get in touch with me, in writing, by phone or by email: 
 
Principal Investigator: 
 
Tony Dawkins 
52 Goldings Road, Loughton, Essex, IG10 2QN 
07906272430 
tonydawkins@hotmail.co.uk 
 
Although we hope it is not the case, if you have any complaints or concerns about 
any aspect of the way you have been approached or treated during the course of this 
study, please write to the University Secretary and Registrar. 
 
 
Thank you very much for reading this information and giving consideration to taking 
part in this study. 
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Appendix 2: Study 2 Participant Information Sheet for Control Group  
 
UNIVERSITY OF HERTFORDSHIRE 
 
ETHICS COMMITTEE FOR STUDIES INVOLVING THE USE OF HUMAN PARTICIPANTS 
(‘ETHICS COMMITTEE’) 
 
 
FORM EC6: PARTICIPANT INFORMATION SHEET 
 
 
 
Title of Research 
 
The Influence of Ultra-Endurance Exercise on the Cardiovascular and Related Physiological 
Systems. 
 
Introduction 
 
 You are being invited to take part in a research study.  Before you decide whether to 
do so, it is important that you understand the research that is being done and what your 
involvement will include.  Please take the time to read the following information carefully and 
discuss it with others if you wish.  Do not hesitate to ask us anything that is not clear or for any 
further information you would like to help you make your decision. Please do take your time to 
decide whether or not you wish to take part.  Thank you for reading this. 
 
What is the purpose of this study? 
 
 Participation trends in ultra-endurance events have increased several fold in the past 
decade. As such, there has been an increased interest in providing scientific research in the 
area. An important aspect of this research is the health benefits/disadvantages that occur as 
a consequence of participating in an extreme endurance event and also the accumulative 
effect of excessive training. In addition, limited research focuses on individuals who undertake 
longer distance events from a relatively 'novice' or 'recreational' background. The heart is of 
particular interest to healthcare practitioners due to the problems that are associated with 
pathological functioning and exercise such as exercise-induced sudden cardiac death.  
 Emerging data has suggested that excessive endurance training may induce 
pathologic structural remodelling of the heart and large arteries in a small subgroup of 
individuals (Mastaloudis et al., 2001). Epidemiological studies have identified an increased 
relative risk of cardiovascular disease, hypertension, and risk of death in those participating in 
the most aerobic exercise indicative of a detrimental, accumulative, effect of excess exercise 
over time (Quinn et al., 1990; Paffenbarger et al., 1986). However, it has been suggested that 
these responses may in fact be mitigated in ultra-endurance athletes as a result of exercise-
induced adaptations (Knez et al., 2006). This statement is supported by many studies 
presenting a transient cardiovascular dysfunction post ultra-endurance exercise, however, 
Neilan, et al. (2006) recently found a more prolonged dysfunction in a small number of 
subjects. 
 The aim of the forthcoming study will be to investigate the cardiovascular and cardiac-
related response to completing an ironman distance triathlon; including the short-term and 
more long-term consequences. You are asked to take part in this study to act as part of the 
control population, you will not be required to complete an ultra-endurance event.  
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Aims of project 
The key aims of the project include: 
4. To investigate the effects of prolonged endurance exercise on cardiovascular and 
cardiac-related variables in multiple subgroups. 
5. To investigate the effects of dietary intake and prolonged endurance exercise on 
cardiovascular and cardiac-related variables. 
6. To investigate the relationship between various diagnostic biomarkers and 
cardiovascular/cardiac-related variables over a period of prolonged endurance 
exercise. 
 
Do I have to take part? 
 
 It is completely up to you whether or not you decide to take part in this study.  If you 
do decide to take part you will be given this information sheet to keep and be asked to sign a 
consent form.  Agreeing to join the study does not mean that you have to complete it.  You 
are free to withdraw at any stage without giving a reason.  A decision to withdraw at any time, 
or a decision not to take part at all, will not affect the rest of the treatment/care that you receive. 
 
What will happen to me if I take part? 
 
If you decide to take part in this study you will be asked to: 
5. Attend the university of Hertfordshire 4 times over a 5 week period to carry out non-
invasive assessments of the cardiovascular system which includes the following 
measurements: 
 12 lead electrocardiogram (ECG)  
 Pulse wave analysis, using SphygmoCor 
 Pulse wave velocity, using SphygmoCor 
 
Measurements will be obtained at baseline, one week, two weeks and five weeks.  
 
Preparation 
 Please avoid alcoholic substances and caffeinated substances such as coffee/tea, 
chocolate and energy drinks 12 hours prior to your appointment. 
 Please refrain from exercising 12 hours prior to your appointment. 
 Provide the investigator with current medication and/or supplementation on each 
occasion. 
 
What is electrocardiography (ECG) and what is required of me? 
 ECG is a non-invasive procedure used to record the electrical activity of the heart over 
a short period of time.  
 
During the procedure  
 You will be asked to lie down and an investigator will clean several areas of your upper 
body. Small patches called electrodes will be attached to these areas which will be 
connected by cables to the ECG apparatus. 
 You are required to remain still during the procedure which should not take long. 
 When the procedure is finished the wires will be disconnected by the investigator and 
you will be free to remove the electrodes. 
 
What is SphycmaCor and what is required of me? 
 A SphygmaCor is a tool used to provide a comprehensive yet non-invasive 
assessment of the cardiovascular system. By recording various pulse waveforms and using 
Appendices 
158 
 
several equations the equipment is able to calculate various important cardiovascular 
parameters. 
 
Pulse Wave Analysis (PWA) 
Pulse waveforms are obtained through a measurement taken at the wrist. Central blood 
pressures among other parameters are then calculated using several carefully designed 
equations. 
 
During the procedure  
 Your peripheral blood pressure will be obtained prior to the 
procedure. A cuff will be placed around your arm which will 
inflate fairly quickly, then deflate at a slower rate. 
 You will be asked to sit with your arm resting on a stable 
surface with your palm facing upwards. 
 The investigator will place a tonometer (probe) over the 
lower part of your wrist until an acceptable 10 second 
reading has been obtained. 
 
Pulse Wave Velocity (PWV) 
PWV is used to estimate arterial stiffness by 
measuring the velocity of the blood pressure 
waveform between two superficial artery sites. 
Pulse waveforms are obtained through 
measurements taken at the carotid and femoral 
site. A 3 cable ECG will be recorded 
simultaneously to act as a timing reference.  
During the procedure  
 Your peripheral blood pressure will be 
obtained prior to the procedure. A cuff 
will be placed around your arm which will 
inflate fairly quickly, then deflate at a 
slower rate. 
 You will be asked to lie face up on a stable surface. 
 Three electrodes will be placed on your chest which will be connected by cables to the 
SphygmoCor equipment. 
 The investigator will place a tonometer (probe) over the carotid artery until an 
acceptable 11 second reading has been obtained. (See diagram above for site 
location.) 
 The investigator will place a tonometer (probe) over the femoral artery until an 
acceptable 11 second reading has been obtained. (See diagram above for site 
location.) 
 
In addition, template will be provided for you to keep a record of training sessions over the 
testing period. 
 
 
What are the possible disadvantages, risks or side effects of taking part? 
 
Electrocardiography (ECG) 
 Participants may be required to shave the chest area where electrodes are will be 
placed. You may experience slight discomfort upon removal of the electrodes. No electricity 
is sent through the body, so there is no risk of shock.  
 
 
 
 
Femoral Pulse 
 
Carotid Pulse Site 
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SphygmoCor 
 There should be no pain associated with the use of this equipment, if there is any 
discomfort please inform the investigator.  
 
What are the possible benefits of taking part? 
 
 All participants will benefit in terms of personal knowledge of the test data once 
analysed. Participants will be debriefed post study and if requested will receive feedback in 
terms of cardiovascular function. If necessary participants will be advised to take further 
action with their general practitioner. 
 
How will my taking part in this study be kept confidential? 
  
 The information that is obtained during the study will follow ethical and legal practice 
and handled in strict confidence. The information obtained, however, will be used for statistical 
analysis with your right to privacy retained. All information will be anonymised; that is, all 
figures and numbers will not be traceable to you and personal details will be removed. All data 
you provide will be stored on a password protected computer. 
 
What will happen to the results of the research study? 
 
 If you agree to take part, your results will be stored on a password protected computer 
and disk drive, with your name and other details removed. All paper data will be locked in a 
filing cabinet in a room which will be locked when it is not being occupied by a member of the 
research team at University of Hertfordshire. Hopefully, we expect that the data will be 
published in a scientific journal. On publication of results it will not be possible to identify 
individual participants and all personal data will be destroyed upon completion. 
 
Who has reviewed this study? 
 
 This research study has been reviewed by an independent group of people, called a 
Research Ethics Committee, to protect your interests. This study has been reviewed and given 
a favorable opinion by the Hertfordshire University Ethics Committee. The study design and 
suitability has been discussed with Dr. Michael Roberts and Dr. Justin Roberts. 
 
Who can I contact if I have any questions? 
 
 If you would like further information or would like to discuss any details personally, 
please get in touch with me, in writing, by phone or by email: 
 
Principal Investigator: 
 
Tony Dawkins 
52 Goldings Road, Loughton, Essex, IG10 2QN 
07906272430 
tonydawkins@hotmail.co.uk 
 
Although we hope it is not the case, if you have any complaints or concerns about 
any aspect of the way you have been approached or treated during the course of this 
study, please write to the University Secretary and Registrar. 
 
Thank you very much for reading this information and giving consideration to taking 
part in this study. 
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Appendix 3: Study 2 Consent Form 
 
 
 FORM EC3 
  
 
                                             University of Hertfordshire 
 
 
 CONSENT FORM FOR STUDIES INVOLVING HUMAN PARTICIPANTS 
 
  
I, the undersigned [please give your name here, in BLOCK CAPITALS] 
 
…………………………………………………………………………………………………………………………. 
of  [please give contact details here, sufficient to enable the investigator to get in touch with you, such as a postal  
or email address] 
 
…..…………………………………………………………………………………………………………………… .. 
hereby freely agree to take part in the study entitled : 
 
The Influence of Ultra-Endurance Exercise on the Cardiovascular and Related Physiological 
Systems. 
 
 
1  I confirm that I have been given a Participant Information Sheet (a copy of which is attached to this form) giving 
particulars of the study, including its aim(s), methods and design, the names and contact details of key people 
and, as appropriate, the risks and potential benefits, and any plans for follow-up studies that might involve further 
approaches to participants.  I have been given  details of my involvement in the study.  I have been told that in 
the event of any significant change to the aim(s) or design of the study I will be informed, and asked to renew my 
consent to participate in it.  
 
 
2  I have been assured that I may withdraw from the study at any time without disadvantage or having to give a 
reason. 
 
3  I have been given information about the risks of my suffering harm or adverse effects.   I have been told about 
the aftercare and support that will be offered to me in the event of this happening, and  I have been assured that 
all such aftercare or support  would be provided at no cost to myself.  
 
4  I have been told how information relating to me (data obtained in the course of  the study, and data provided 
by me about myself) will be handled: how it will be kept secure, who will have access to it, and how it will or may 
be used.   
 
5 I confirm that my questions regarding involvement with this study have been answered to my satisfaction. 
 
    
 
  
Signature of 
participant……………………………………………………………………………………Date…………………………. 
 
 
 
Signature of (principal) investigator……………………………………………………… Date………………………… 
 
Name of (principal) investigator [in BLOCK CAPITALS please] 
………………………………………………………………………………………………………………………………... 
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Appendix 4: Flow Diagram of Study 1 Method 
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Appendix 5: Study 1 Descriptive Data 
Part 1 
 
Descriptive statistics of physiological data over 6 month period of a progressive training programme, mean ± 
SD. 
Measurement Age Category Month 0 Month 2 Month 4 Month 6 
Relative V̊O2max 
(ml·kg-1·min-1) 
18 to 32 
33 to 38 
39 to 50 
Total (n = 55) 
 
49.7 ± 6.2 
46.9 ± 6.0 
43.4 ± 4.7 
46.6 ± 6.1 
52.6 ± 6.7 
50.4 ± 5.9 
47.7 ± 4.8 
a 50.1 ± 6.1 
53.4 ± 5.2 
50.4 ± 6.2 
49.0 ± 5.7 
a 50.9 ± 5.9 
54.6 ± 6.1 
52.0 ± 5.6 
49.6 ± 4.4 
a 52.0 ± 5.6 
Absolute V̊O2max 
(L·min-1) 
18 to 32 
33 to 38 
39 to 50 
Total (n = 55) 
 
3.666 ± 0.399 
3.855 ± 0.523 
3.529 ± 0.403 
3.676 ± 0.454 
3.867 ± 0.487 
4.103 ± 0.575 
3.885 ± 0.579 
a 3.946 ± 0.549 
3.928 ± 0.467 
4.077 ± 0.512 
3.998 ± 0.550 
a  3.999 ± 0.506 
3.981 ± 0.411 
4.173 ± 0.431 
3.968 ± 0.530 
a 4.035 ± 0.464 
Maximal Heart Rate 
(beats·min-1) 
18 to 32 
33 to 38 
39 to 50 
Total (n = 55) 
 
189 ± 9 
182 ± 6 
181 ± 9 
184 ± 9 
187 ± 10 
182 ± 6 
180 ± 8 
183 ± 9 
187 ± 9 
180 ± 7 
179 ± 9 
a 182 ± 9 
187 ± 10 
181 ± 9 
178 ± 8 
182 ± 9 
Max Power (Watts) 18 to 32 
33 to 38 
39 to 50 
Total (n = 55) 
 
275 ± 35 
279 ± 33 
270 ± 40 
274 ± 36 
284 ± 29 
299 ± 34 
286 ± 48 
a 289 ± 38 
295 ± 32 
309 ± 36 
294 ± 44 
a b 299 ± 38 
299 ± 33 
318 ± 34 
303 ± 41 
a b c 306 ± 37 
Body Fat (%) 18 to 32 
33 to 38 
39 to 50 
Total (n = 55) 
 
16.5 ± 4.9 
18.3 ± 5.9 
20.7 ± 5.6 
18.6 ± 5.7 
15.9 ± 5.1 
17.3 ± 5.3 
19.6 ± 5.3 
17.7 ± 5.3 
15.4 ± 4.5 
16.7 ± 5.4 
18.8 ± 5.1 
17.1 ± 5.1 
14.9 ± 5.0 
15.8 ± 5.8 
17.8 ± 5.1 
16.3 ± 5.4 
Weight 18 to 32 
33 to 38 
39 to 50 
Total (n = 55) 
 
73.9 ± 7.4 
82.4 ± 9 
81.9 ± 11.6 
79.4 ± 10.2 
 
74.1 ± 7.3 
 81.5 ± 8.4 
81.6 ± 11.7 
79.1 ± 9.9 
74.1 ± 7.1 
81.5 ± 8.3 
80.6 ± 11.6 
78.8 ± 9.7 
73.5 ± 7.3 
80.3 ± 7.7 
80.3 ± 11.4 
78.1 ± 9.5 
V̊O2max = maximal volume of oxygen consumption 
Age category, 18 to 32 (n = 18); 33 to 38 (n = 17); 39 to 50 (n = 20). a significantly different form month 0, p < 0.05; b 
significantly different from month 2, p < 0.05; c significantly different from month 4, p < 0.05. 
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Part 2 
 
Quartile representation of 12-lead ECG variables over the course of a 6 month incremental training 
programme with Friedman test significance and rank (n = 50). 
ECG variable  Time-point Median (IQR) Rank 
 
Resting Heart Rate (beats·min-1) 
 
Month 0 
Month 2 
Month 4 
Month 6 
 
59 (52 to 65) 
a 56 (48 to 61) 
a 53 (47 to 61) 
a 50 (47 to 58) 
 
3.21 
2.41 
2.34 
2.04 
 
QRS Complex Axis 
(°) 
 
Month 0 
Month 2 
Month 4 
Month 6 
52 (44 to 62) 
52 (35 to 65) 
53 (40 to 61) 
55 (42 to 62) 
 
2.58 
2.36 
2.27 
2.79 
P Wave Axis 
(°) 
Month 0 
Month 2 
Month 4 
Month 6 
76 (54 to 84) 
72 (59 to 84) 
76 (60 to 84) 
75 (61 to 87) 
2.48 
2.32 
2.56 
2.64 
T Wave Axis 
(°) Month 0 
Month 2 
Month 4 
Month 6 
61 (46 to 70) 
58 (42 to 69) 
56 (41 to 70) 
59 (45 to 74) 
2.60 
2.48 
2.34 
2.58 
 
QTc Interval 
(ms) 
 
Month 0 
Month 2 
Month 4 
Month 6 
 
409 (393 to 424) 
422 (404 to 444) 
b 404 (388 to 420) 
b 402 (384 to 418) 
 
2.63 
3.16 
2.28 
1.93 
 
QTc dispersion 
(ms) 
 
Month 0 
Month 2 
Month 4 
Month 6 
 
32 (26 to 44) 
31 (26 to 43) 
30 (20 to 44) 
32 (25 to 43) 
 
2.46 
2.64 
2.36 
2.54 
 
QRS Interval 
(ms) 
 
Month 0 
Month 2 
Month 4 
Month 6 
 
102 (98 to 106) 
101 (96 to 105) 
102 (97 to 106) 
103 (98 to 105) 
 
2.46 
2.31 
2.43 
2.80 
QTc = QT interval corrected for a heart rate of 60 beats·min-1. Significance level set to 0.008 after Bonferroni 
adjustment for multiple comparisons (0.05/6). 
 a significantly different from month 0, p < 0.008; b significantly different from month 2, p < 0.008. 
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Appendix 6: Study 2 Supplementation Information 
Daily supplementation was provided by Biocare LTD for study 2 (chapter six). Ingredients for each 
supplement are listed below, whilst nutritional information regarding each supplement is provided 
below. 
 An adult multinutrient – Adult multivitamin and minerals formula (Biocare Ltd., UK) - 1 capsule 
per day (containing a broad spectrum multinutrient with high bioavailability, taken with 
breakfast). 
 An essential fatty acid formula – Mega EPA (Biocare Ltd., UK) – 2 capsules per day containing 
a total of 524mg of eicosapentaenoic acid (EPA) and 375mg of docosahexaenoic acid (DHA), 
taken with meals. 
 An antioxidant formula – Antioxidant Complex (Biocare Ltd., UK) – 1 capsule per day 
containing 150mg quercitin, 50mg turmeric extract, 15mg lycopene powder, 15mg of green 
tea extract, 15mg of grapeseed extract and 8mg lutein powder, taken with meals. 
 A probiotic formula – Bio-acidophillus (Biocare Ltd., UK) – 2 capsules per day containing a total 
of 80mg.d-1 lactobacillus acidophilus. Taken with food in the afternoon/ evening.  
 
Phase 3 supplementation information for individual products supplemented daily 12 weeks prior 
to iron-distance triathlon. 
Adult Multivitamin and Minerals Formula 
Ingredient 
 
Amount per Capsule 
 
Vitamin C 240.9mg 
Pantothenic Acid (Vitamin B5) 100mg 
Niacin (Vitamin B3) 50mg NE 
Vitamin E 75iu natural source 50mg 
Thiamine (Vitamin B1) 25mg 
Riboflavin (Vitamin B2) 25mg 
Vitamin B6 (Cobalamin) 25mg 
Magnesium 22mg 
Inositol 12mg 
P.A.B.A. (para amino benzoic acid) 10mg 
Potassium 8.9mg 
Zinc 8.5mg 
Calcium 6mg 
Vitamin A 600mcg RAE 
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Folic Acid 400mcg 
Manganese 300mcg 
Molybdenum 98.7mcg 
Selenium 50mcg 
Chromium 50mcg 
Iodine 37.8mcg 
Biotin 35mcg 
Cobalamin (vitamin B12) 30mcg 
Ergocalciferol (vitamin D2) 
 
6.25mcg 
 
Antioxidant Complex 
Quercetin 150mg 
Turmeric Extract 50mg 
Lycopene Powder 15mg 
Green Tea Extract (Camellia sinensis) 15mg 
Grapeseed Extract (Vitaflavan®) 15mg 
Lutein Powder 
 
8mg 
 
Mega EPA 
Fish Oil Concentrate 
Of which EPA 
Of which DHA 
2333mg 
524mg 
375mg 
Natural Mixed Tocopherols 10mg 
Bioacidophilus (Probiotic Formula) 
Fructooligosacharrides 200mg 
Lactobacillus acidophilus 80mg 
Bifidobacterium bifidum & 
Bifidobacterium lactis 
 12mg 
 
B Vitamin Complex 
Thiamine (vitamin B1) 50mg 
Riboflavin (vitamin B2) 50mg 
Niacin (Vitamin B3) 50mg 
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Pantothenic Acid (vitamin B5) 50mg 
Folic acid (vitamin B6) 50mg 
Vitamin C 40mg 
Choline 30mg 
Inositol 30mg 
L-Glycine 30mg 
P.A.B.A (para amino benzoic acid) 30mg 
Magnesium 9.5mg 
Folic Acid 400mcg 
Biotin 200mcg 
Cobalamin (vitamin B12) 50mcg 
NE = niacin equivalent, iu = international units, RAE = retinol activity equivalent, EPA = 
eicosapentaenoic acid, DHA = docosahexaenoic acid. 
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Appendix 7: Flow Diagram of Study 2 Method 
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Appendix 8: Genova Optimal Nutrition Evaluation Details 
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Appendix 9: Study 2 Descriptive Data 
Table. Descriptive statistics of participant characteristics and cardiovascular measurements of triathletes and 
recreationally active participants. 
  Triathletes Recreationally 
Active 
Measurement Time-Point NS 
(n = 6) 
S 
(n = 5) 
Overall  
(n = 11) 
NOTRI 
n = 10 
PWV T1 – 7d Pre 
T2 – 12-18h Post 
T3 – 7d Post 
T4 – 28d Post 
 
5.9 ± 0.6 
6.2 ± 0.3 
6.1 ± 0.7 
6.0 ± 0.6 
6.0 ± 0.6 
6.1 ± 0.6 
6.4 ± 0.8 
6.1 ± 0.6 
5.9 ± 0.6 
6.1 ± 0.4 
6.3 ± 0.7 
6.1 ± 0.6 
5.6 ± 0.8 
5.5 ± 0.6 
5.6 ± 0.6 
5.8 ± 0.8 
 
Aix T1 – 7d Pre 
T2 – 12-18h Post 
T3 – 7d Post 
T4 – 28d Post 
 
11.7 ± 14.3 
11.0 ± 9.8 
3.3 ± 15.1 
9.3 ± 12.5 
18.2 ± 9.1 
7.0 ± 9.7 
9.4 ± 9.8 
13.4 ± 6.7 
14.6 ± 12.1 
9.2 ± 9.5 
6.1 ± 12.7 
11.2 ± 10.0 
10.0 ± 10.4 
12.7 ± 7.6 
7.9 ± 7.9 
12.2 ± 8.2 
Aix@HR75 T1 – 7d Pre 
T2 – 12-18h Post 
T3 – 7d Post 
T4 – 28d Post 
 
2.8 ± 12.8 
5.8 ± 8.6 
0.8 ± 13.5 
3.3 ± 12.7 
8.8 ± 7.1 
6.8 ± 4.9 
2.6 ± 5.7 
4.4 ± 6.1 
5.5 ± 10.5 
6.3 ± 6.9 
1.6 ± 10.3 
3.8 ± 9.8  
5.5 ± 9.8 
5.8 ± 7.6 
2.9 ± 8.1 
5.4 ± 6.9 
Resting HR T1 – 7d Pre 
T2 – 12-18h Post 
T3 – 7d Post 
T4 – 28d Post 
 
55 ± 6 
64 ± 5 
67 ± 5 
61 ± 10 
55 ± 9 
74 ± 11 
61 ± 10 
56 ± 6 
56 ± 7 
69 ± 9 
65± 8 
58 ± 9 
63 ± 13 
56 ± 11 
60 ± 8 
61 ± 10 
aSBP (mmHg) T1 – 7d Pre 
T2 – 12-18h Post 
T3 – 7d Post 
T4 – 28d Post 
 
110 ± 12 
105 ± 6 
106 ± 10 
101 ± 10 
108 ± 12 
100 ± 10 
110 ± 11 
107 ± 9 
109 ± 12 
103 ± 8 
108 ± 10 
103 ± 9 
103 ± 11 
103 ± 11 
102 ± 8 
101 ± 7 
aDBP (mmHg) T1 – 7d Pre 
T2 – 12-18h Post 
T3 – 7d Post 
T4 – 28d Post 
 
72 ± 4 
73 ±7 
75 ± 6 
69 ± 9 
74 ±8  
67 ± 6 
73 ± 5 
71 ± 5 
73 ± 6 
70 ± 7  
74 ± 6 
70 ± 7 
70 ± 11 
67 ± 11 
67 ± 9 
67 ± 8 
pSBP (mmHg) 1 – 7d Pre 
2 – 18h Post 
3 – 7d Post 
4 – 28d Post 
 
124 ± 6 
122 ± 9 
124 ± 9 
16 ± 8 
120 ± 11 
117 ± 9 
121 ± 6 
120 ± 6 
122 ± 8 
119 ± 9 
122 ± 8 
118 ± 7 
119 ± 11 
119 ± 11 
119 ± 8 
118 ± 8 
pDBP (mmHg) 1 – 7d Pre 
2 – 18h Post 
3 – 7d Post 
4 – 28d Post 
 
71 ± 5 
72 ± 7 
73 ± 6 
68 ± 9 
73 ± 7 
65 ± 6 
73 ± 5 
66 ± 9 
 
72 ± 6 
69 ± 7 
73 ± 5 
69 ± 7 
69 ± 10  
66 ± 11 
66 ± 9 
66 ± 8 
LVED (ms) T1 – 7d Pre 
T2 – 12-18h Post 
T3 – 7d Post 
T4 – 28d Post 
 
322 ± 15 
309 ± 18 
291 ± 22 
304 ± 19 
 
308 ± 24 
284 ± 16 
287 ± 10 
301 ± 23 
316 ±  20 
298 ± 21 
290 ± 17 
302 ± 20 
301 ± 21 
311 ± 21 
306 ± 17 
293 ± 21 
Weight (kg) 1 – 7d Pre 
2 – 18h Post 
3 – 7d Post 
4 – 28d Post 
 
70.8 ± 10.6 
70.7 ± 10.6 
70.0 ± 10.6 
70.5 ± 10.1 
 
77.6 ± 9.6 
77.0 ± 9.9 
77.0 ± 9.4 
78.0 ± 10.0 
73.9 ± 10.3 
73.5 ± 10.3 
73.2 ± 10.2 
73.9 ± 10.3 
72.7 ± 5.6 
72.9 ± 5.5 
73.1 ± 5.7 
72.0 ± 5.6 
NS = non-supplementation group; S = supplementation group; aSBP = aortic systolic blood pressure; aDBP = aortic diastolic 
blood pressure; pSBP = peripheral systolic blood pressure; pDBP = peripheral diastolic blood pressure; LVED = left ventricular 
ejection duration.  
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Appendix 10: Demonstration of SphygmoCor Equipment in Use  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The SphygmoCor equipment 
being used during the pulse wave 
analysis (PWA) protocol with the 
participants radial artery of the 
left arm. 
Partial occlusion of the carotid artery (site A) 
with the tonometer, attached to the 
SphygmoCor equipment, during the pulse wave 
velocity (PWV) procedure.  
 
 Subsequent measurement of the femoral artery 
(site B) would be conducted once appropriate 
site A recordings are obtained. 
Electrode set up for electrocardiography (ECG) during pulse 
wave velocity (PWV) measurement. 
 
Electrodes were positioned on the suprasternal notch, the 
xiphoid process and the lower left side of the abdominal 
trunk according to the SphygmoCor manual. 
 
R wave of ECG used as a timing reference for the calculation of 
PWV since carotid and femoral pressure pulse waves cannot be 
obtained simultaneously with this procedure.     
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Appendix 11: Demonstration of pulse wave velocity output from SphygmoCor  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Example of pulse wave velocity (PWV) output screen from SphygmoCor apparatus. 
PWV assessed via the foot-to-foot method. Sequential measurements obtained at the common carotid and femoral 
artery with simultaneous 3-cable ECG for timing reference (located below both carotid and femoral pulse waves). 
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Appendix 12: Demonstration of pulse wave analysis output from SphygmoCor  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aortic augmentation 
index (Aix) = 
AP 
PP 
Example of pulse wave analysis (PWA) output screen from SphygmoCor apparatus, displaying 
aortic augmentation index (Aix), Aix corrected for a heart rate of 75 beats·min-1, aortic systolic 
and diastolic blood pressure and ejection duration. 
Measurements obtained via applanation tonometry from the right radial artery. The inbuilt generalised transfer 
function was utilised to produce aortic values from peripheral measurements. 
 
 
